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ABSTRACT 
Ischemic stroke is one of the leading causes of long-term disability and death worldwide. 
Despite the importance of medical treatment, the underlying molecular mechanisms are not 
fully understood. A critical factor of ischemic stroke is hypoxia, leading to hypoxia-induced 
spreading depression (HSD) in the affected brain tissue. HSD is characterized by strong cell 
depolarization and disrupted ion homeostasis, which shuts down neuronal function and can 
cause severe cell damage. Importantly, two DLG-MAGUKs (Discs large membrane-associated 
guanylate kinases), namely PSD-95 and PSD-93, have been implicated in NMDA receptor 
(NMDAR)-mediated excitotoxicity processes contributing to stroke pathology. Both proteins 
are important players in the core organization of the postsynaptic density and exhibit opposing 
roles in experience-dependent synapse maturation during early development and in synaptic 
plasticity in the adult brain. The present study aimed at further investigating the role of PSD-95 
and PSD-93 in synaptic transmission and excitotoxicity processes using a model of transient 
hypoxia in acute hippocampal slices of adult PSD-95 knockout (KO), PSD-93 KO and PSD-
93/95 double knockout (DKO) mice.  
The strength of basal synaptic transmission was substantially reduced in PSD-95 KO and 
PSD-93/95 DKO, but not in PSD-93 KO mice. Diminished synaptic function of PSD-95 KO 
mice is consistent with the previous finding that they maintain high levels of silent synapses 
into adulthood. Silent synapses lack functional AMPARs and therefore do not transmit at 
resting potential. Normally, such silent synapses undergo experience-dependent maturation 
into AMPAR-transmitting synapses during early development, thereby consolidating pre-
existing wiring patterns. In contrast to PSD-95 KO, silent synapses in PSD-93 KO mice mature 
faster during development than in wildtype (WT) mice. Despite silent synapse number in 
younger DKO mice has been reported to be unchanged, the present results strongly indicate 
impaired excitatory transmission in adult DKO mice.  
Differential effects of MAGUK KO were further seen in HSD. Importantly, the absence of PSD-
95 provided protection against hypoxia-induced metabolic compromise of neuronal function. 
Indeed, PSD-95 KO mice exhibited reduced HSD effects as demonstrated by multiple 
parameters including delayed onset of HSD, attenuated change of intrinsic optical signals and 
improved recovery of synaptic function. By contrast, single KO of PSD-93 had no effect on the 
susceptibility to hypoxia. Interestingly, the protective effects in PSD-95 KO mice were 
consistently abolished by additional KO of PSD-93, except for improved synaptic recovery. 
Given its interaction with NMDARs, PSD-95 might couple the massive hypoxia-induced 
calcium influx to downstream signaling cascades involved in excitotoxicity processes such as 
toxic nitric oxide production. Toxic signal transduction mainly occurs at extrasynaptic sites 
involving GluN2B-containing NMDARs. Notably, further biochemical analysis of brain 
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homogenates revealed an impaired switch from GluN2B- to GluN2A-NMDARs in PSD-95 KO 
mice, which normally occurs at synaptic sites during early development. Thus, silent synapses 
might mainly contain synaptic GluN2B-NMDARs, rather than extrasynaptic ones mediating 
excitotoxicity, therefore providing protection. Another important aspect of high silent synapse 
levels in PSD-95 KO mice is the increased potential for synaptic plasticity, maintaining the 
brain in a partly premature state. Since stroke is highly influenced by aging, which is 
associated with low silent synapse levels, increased levels of silent synapses may represent 
an important substrate for the reduced hypoxia-susceptibility in PSD-95 KO mice. Silent 
synapses provide opportunities of reorganization and refinement of neuronal networks and 
might therefore be particularly beneficial for synaptic recovery, which is consistent with the 
improved recovery in the absence of PSD-95.  
Taken together, my data reveals that the KO of PSD-95 provides protection against hypoxia, 
which is likely due to high levels of silent synapses. 
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1. INTRODUCTION 
1.1. Neuronal network 
The central nervous system (CNS) mediates all our thoughts, emotion and behavior. As 
diverse the neuronal network is, so various are impairments, dysfunctions and diseases 
occurring on the neuronal level, which we are trying to understand and in the best case, 
prevent or cure. To enable appropriate research aiming in improving medical development, we 
have to investigate and understand the molecular processes underlying neuronal function. 
These processes occur in the neurons themselves, in their interaction with surrounding glial 
cells and in specialized structures called synapses. Synapses are the pivotal spots where two 
neurons come close enough to each other so that they are able to communicate. In a mature 
network composed of various interconnected neurons, information is transferred via electrical 
signals passing through the presynaptic neuron towards the synaptic cleft, where information 
is transmitted to the postsynapse. In the case of excitatory synapses, the postsynaptic density 
(PSD), which contains neurotransmitter receptors and an elaborate complex of other proteins, 
is receiving the signals in order to transfer and react to incoming information. This study 
addresses specific PSD-located proteins which are thought to execute a crucial role in 
synaptic plasticity – the basis of learning and memory – and have further been implicated in 
mechanisms of neuronal disorders. 
1.2. Synaptic transmission 
Every neuron generates around 1000 synaptic connections to neighboring cells and receives 
about 10,000 or even more. In this huge network, information is propagated via action 
potentials. In general, synapses can be electrical or chemical. Electrical synapses directly 
transfer signals as ion currents across small gap junctions of ~3.5 nm width. In contrast, the 
presynaptic neuron of chemical synapses first converts electrical signals into neurotransmitter. 
These transmitters are released into the 20–40 nm wide synaptic cleft to mediate either 
excitatory or inhibitory actions in the postsynaptic cell. Specifically, when an action potential 
reaches the presynaptic axon terminal, voltage-gated calcium (Ca2+) channels open, resulting 
in high Ca2+ influx into the so-called “active zone”. Subsequently, specialized vesicles fuse 
with the presynaptic membrane and release neurotransmitters into the synaptic cleft. These 
chemical messengers can diffuse through the cleft and bind to receptors on the postsynaptic 
membrane, causing ion channels to open and therefore modifying conductance and potential 
of the postsynaptic cell. Thereby, the chemical signal is re-converted into an electrical signal, 
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which induces an action potential in the postsynaptic neuron, if a distinct threshold is reached 
(Kandel et al., 2000). 
1.3. Types of neurotransmitter receptors 
Neurotransmitters can act via binding to either ionotropic or metabotropic receptors. Ionotropic 
receptors are also termed ligand-gated channels. These macromolecules are integral 
membrane proteins containing an extracellular domain forming the neurotransmitter binding 
pocket and a transmembrane domain which constitutes the ion channel. The channel opens 
upon conformational change caused by neurotransmitter binding. On the contrary, 
metabotropic receptors, such as serotonin or norepinephrine receptors in the cerebral cortex, 
are located distinctly from the ion channels they act on and therefore require another signaling 
machinery to transfer the incoming information. Specifically, the so-called G-protein-coupled 
receptors activate guanosine triphosphate (GTP)-binding proteins which often engage in a 
second messenger cascade triggering the production of cyclic adenosine monophosphate 
(cAMP). In case of receptor tyrosine kinases, the incoming signal is transferred via a protein 
phosphorylation cascade (Kandel et al., 2000). 
Depending on the ion channel type gated by the incoming neurotransmitter, the effect of a 
chemical synapse can be modulatory, inhibitory or excitatory. Modulatory transmitters, such as 
serotonin and dopamine, act via second messengers in order to modify the metabolism or 
membrane permeability of the postsynaptic neuron. In contrast, the neurotransmitters γ-
aminobutyric acid (GABA) and glycine typically affect inhibitory ionotropic receptors. 
Glutamate – the major excitatory transmitter in the CNS – primarily acts on receptors that 
produce excitation.  
Glutamate receptors (GluRs) conduct cations, mainly sodium (Na+) and potassium ions (K+), 
thereby provoking depolarization of the postsynaptic cell. Specifically, the activated 
presynapse releases glutamate with a certain probability (Pr, release probability) into the 
synaptic cleft. Subsequent binding of glutamate to postsynaptic GluRs leads to Na+ influx 
which in turn generates a depolarizing excitatory postsynaptic current (EPSC). If the 
membrane potential reaches a certain threshold, an action potential is evoked at the axon 
hillock, which travels along the axon and reaches the presynaptic terminals, where it again 
triggers neurotransmitter release. On the contrary, inhibitory neurotransmitters mainly affect 
channels permeable to chloride ions (Cl-), thereby hyperpolarizing the postsynaptic membrane 
which leads to reduced probability of action potential firing.  
Regarding one single neuron, the convergence of many excitatory synaptic potentials from 
afferent neurons need to be integrated to reach the threshold for an action potential. This can 
be countervailed by inhibitory inputs, preventing the membrane potential from reaching 
threshold (Kandel et al., 2000). 
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1.3.1. Glutamate receptors at excitatory synapses 
Glutamate is the major excitatory neurotransmitter in the brain and can activate both 
metabotropic and ionotropic receptors. Metabotropic GluRs (mGluRs) are G-protein coupled 
receptors mediating relatively slow or modulatory responses to glutamate through intracellular 
signaling of second messenger cascades (Conn & Pin, 1997). On the other hand, ionotropic 
GluRs (iGluRs) – which will play an important role in this study – mediate rather fast synaptic 
transmission. They consist of three major groups, i.e. AMPA, NMDA and kainate receptors, 
named according to the synthetic agonist that preferentially stimulates them (Nicoll et al., 
1990). 
1.3.1.1. AMPA receptors 
α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic receptors (AMPARs) are the predominant 
fast signaling element at synapses and play a key role in the expression of plasticity (Traynelis 
et al., 2010). The rapid kinetics of AMPARs enable fast depolarization of the postsynaptic 
neuron and thus high-fidelity transfer of information. During synaptic plasticity, AMPARs can 
change in their number by lateral diffusion, endocytosis or exocytosis; interact with different 
binding partners or vary in their phosphorylation state and subunit composition (Malinow & 
Malenka, 2002; Bredt & Nicoll, 2003; Shepherd & Huganir, 2007). 
Functional AMPARs are homo- or heterotetramers composed of four core subunits GluA1–A4, 
with each of them having distinct influence on AMPAR trafficking properties, channel kinetics 
and ion selectivity (Wisden & Seeburg, 1993; Hollmann & Heinemann, 1994). Thus, 
heteromerization produces high diversity in AMPAR function.  
The most prominent example is the impact exerted by presence or absence of the subunit 
GluA2 in the receptor signaling machinery. The majority of AMPARs are GluA2-containing 
heteromers which are impermeable to Ca2+. In contrast, GluA2-lacking AMPARs also conduct 
Ca2+ and are therefore supposed to play important roles in the activation of downstream 
signaling cascades, eventually affecting postsynaptic mechanisms like synaptic plasticity and 
disease-related neuronal changes (Dingledine et al., 1999; Burnashev & Rozov, 2000; Cull-
Candy et al., 2006; Lüscher & Malenka, 2011). 
The subunit composition varies among brain regions and developmental stages. Whereas 
GluA4-containing AMPARs are found in immature hippocampal neurons, they are getting 
progressively replaced by GluA2-containing AMPARs during development (Zhu et al., 2000). 
In mature hippocampus and cortex, the predominant AMPARs are GluA1/A2 and to a lesser 
extent GluA2/A3 heterodimers (Wenthold et al., 1996; Lu et al., 2009). While each subunit 
possesses one binding site for the neurotransmitter glutamate, the channel only opens if two 
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glutamate molecules are bound to the receptor complex, resulting in cation flow in respect to 
their electrochemical gradient (Clements et al., 1997; Rosenmund et al., 1998).  
1.3.1.2. NMDA receptors 
Similar to AMPARs, N-methyl-D-aspartate receptors (NMDARs) are tetrameric receptor 
complexes. They are assembled out of seven subunits, namely GluN1, GluN2A–D, GluN3A 
and GluN3B (also referred to as NR1, NR2A–D, NR3A and NR3B), which form di- or 
triheteromers. Each receptor consists of two obligatory GluN1 subunits with either two GluN2 
or a mixture of GluN2 with GluN3 subunits (Monyer et al., 1992; Schorge & Colquhoun, 2003; 
Ulbrich & Isacoff, 2007).  The immense diversity of subunit composition generates NMDARs 
with distinct pharmacological properties and biological functions (Vicini et al., 1998). They are 
involved in various neuronal processes, such as synaptic potentiation and depression, cell 
survival and trauma resistance, but also in neuronal cell death (Cull-Candy & Leszkiewicz, 
2004; Papadia & Hardingham, 2007). 
NMDARs require two co-agonists for activation and certain electrophysiological 
circumstances. While glutamate binds to GluN2 subunits, GluN1 contains a binding site for 
glycine (Benveniste & Mayer, 1991; Clements & Westbrook, 1991). Moreover, NMDARs are 
coupled to voltage-sensitive conductance: at resting membrane potential (-60 to -70 mV) the 
cation channel is blocked by an extracellular magnesium ion (Mg2+), which will only be 
released upon membrane depolarization (Mayer et al., 1984; Nowak et al., 1984). Opening of 
the pore primarily allows influx of Ca2+, but as well influx of Na+ and efflux of K+ ions, according 
to their respective electrochemical gradient. Ca2+ influx into the postsynapse can affect diverse 
downstream signaling cascades, e.g., mediating synaptic plasticity or cell fate  (Bliss & 
Collingridge, 1993; Kessels & Malinow, 2009). 
NMDARs are incorporated into glutamatergic synapses early in development. However, their 
subunit composition changes during activity- and experience-dependent critical periods, which 
is accompanied by alterations in receptor kinetics and synaptic localization (Hadzic et al., 
2017). At birth, the predominant subunit in the forebrain – apart from obligatory GluN1 – is 
GluN2B, while more GluN2A subunits are progressively incorporated during development, 
triggered by receptor activity and sensory input (Monyer et al., 1994; Sheng et al., 1994). 
NMDARs in the adult hippocampus and neocortex are mostly composed of GluN1/2A and to a 
lesser extent of GluN1/2B heteromers, having relatively high ion conductance and sensitivity 
to the Mg2+ block (Monyer et al., 1994; Sheng et al., 1994). The subunit GluN2C appears 
postnatally in the cerebellum, whereas GluN2D is found in the brain stem and diencephalon 
during embryonic and neonatal stages (Monyer et al., 1994; Goebel & Poosch, 1999). GluN3 
subunits are mainly present at late prenatal and early postnatal brain development (Sun et al., 
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1998). All three of them (GluN2C, GluN2D and GluN3) render the NMDAR complex less 
sensitive to Mg2+ blockage and less conductive (Pérez-Otaño & Ehlers, 2004; Pachernegg et 
al., 2012). 
1.3.1.3. Kainate receptors 
Kainate receptors (KARs) mediate synaptic transmission both pre- and postsynaptically and 
are ubiquitously expressed in the CNS (Petralia et al., 1994; Frerking & Nicoll, 2000; Gallyas 
et al., 2003). At the postsynapse, KARs modulate the membrane potential similar to NMDARs 
and AMPARs, whereas at the presynaptic level, they influence neurotransmitter release both 
at excitatory and inhibitory synapses (Kullmann, 2001; Lauri et al., 2001). KARs share several 
agonists and antagonists with AMPARs, therefore both receptors are collectively referred to as 
“non-NMDA receptors”. The issue of common binding partners hindered investigations on the 
physiological role of KARs for many years, lacking pharmacological tools selective for this 
receptor type (Lerma, 2003). 
It could be shown that, like the other iGluRs, KARs are formed by tetrameric assembly of 
receptor subunits around a central ion pore. They can build homo- or heteromers out of 
subunits GluR5–7, which eventually co-assemble with KA-1 and KA-2 subunits (Gallyas et al., 
2003; Lerma, 2003).  
KARs are implicated in synaptic plasticity (Bortolotto et al., 1999; Contractor et al., 2001) and 
furthermore linked to the generation of seizure activity (Mulle et al., 1998). 
1.3.2. GABA receptors at inhibitory synapses 
GABA is the major inhibitory neurotransmitter in the adult brain. It mainly acts through 
ionotropic GABA type A (GABAA) receptors and to a lesser extent via metabotropic GABA type 
B (GABAB) receptors. Together with the main excitatory neurotransmitter glutamate, GABA 
regulates the balance of neuronal excitation and inhibition, which is crucial for proper brain 
function (Wu & Sun, 2015). 
In the adult mammalian CNS, GABA predominantly interacts with postsynaptically located 
GABAA receptors. Upon GABA release from presynaptic vesicles and its binding to the 
receptor, the ion channel opens and mediates transient Cl- influx along the electrochemical 
gradient. This evokes a hyperpolarizing postsynaptic response – the inhibitory postsynaptic 
potential (IPSP) – which lowers the likelihood of action potential firing in the postsynaptic cell 
(Farrant & Nusser, 2005). Apart from this fast mechanism, also referred to as “phasic 
inhibition”, GABA can as well bind to high-affinity extrasynaptic receptors, resulting in a so-
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called persistent or “tonic” inhibition (Kaneda et al., 1995; Bai et al., 2001; Semyanov et al., 
2003; Farrant & Nusser, 2005). 
GABAA receptors are anion-specific channels and comprise a heterotetrameric structure. In 
the human brain, various subunits have been discovered, i.e., 6 α subunits, 3 β subunits, 3 γ 
subunits, 3 ρ subunits, and one ε, δ, ϕ and π subunit, respectively. GABAA receptors with 
unique subunit compositions are differentially expressed throughout the mature brain 
(Macdonald & Olsen, 1994; Blednov et al., 2014). While receptors which contain the subunits 
α1 and γ2 are localized at the postsynapse, the subunits α4–6 and δ were found peri- or 
extrasynaptically (Lee & Maguire, 2014; Wu & Sun, 2015). 
Interestingly, apart from their inhibitory function, GABAA receptors are implicated in excitatory 
synaptic transmission during early development, playing a fundamental role in early 
maturation of diverse brain structures (Sernagor et al., 2010; Wang & Kriegstein, 2011; Ben-
Ari et al., 2012). The depolarizing effect of GABAA receptors lies in the fact that immature 
neurons tend to accumulate Cl- in their intracellular space (via Na+-K+-2Cl- co-transporter). 
Hence, Cl- diffuses out of the postsynaptic cell upon GABAA receptor activation, resulting in 
membrane depolarization. In later developmental stages, neurons predominantly express a 
different co-transporter (K+-2Cl-), thereby reducing intracellular Cl- levels and shift GABAA 
function from mainly excitatory to inhibitory and hyperpolarizing in adolescent and adult brains 
(Ben-Ari et al., 2012; Deidda et al., 2015). 
1.4. Synaptic plasticity 
Synaptic plasticity is the ability of synapses to strengthen or weaken in response to changes in 
activity, thereby rendering them bidirectionally plastic. The mechanisms involved are diverse 
and can be located presynaptically, e.g. by alterations in neurotransmitter release, or 
postsynaptically by affecting the strength of the postsynaptic response. Synaptic plasticity is 
assumed to be the key mechanism for multiple brain functions like learning, memory formation 
and consolidation, as well as developmental network refinement (Katz & Shatz, 1996; Chater 
& Goda, 2014). 
1.4.1. Short-term plasticity 
Short-term forms of synaptic plasticity are generally mediated by lateral diffusion of AMPARs 
between synaptic and peri-synaptic regions due to high receptor mobility – with a diffusion 
speed depending on neuronal activity (Borgdorff & Choquet, 2002; Groc et al., 2004). Since 
AMPARs contain relatively low affinity for glutamate, they can only be effectively activated 
when located close or directly opposite to presynaptic sites of neurotransmitter release 
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(Lisman & Raghavachari, 2006). AMPAR surface mobility and their subsequent incorporation 
and retention at synaptic sites is affected by extracellular matrix components (Frischknecht et 
al., 2009; Szepesi et al., 2014), receptor endocytosis and recycling (Petrini et al., 2009). 
1.4.2. Long-term plasticity – LTP and LTD 
Long-term strengthening of synapses is referred to as long-term potentiation (LTP) and was 
first described by Bliss & Lomo in 1973. LTP can be viewed as a long-lasting increase of 
synaptic transmission in an activity-dependent manner and is considered to be the cellular 
correlate of learning and memory. The pivotal change during LTP is an increase in AMPAR 
number at the postsynapse. This can be induced by high frequency stimulation leading to 
AMPAR opening, Na+ influx and subsequent membrane depolarization, which activates 
NMDARs to allow Ca2+ influx. Ca2+ – as a second messenger – triggers downstream signaling 
cascades of phosphorylation events to potentiate synaptic transmission, involving transient 
activation of Ca2+/calmodulin-dependent protein kinase II (CaMKII) upon autophosphorylation 
(Barria et al., 1997; Mammen et al., 1997; Shen & Meyer, 1999; Lee et al., 2009).  
There is a distinct proportion of synapses which just contain NMDARs (and no AMPARs) and 
therefore do not conduct current at their resting state. These synapses are termed “silent 
synapses” and can incorporate functional AMPARs upon LTP induction by triggering rapid 
AMPAR trafficking (Isaac et al., 1995; Liao et al., 1995). The fast unsilencing during LTP is 
supposed to enable the neuronal network to quickly encode new memories in form of new 
patterns of functional connectivity (Chater & Goda, 2014). 
While LTP enhances synaptic strength, long-term depression (LTD) weakens the synaptic 
connection between two neurons. Typical LTD, as reported for the hippocampus (Dudek & 
Bear, 1992), relies on NMDAR-mediated Ca2+ influx and subsequent activation of high affinity 
Ca2+-sensors such as calcineurin (Mulkey & Malenka, 1992; Mulkey et al., 1994). In turn 
triggered downstream transduction pathways involve dephosphorylation events on target 
molecules like the AMPAR subunit GluA1, resulting in AMPAR removal via endocytosis or 
lateral diffusion and hence in decreased synaptic strength (Lee et al., 1998, 2000; Carroll et 
al., 1999; Beattie et al., 2000). 
Thus, both LTP and LTD are dependent on NMDAR activation and lead to altered number of 
synaptic AMPARs. The direction of plasticity is thought to be mostly guided by the spatio-
temporal characteristics of intracellular Ca2+ increase at the postsynapse, while detailed 
mechanisms underlying the linkage of NMDARs to signaling cascades related to LTP or LTD 
remain to be clarified (Chater & Goda, 2014). 
Introduction 
 
8 
 
1.4.3. Synaptic scaling 
Apart from the so far addressed input-specific “Hebbian” forms of synaptic plasticity (Brown et 
al., 1990) – LTP and LTD – neuronal networks also execute homeostatic plasticity. This is a 
form of plasticity referring to cell-autonomous reactions to changes in the overall level of 
network activity (Maffei & Fontanini, 2009; Vitureira et al., 2012). While LTP and LTD are 
limited to the stimulated synapse, homeostatic plasticity affects synaptic AMPAR number 
across the whole neuronal dendrite, thereby preserving relative strength differences between 
individual synapses (Turrigiano et al., 1998). This phenomenon is termed “synaptic scaling” as 
it scales up or down all of a neuron’s synaptic inputs. 
Homeostatic plasticity was first monitored by miniature EPSCs (mEPSCs, postsynaptic 
response to a spontaneously released synaptic vesicle) in 1998, when Turrigiano et al. 
showed that cortical culture neurons adjust their synaptic AMPAR levels in response to 
external changes in activity. Specifically, blocking of neuronal activity (e.g. via TTX incubation) 
caused scaling up by AMPAR accumulation at excitatory synapses, whereas the stimulation of 
neuronal networks (i.e., by blocking of inhibitory neurons via GABAA receptor antagonist 
bicuculline) evoked scaling down (Turrigiano et al., 1998). Interestingly, other studies revealed 
that chronic bicuculline-treatment of organotypic slice cultures increases excitatory synaptic 
transmission (Abegg et al., 2004; Krüger et al., 2013). Thus, the phenomenon of synaptic 
downscaling is not necessarily common. 
1.5. Role of PSD-95 and PSD-93 in neuronal function and 
plasticity 
1.5.1. MAGUKs at the postsynaptic density 
Excitatory glutamatergic synapses contain a prominent electron-dense region at the 
postsynaptic membrane opposite to the presynaptic terminal – the PSD. The PSD mainly 
consists of four major classes of components, which are (I.) plasma membrane proteins (e.g. 
GluRs) and specific cell adhesion molecules such as neuroligins (Kennedy, 1997, 2000), (II.) 
signaling proteins like CaMKII, SynGAP and the tyrosine kinases Src and Fyn (Kennedy et al., 
1983; Ellis et al., 1988; Chen et al., 1998; Kim et al., 1998), (III.) cytoskeletal proteins like actin 
(Kelly & Cotman, 1978), and (IV.) scaffolding proteins such as the disc-large (DLG) subfamily 
of membrane-associated guanylate kinases (MAGUKs) (Gomperts, 1996; Sheng & Kim, 
1996). Therefore, the PSD contains neurotransmitter receptors which are associated with 
signaling and scaffolding proteins to coordinate downstream signaling pathways in response 
to synaptic input. 
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DLG-MAGUKs play a pivotal role in organizing the PSD, mainly by affecting receptor 
clustering and function (Sheng & Kim, 1996; Ziff, 1997), and linking receptor activation to 
postsynaptic signal transduction machineries (Kennedy, 2000). Each family member 
possesses five protein-protein interaction domains (Cho et al., 1992). Specifically, three N-
terminal PSD-95/discs-large/zona occludens-1 (PDZ) domains are followed by one src-
homology-3 (SH3) domain and one guanylate kinase (GK) domain, which lacks enzymatic 
activity. The four DLG-MAGUK family members are: the postsynaptic density protein 95 (PSD-
95), PSD-93, synapse-associated protein 97 (SAP97) and SAP102. Apart from their common 
domain structure, the members feature distinct N-terminal motives which can mediate unique 
functions (Cho et al., 1992; Schlüter et al., 2006). 
The NMDAR subunits GluN2A and GluN2B are shown to directly interact with all DLG-
MAGUK family members via their intracellular C-terminal domain (Kornau et al., 1995; Lau et 
al., 1996; Niethammer et al., 1996). In contrast, only SAP97 can directly interact with AMPARs 
via the GluA1 subunit (Leonard et al., 1998; Cai et al., 2002). PSD-95, PSD-93 and SAP102 
are linked to AMPARs via transmembrane AMPAR regulatory proteins (TARPs), such as 
stargazin in case of PSD-95 (Fukata et al., 2005). DLG-MAGUKs are shown to mediate 
AMPAR trafficking at different developmental stages and exhibit a striking ability to functionally 
compensate for each other (Sans et al., 2000; Elias et al., 2006). 
1.5.2. Developmental profiles und functions of DLG-MAGUKs 
In the mammalian brain, DLG-MAGUKs show distinct expression patterns throughout neuronal 
development. SAP102 is highly expressed already at postnatal day 10 (P10), followed by 
gradually decreasing levels across development (Sans et al., 2000). This is consistent with the 
important role of SAP102 in immature synapses, primarily regulating NMDAR function and 
targeting AMPARs in early development (Elias et al., 2008; Chen et al., 2012; Bonnet et al., 
2013). Indeed, knockdown (KD) of SAP102 diminishes AMPAR-mediated transmission 
specifically at immature synapses (Elias et al., 2006). Furthermore, SAP102 has the ability to 
upregulate itself and thereby compensate for the loss of synaptic AMPARs caused by deletion 
of PSD-95 (Bonnet et al., 2013) or of both PSD-95 and PSD-93 (Elias et al., 2006). 
Accordingly, double knockout (DKO) of PSD-95 and SAP102 is lethal (Cuthbert et al., 2007).
  
Likewise, germline KO of the paralog SAP97 is lethal, mainly due to disturbed cell-cell contact 
formation throughout embryogenesis (Woods & Bryant, 1991; Caruana & Bernstein, 2001). In 
wildtype (WT) mice, about 50% of SAP97 levels are already observed at birth, reaching adult 
levels around P14 (Wang et al., 2006). During synaptogenesis, SAP97 overexpression in vivo 
increases AMPAR- as well as NMDAR-mediated currents, while conditional KD or 
overexpression of SAP97 in mature neurons has no effect on glutamatergic transmission or 
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neuronal plasticity (Schnell et al., 2002; Schlüter et al., 2006; Howard et al., 2010). 
Interestingly, similar to SAP102, the overexpression of SAP97 was reported to compensate for 
AMPAR trafficking deficits in mature PSD-93/95 DKO neurons (Howard et al., 2010). 
Nevertheless, the effects of SAP97 overexpression seem inconsistent when considering the 
enhanced surface AMPAR levels and mEPSC frequency observed in a different study using 
primary cortical cultures (Rumbaugh et al., 2003).  
In contrast to SAP102 and SAP97, PSD-95 and PSD-93 show very low expression levels at 
neonatal stages with a subsequent steep increase between ~P10–P35 as reported for 
hippocampus (Sans et al., 2000). Interestingly, studies on primary visual cortex (V1) showed a 
sharp increase directly after eye opening and in parallel to silent synapse maturation (D. 
Favaro et al., in press; Huang et al., 2015a). 
Collectively, the different developmental profiles likely suggest distinct functions of DLG-
MAGUK proteins depending on experience-dependent maturational states and of neuronal 
networks. Importantly, the expression levels of PSD-95 and PSD-93 indicate specific roles in 
neuronal network refinement throughout development. 
1.5.3. PSD-95 
PSD-95 exhibits particularly high abundance at the PSD of excitatory synapses and is the 
most extensively studied DLG-MAGUK family member (Cho et al., 1992; Kistner et al., 1993; 
Peng et al., 2004). Its predominant palmitoylated α-isoform was shown to regulate synaptic 
AMPAR number and thereby excitatory synaptic strength (Elias et al., 2006; Schlüter et al., 
2006). Specifically, the expression of PSD-95 is positively correlated with AMPAR-mediated 
EPSCs: While acute KD (Nakagawa et al., 2004; Elias et al., 2006; Schlüter et al., 2006) or 
genetic deletion of PSD-95 (Béïque et al., 2006; Carlisle et al., 2008) diminishes AMPAR-
mediated synaptic currents to ~50%, AMPAR-transmission is enhanced two- to threefold upon 
synaptic PSD-95 overexpression (Schnell et al., 2002; Ehrlich & Malinow, 2004; Nakagawa et 
al., 2004; Schlüter et al., 2006; Xu et al., 2008). This increase in AMPAR EPSCs is 
presumably caused by PSD-95-mediated trafficking of AMPARs to synaptic sites, which 
possibly results in augmented spine size and suggests a “slot” function of PSD-95 for synaptic 
AMPARs (Schnell et al., 2002; Ehrlich & Malinow, 2004). Furthermore, N-terminal di-/ 
multimerization of PSD-95 was found to be essential for its effect on basal AMPAR function 
(Xu et al., 2008).  
In contrast to the marked influence of PSD-95 on AMPARs, NMDAR-mediated EPSCs are 
largely unaffected by changes in PSD-95 expression (Migaud et al., 1998; Schnell et al., 2002; 
Ehrlich & Malinow, 2004; Nakagawa et al., 2004; Elias et al., 2006; Schlüter et al., 2006). 
However, PSD-95 is essential for the switch of GluN2B- to GluN2A-containing NMDARs 
during normal synaptic maturation (Elias et al., 2008). 
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Studies on the function of PSD-95 in synaptic plasticity revealed that LTP is enhanced and 
LTD absent upon PSD-95 KO (Migaud et al., 1998; Béïque et al., 2006; Carlisle et al., 2008). 
Concurrently, overexpression of PSD-95 occludes LTP and enhances LTD (Béïque & 
Andrade, 2003; Stein et al., 2003; Ehrlich & Malinow, 2004). These results seem surprising 
considering the slot theory of PSD-95 for synaptic AMPARs, which would have suggested 
exactly opposite effects of PSD-95 levels on LTP and LTD. To unravel this discrepancy, a 
study using molecular manipulations of PSD-95 provided evidence that the role of PSD-95 in 
controlling basal AMPAR strength on one side, and affecting LTD on the other, can be 
dissociated. Specifically, while PSD-95 serves as a structural scaffold protein for tethering 
AMPARs at synaptic sites during basal transmission, it operates as a signaling scaffold to 
connect NMDAR-dependent Ca2+ influx to downstream enzymatic machineries required for 
LTD generation (Xu et al., 2008). This theory is consistent with the reported direct interaction 
of PSD-95 PDZ-domains with NMDAR subunits (Kornau et al., 1995; Niethammer et al., 
1996), while not influencing NMDAR-mediated EPSCs. 
Comparable functions of PSD-95 are indicated for synaptic scaling. Indeed, it has been shown 
that PSD-95 levels do not directly determine quantal amplitude, but rather serve as a key 
synaptic organizer to mediate accumulation or reduction of synaptic AMPARs during 
homeostatic regulation of postsynaptic strength (Sun & Turrigiano, 2011). 
1.5.4. PSD-93 
In contrast to PSD-95, much less evidence is available on the synaptic function of PSD-93. 
Interestingly, conflicting results on PSD-93 function were gained in different brain regions and, 
to some extent, different developmental states:  
In the cerebellum, PSD-93 appears to have no effect on structure and function of Purkinje 
neurons (McGee et al., 2001; Liaw et al., 2008), whereas studies on forebrain cortex and 
spinal cord revealed impaired NMDAR-mediated EPSCs due to NMDAR surface reduction 
upon PSD-93 KO (Tao et al., 2003; Liaw et al., 2008). Consistent throughout these studies is 
unaltered AMPAR-mediated synaptic transmission. In the visual cortex, NMDAR-mediated 
EPSCs are unaffected upon PSD-93 KO during critical period, whereas AMPAR/NMDAR ratio 
is increased (critical period will be examined in detail in section 1.5.6) (D. Favaro et al., in 
press).   
On the contrary, acute KD and overexpression experiments in hippocampal cultures suggest 
that PSD-93 has PSD-95-like functions. According to Elias et al. (2006), RNA interference 
(RNAi)-mediated KD of PSD-93 in organotypic slice cultures reduces AMPAR-mediated 
transmission by ~50%, while overexpression of PSD-93 strongly enhances AMPAR function. 
In contrast, no influence on NMDAR-mediated EPSCs was observed. Partly opposing results 
were obtained by genetic KO of PSD-93, which revealed no impairments in basal AMPAR- (as 
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well as NMDAR-) mediated transmission in the hippocampus of young mice (Migaud et al., 
1998; Elias et al., 2006; Carlisle et al., 2008; Krüger et al., 2013). Notably, Krüger et al. (2013) 
additionally detected decreased AMPAR/NMDAR ratios in older hippocampal neurons (P60–
74 mice) and thereby a phenotype similar to KD of PSD-93 in organotypic cultures, which 
resulted in diminished AMPAR function (Elias et al., 2006).  
Collectively, these studies show that function of PSD-93 in basal synaptic transmission seems 
to be brain region-specific and besides that, PSD-93 may become more relevant to maintain 
the strength of glutamatergic synapses at later developmental states of hippocampal neurons. 
While basal NMDAR-mediated transmission consistently appears unaffected by PSD-93 levels 
in the hippocampus, PSD-93 deletion elevates the threshold for LTP induction, but has no 
influence on LTD (Carlisle et al., 2008) – therefore indicating an opposing role as compared to 
PSD-95 (Migaud et al., 1998; Béïque & Andrade, 2003). 
1.5.5. Double knockout of PSD-95 and PSD-93 
Mice lacking both PSD-95 and PSD93 display much stronger impairments than single KO 
mice. Besides smaller body size and low survival rate, DKO mice suffer from hypokinesia and 
gait abnormalities (Elias et al., 2006). Nevertheless, little is known so far about the underlying 
molecular mechanisms and how the absence of two dominant DLG-MAGUK proteins influence 
neuronal function. 
Elias et al. (2006) reported that simultaneous KO of PSD-95 and PSD93 results in impaired 
basal synaptic transmission in the hippocampus by reducing field excitatory postsynaptic 
potentials (fEPSPs) to 55% and AMPA/NMDAR ratio to ~50%. This observation is similar to 
the markedly diminished AMPAR EPSCs in PSD-95 KO mice and again highlights the crucial 
role of PSD-95 in basal synaptic transmission (Béïque et al., 2006; Carlisle et al., 2008). Some 
more information about synaptic function in DKO mice is provided with respect to silent 
synapses as addressed in the following paragraphs. 
1.5.6. Silent synapses 
Excitatory glutamatergic synapses typically contain both functional NMDARs and AMPARs at 
their postsynaptic site. By contrast, nascent or immature excitatory synapses exhibit reliable 
NMDAR-mediated synaptic transmission, but, either absent or highly labile AMPAR-mediated 
transmission (Isaac et al., 1995; Liao et al., 1995; Petralia et al., 1999). Therefore, these 
synapses are functionally dormant – or “silent” – at their resting state, owing to Mg2+-mediated 
blockage of NMDARs in the absence of sufficient postsynaptic membrane depolarization 
(Petralia et al., 1999; Kerchner & Nicoll, 2008). Following NMDAR activation, silent synapses 
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can mature (or become unsilenced) by incorporation of functional AMPARs, resulting in LTP of 
glutamatergic synaptic transmission (Liao et al., 1995; Durand et al., 1996; Isaac & Crair, 
1997; Itami et al., 2003).   
While silent synapses abundantly occur during early development and provide important 
substrates for experience-dependent plasticity, they are not normally enriched in the mature 
brain (Groc et al., 2006; Kerchner & Nicoll, 2008). Indeed, the typical window for silent 
synapse maturation is the critical period, referring to times of enhanced neuronal plasticity, in 
which experience-dependent cortical network refinement and consolidation of synaptic 
connections take place (Fagiolini & Hensch, 2000; Feldman, 2009; Espinosa & Stryker, 2012). 
As a result of their highly unstable and plastic nature, silent synapses may not only trigger the 
formation of new neuronal circuits, but as well the elimination of old neuronal connections due 
to synaptic pruning (Huang et al., 2015b) – always aiming at optimizing functional connectivity. 
Silent synapses can be indirectly detected via AMPAR-mediated mEPSC measurements: 
While mEPSC amplitude changes are considered to result from changes in AMPAR number or 
single-channel conductance, mEPSC frequency reflects either changes in presynaptic 
glutamate release or altered proportion of silent synapses (Béïque & Andrade, 2003). 
Additionally, the fraction of silent synapses can be directly determined using the so-called 
minimal stimulation assay (Liao et al., 1995). In this assay, failure rates of glutamatergic 
transmission near resting potential (e.g. -60 mV) and at depolarized states (e.g. +40 mV) are 
compared. In a neuronal connection with high fraction of silent synapses, the failure rate at 
+40 mV will be lower as compared to -60 mV since both AMPARs and NMDARs are 
transmitting, including AMPAR-silent synapses. 
Interestingly, both PSD-95 and PSD-93 have been linked to silent synapse maturation, but 
with opposing effects. It is reported that manipulations of PSD-95 levels affect mEPSC 
frequency, but not the amplitude, indicating selective changes in the number of AMPAR-
positive synapses, while normal glutamate release is preserved (Béïque & Andrade, 2003; 
Stein et al., 2003; Béïque et al., 2006; Carlisle et al., 2008). This phenomenon results from the 
ability of PSD-95 to trigger silent synapse maturation, presumably by AMPAR recruitment and 
stabilization, which leads to a higher number of transmitting synapses at resting potential and 
thus enhanced mEPSC frequency. Accordingly, deletion of PSD-95 causes diminished 
AMPAR mEPSC frequency and an increased proportion of silent synapses.  
Consistently, subsequent studies on diverse brain areas – namely, V1, medial prefrontal 
cortex (mPFC) and hippocampus – showed that PSD-95 KO mice preserve very high levels of 
~50% silent synapses into adulthood, whereas silent synapse fraction in WT mice is 
dramatically reduced upon early brain development (Huang et al., 2015; D. Favaro et al., in 
press). Furthermore, PSD-95-dependent maturation of silent synapses in V1 terminates the 
critical period for ocular dominance (OD) plasticity (Huang et al., 2015a). OD plasticity is a 
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widely used paradigm for experience-dependent cortical plasticity and has a critical period for 
mice lying between P19 and P32 with peak plasticity at P28, the so-called juvenile period 
(Hubel & Wiesel, 1970; Gordon & Stryker, 1996; Feldman, 2009; Espinosa & Stryker, 2012). 
Importantly, PSD-95 KO mice exhibit lifelong juvenile OD plasticity, due to impaired silent 
synapse maturation (Huang et al., 2015a). Notably, the function of PSD-95 seems to be 
specific for visual experience-dependent maturation, since silent synapse number already 
decreased to ~50% before eye opening, independently of PSD-95. 
In contrast to PSD-95, its paralog PSD-93 shows clear inhibiting effects on silent synapse 
maturation as indicated by increased mEPSC frequency and decreased silent synapse 
fraction (determined by minimal stimulation assay) in mice lacking PSD-93 (D. Favaro et al., in 
press). In the absence of PSD-93, silent synapses already mature completely during critical 
period in V1, reaching zero-levels at P28 (compared to ~25% in WT and ~50% in PSD-95 KO 
mice). Intriguingly, by loss of PSD-93, the developmental decline of silent synapse fraction is 
rendered independent of visual experience. Comparable reductions in silent synapse levels 
are also reported for mPFC and hippocampus, showing ~10% at P15 and P20, respectively 
(D. Favaro et al., in press). In nucleus accumbens, PSD-93 KO mice maintain less than 10% 
silent synapses at ~P28, whereas loss of SAP102 has only limited effects on silent synapse 
number in this brain area (Shukla et al., 2017).  
In mice lacking both paralogs and therefore PSD-95-mediated promoting and PSD-93-
mediated inhibiting effects on silent synapse maturation, the maturation time course and 
proportion of silent synapses is similar to WT as reported until late critical period of V1 (P28) 
(D. Favaro et al., in press). Nevertheless, the maturation is independent of visual experience, 
indicating a distinct mechanism in the absence of PSD-95 and PSD-93. mEPSC frequency 
appears normal in DKO mice, but the amplitude is decreased. On one hand, this indicates that 
DKO mice possess unaltered fraction of AMPAR-transmitting synapses, but on the other hand, 
reduced AMPAR number at individual excitatory synapses. Interestingly, D. Favaro et al. (in 
press) also detected reduced mEPSC amplitudes in PSD-95 KO mice in V1. This finding is in 
contrast to previous studies on mPFC, somatosensory cortex (Béïque & Andrade, 2003) and 
hippocampus (Stein et al., 2003; Béïque et al., 2006), all showing unaffected mEPSC 
amplitudes upon PSD-95 KO. However, increased amplitudes induced by PSD-95 
overexpression were reported before in hippocampal cultures (El-Husseini et al., 2000).  
Thus, while silent synapses apparently mature in the absence of both PSD-95 and PSD-93, 
PSD-95 seems to be necessary for normal function of matured excitatory synapses as 
indicated by normal AMPAR number in mice only lacking PSD-93 (D. Favaro et al., in press). 
Furthermore, it is shown that both paralogs are necessary for finetuning of visual perception, 
with either protein promoting visual acuity (D. Favaro et al., in press; Huang et al., 2015a). 
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An important question raised by this balancing effect of PSD-95 and PSD-93 on silent synapse 
maturation is, whether both proteins are actually located at the same synapse. Albeit some 
studies reported a rather distribution to different synapses in the hippocampus (i.e., just 33% 
of co-localization) (Sans et al., 2000) or in hippocampal cultures (Elias et al., 2006), others 
revealed similar, homogenous distributions and co-localization at single isolated PSDs of rat 
cortex (DeGiorgis et al., 2006) and mouse V1 (D. Favaro et al., in press).  
Taken together, these results show opposing roles of the two MAGUKs PSD-95 and PSD-93 
in experience-dependent maturation of silent synapses during critical period. This mechanism 
is essential for developmental finetuning and consolidation of synaptic connections into final 
wiring patterns, and therefore for optimized brain function. 
1.6. Link of glutamate receptor complexes to neuronal 
dysfunction   
1.6.1. Genetic studies link PSD-95 and PSD-93 to neuro-
developmental and neuropsychiatric disorders 
As members of the DLG-MAGUK family possess a multidomain structure, they interact with a 
variety of membrane and intracellular proteins, thereby forming complexes with GluRs to link 
channel activity to downstream signal transduction pathways. These complexes typically 
contain diverse interacting proteins such as SAP90/PSD-95-associated proteins (SAPAPs) 
(Takeuchi et al., 1997), Shanks (Boeckers et al., 2002; Hayashi-Takagi et al., 2015) and 
neuroligins (Kennedy, 1997, 2000). Importantly, each of these protein families has been 
implicated in neuropsychiatric or neurodevelopmental disorders by genetic studies. 
Specifically, SAPAP3 is associated with obsessive-compulsive disorder (Bienvenu et al., 
2009), Shank family proteins with autism spectrum disorder (ASD) (Durand et al., 2007; Berkel 
et al., 2010) and schizophrenia (Gauthier et al., 2010), and neuroligins with ASD (Jamain et 
al., 2003). The most prevalent MAGUK, PSD-95, was identified in genetic studies of Williams 
syndrome, representing a neurodevelopmental disorder occasionally referred to as the 
opposite to ASD in terms of social behavior (Feyder et al., 2010; Asada & Itakura, 2012). 
Furthermore, dysregulated expression of PSD-95, PSD-93 and NMDAR subunits was found in 
post-mortem brain samples from schizophrenic patients (Toro & Deakin, 2005; Kristiansen et 
al., 2006). In fact, the gene encoding PSD-93 (namely dlg2) shows an above-average 
likelihood for spontaneous somatic mutations, which can cause idiopathic forms of 
schizophrenia (Kirov et al., 2011; Fromer et al., 2014; Erwin et al., 2016). Consistently, 
abnormal social behavior and cognitive impairments similar to defects seen in ASD and 
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schizophrenia, respectively, have been described in PSD-95 KO and PSD-93 KO mice 
(Nithianantharajah et al., 2013; Shukla et al., 2017; Winkler et al., 2018). It still needs to be 
clarified how PSD-95- and PSD-93-associated complexes are involved in disease 
development and if their influence on silent synapse maturation may play an important role 
therein. 
1.6.2. Involvement of PSD-95 and PSD-93 in NMDAR-mediated 
excitotoxicity 
PSD-95 and PSD-93 play central roles in orchestrating synaptic function in excitatory neurons, 
which primarily depend on the neurotransmitter glutamate. Dysfunctions in glutamate-
mediated neurotransmission have been implicated in various neuropathologies including 
epilepsy, ischemic stroke, Huntington’s, Parkinson’s and Alzheimer’s disease, dementia and 
acute brain injury (Dawson & Dawson, 1996; Liu et al., 2009b; Gardoni et al., 2010; Parsons & 
Raymond, 2014). Glutamate concentrations are strictly controlled in the brain and excessive or 
persistent release results in overactivation of GluRs, which can cause neuronal damage 
referred to as excitotoxicity (Dawson et al., 1992; Coyle & Puttfarcken, 1993). Excitotoxicity is 
primarily mediated via enhanced activation of GluN2B-containing NMDARs, which provokes 
intracellular Ca2+ overload and triggers Ca2+-dependent toxic downstream signaling cascades. 
There are two major pathways proposed to be stimulated upon excessive Ca2+ influx and to 
mediate neuronal cell damage. On one hand, extrasynaptic NMDARs trigger pro-apoptotic 
cascades mediated by the Ca2+-dependent protease calpain. On the other hand, NMDAR-
dependent Ca2+-overload induces nitric oxide (NO) production, which can be highly toxic in 
non-physiological concentrations.  
1.6.2.1. Extrasynaptic NMDAR/calpain-mediated excitotoxicity 
NMDARs located at extrasynaptic sites are considered to be specifically vulnerable to the 
activation of proapoptotic signaling cascades (Hardingham & Bading, 2010). Typically, the 
Ca2+-dependent protease calpain is involved, which appears to be exclusively activated by 
extrasynaptic and not by synaptic NMDARs (Xu et al., 2009). While in immature hippocampal 
neurons, the fraction of extrasynaptic NMDARs reaches up to 75% of all NMDARs (Tovar & 
Westbrook, 1999), it gradually decreases throughout development, but still represents a 
substantial population in the adult brain (Petralia et al., 2010). Extrasynaptic NMDARs can be 
activated by glutamate spillover from adjacent synapses or via ectopic glutamate release from 
close-by located axons, dendrites or glial processes (Matsui et al., 2005; Petralia, 2012). 
Additionally, malfunction of glutamate transporters (e.g. defective glutamate transport or 
reverse operation), increased presynaptic glutamate release probability and enhanced 
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number/stability of NMDARs can lead to excessive glutamatergic activity at extrasynaptic sites 
(Parsons & Raymond, 2014). There is a multiplicity of Ca2+-triggered proapoptotic signaling 
cascades which may be activated (for review see Hardingham & Bading, 2010). The best-
known pathway involves calpain, which gets activated upon intracellular Ca2+ overload and 
results in activation of p38 mitogen-activated protein kinase (MAPK) and subsequent 
activation of caspases acting as “death signals” by promoting cell apoptosis (Volbracht et al., 
2005).  
Besides synaptic NMDARs, also NMDARs located at extrasynaptic sites are reported to 
associate with DLG-MAGUKs (Allison et al., 1998; Petralia et al., 2010). Hence, PSD-95 and 
PSD-93 might contribute to the molecular mechanism leading to neuronal damage in 
prominent neurodevelopmental brain disorders and acute brain injury. 
1.6.2.2. NMDAR/nNOS-mediated excitotoxicity 
A major component of glutamate excitotoxicity is proposed to be mediated by NO. Excessive 
intracellular Ca2+, channeled primarily by GluN2B-containing NMDARs, can activate the 
neuronal NO synthase (nNOS), leading to NO production and derivates with harmful free-
radical character. Specifically, nNOS gets activated via Ca2+/calmodulin and converts L-
arginine to citrulline and NO (Dawson et al., 1992; Garthwaite & Boulton, 1995). Under normal 
physiological conditions, NO has an important role as a second messenger in the CNS 
including diverse forms of synaptic plasticity (Schuman & Madison, 1994). However, high 
concentration of NO can be neurotoxic (Dawson et al., 1992). The critical aspect about NO as 
a second messenger is, that it does not bind to membrane-associated receptors at discrete 
loci like conventional neurotransmitters – but is membrane-permeable and can diffuse among 
neurons to directly act on intracellular constituents. In addition, conventional neurotransmitters 
are inactivated upon reuptake or enzymatic degradation, whereas NO loses its activity only 
after chemical reaction with a substrate. Hence, neurons can hardly regulate NO concentration 
and activity, solely by the control of NO synthesis (Dawson & Dawson, 1996).  
Following NO overproduction, most of the neurotoxic pathways activated are triggered by the 
highly reactive oxidant peroxynitrite (ONOO-), the reaction product of NO and a superoxide 
free radical (O2.-), which can also be generated by nNOS (Pou et al., 1992). The activated 
downstream pathways are diverse and can involve activation of glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH), poly (ADP-ribose) polymerase (PARP) and nucleases. As a result, 
severe damage to cellular components, including DNA, proteins and lipids, as well as 
modulated gene transcription may lead to neuronal apoptosis and/or parthanatos (i.e., PARP-
dependent cell death) (Dawson & Dawson, 2018). 
Importantly, PSD-95 and – to a lesser extent – PSD-93 have been implicated to tether nNOS 
to NMDARs and therefore mediate NO synthesis. Specifically, like the MAGUKs, nNOS 
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contains a PDZ domain, which can interact with PDZ repeats of PSD-95 or PSD-93. These 
MAGUKs in turn bind to the cytosolic C-terminus of GluN2 subunits and thereby effectively 
couple nNOS to NMDAR-mediated Ca2+ influx (Brenman et al., 1996; Stricker et al., 1997; 
Sattler et al., 1999). The co-expression of PSD-95 with nNOS has been shown in the 
developing and mature nervous system (Brenman et al., 1996), as well as the formation of a 
ternary GluN2B-PSD-95-nNOS complex as co-immunoprecipitated from rat forebrain 
(Christopherson et al., 1999). For PSD-93, co-localization and interaction with both NMDAR 
subunit and nNOS in the processes of cultured cortical neurons have been reported (Xu et al., 
2004). 
Glutamate-mediated excitotoxicity via NO synthesis has been especially implicated in 
ischemia and, more specifically, ischemic stroke. Ischemic stroke refers to severely reduced or 
completely blocked cerebral blood flow, which results in the shortage of nutrients and oxygen, 
leading to near-immediate physical and neurological deficits.  
The inhibition of nNOS activity by genetic manipulations or pharmacological tools has been 
shown to prevent NMDAR-mediated excitotoxicity in primary cortical cultures (Dawson et al., 
1991; Dawson & Dawson, 1996) and, furthermore, to reduce infarct volumes and neurological 
deficits in mice subjected to cerebral ischemia (Huang et al., 1994). Consistent with the 
presumed involvement of PSD-95 in coupling NMDAR activity to NO toxicity, antisense RNA-
mediated KD of PSD-95 in cortical cultures attenuates both NO production and excitotoxicity 
with each of them selectively mediated by NMDARs (Sattler et al., 1999). Furthermore, studies 
found modified or induced NMDAR-PSD-95-nNOS interactions upon cerebral ischemia in 
rodent hippocampus (Takagi et al., 2000; Zhou et al., 2010). These observations led to the 
design and synthesis of interfering peptides and small molecules aimed to inhibit PDZ domain-
mediated interactions in the ternary NMDAR-PSD-95-nNOS protein complex and thereby 
uncoupling NMDAR overactivation from toxic NO synthesis (see Figure 1). Notably, the exact 
molecular mechanisms how and with which targets these compounds interact are 
controversially discussed and still unclear (Cui et al., 2007; Lai et al., 2014; Bach et al., 2015). 
Moreover, given the structural similarity of PSD-95 with PSD-93 (Cho et al., 1992), it is likely 
that these peptides can also disrupt the interaction of PSD-93 with NMDAR or nNOS, thereby 
questioning PSD-95 as the in vivo target.  
However, irrespective of its mechanism of action and targeted protein interaction, the so-called 
PSD-95 inhibitor Tat-NR2B9c (NA-1) has been shown to provide protection against ischemic 
stroke in rodents (Aarts et al., 2002; Sun et al., 2008; Jones, 2011) and high-order primates, 
i.e. macaques, (Cook et al., 2012a, 2012b) by reducing infarct volumes and preserving 
neurological functions in neuro-behavioral tests. In these studies, stroke was typically induced 
via middle cerebral artery occlusion (MCAO). NA-1 was also already tested in a phase II 
clinical trial of ischemic stroke occurring after endovascular aneurysm repair, showing fewer 
infarcts in inhibitor-treated patients, but no difference in lesion volumes (Hill et al., 2012). 
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Besides NA-1, other potential inhibitors were designed, and some (namely ZL006 and Tat-N-
dimer) as well appear to reduce cerebral ischemic injury in mouse and rat stroke models 
(Zhou et al., 2010; Bach et al., 2012). 
 
 
Figure 1: Link between NMDARs and nNOS-mediated neurotoxicity through PSD-95. (A) 
The scaffolding protein PSD-95 tethers NO-producing nNOS in close proximity to Ca2+ influx 
channeled by GluN2B-containing NMDARs. Receptor overactivation, e.g., due to excessive 
glutamate release in cerebral ischemia, leads to Ca2+ overload, massive NO production and 
activation of toxic downstream cascades. (B) Interfering peptides including Tat-NR2B9c (also 
named as NA-1) and small molecules like ZL006 are proposed to perturb PSD-95 interactions with 
GluN2B and nNOS, respectively. Hence, inefficient signaling reduces NO levels and protects the 
neuron from cell damage. The exact mechanism how these effector molecules function is still 
under debate (Cui et al., 2007; Bach et al., 2015). Image adapted from (Wu & Tymianski, 2018). 
 
In the meantime, some studies focused on a possible role of PSD-93 in mediating 
NMDAR/nNOS-dependent excitotoxicity. Xu et al. (2004) reported the co-localization and 
ternary complex formation of PSD-93 with NMDAR and nNOS in cultured cortical neurons. 
Furthermore, this study showed that PSD-93 deletion prevents NMDAR/nNOS-dependent 
toxicity induced by platelet-activating factor (PAF) in cortical neurons. PAF is an important 
proinflammatory cytokine which augments presynaptic glutamate release (Clark et al., 1992) 
and is considered to be a critical mediator for neuronal injury in the context of ischemia, 
seizures and brain trauma (Lindsberg et al., 1991; Yue & Feuerstein, 1994). However, the KO 
of PSD-93 did not provide neuroprotection in neonatal mice subjected to hypoxia-induced 
ischemia, but rather enhanced the expression of PSD-95, nNOS and GluN2A/B subunits in the 
affected hippocampal region (Jiang et al., 2003). In contrast, synaptic GluN2A/B levels were 
Introduction 
 
20 
 
reduced in cortical cultures after KD or KO of PSD-93, which additionally decreased Ca2+ 
influx through NMDARs and, more importantly, attenuated NMDAR-mediated neurotoxicity 
(Zhang et al., 2010). The indicated protective effect of loss of PSD-93 against NMDAR 
overactivation is further supported by a mouse MCAO stroke model, which showed reduction 
in infarct size, neurological deficits and neuronal degeneration when PSD-93 was knocked out 
(Zhang et al., 2014). This effect was presumed to result from the inhibition of Fyn-mediated 
GluN2B phosphorylation, which is linked to the neurotoxic cascade following ischemia (Jiang 
et al., 2008). In this study, the KO of PSD-93 did not increase levels of PSD-95, nNOS and 
NMDAR subunits after focal cerebral ischemia in cerebral cortex of adult mice (Zhang et al., 
2014). Hence, by considering the contradictory effects of PSD-93 disruption in the 
hippocampus of neonatal mice (Jiang et al., 2003), a conceivable compensatory response of 
the PSD-95-NMDAR-complex upon PSD-93 KO may depend on brain region, developmental 
stage and disease model. Deletion of PSD-93 was also shown to inhibit the expression of 
proinflammatory cytokines in the early stages of ischemia-reperfusion, whereas the 
mechanism of a possible PSD-93-involved crosstalk between neurons and cytokine-producing 
glial cells is still unclear (Zhang et al., 2015).  
Altogether, these findings suggest important roles for both PSD-95 and PSD-93 in mediating 
ischemia-induced, NMDAR-dependent neuronal excitotoxicity – possibly through distinct 
mechanisms and depending on the developmental state. Since some studies are quite 
controversial and lack mechanistic background, further investigations are needed to specify 
the role of PSD-95 and PSD-93 in ischemic brain injury and excitotoxicity in general. 
1.7. Spreading depression 
1.7.1. Characteristics and clinical relevance of spreading 
depression 
One option to investigate neuronal network susceptibility to metabolic compromise is to induce 
a transient hypoxic state and characterize the consequences regarding neuronal function 
and/or damage, e.g., in acute brain slices. Hypoxia represents an important aspect of cerebral 
ischemia and induces a phenomenon known as “spreading depression” (SD). SD was first 
described by Leão (1944, 1947) as cortical SD of activity due to marked reduction of neuronal 
activity, spreading out from the addressed area like a wave.  
It is first initiated by a profound depolarization of neurons and accompanied by severe 
reduction of membrane resistance and redistribution of ions across cell membranes, leading to 
impaired ion homeostasis. Glial cells also depolarize but retain membrane resistance (Somjen, 
2001). The severe depolarization leads to massive glutamate release and associated Ca2+ 
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overload – a critical excitotoxic state earlier discussed in section 1.6.2. – which shuts down 
neuronal function and may peak in severe cell damage. During SD, K+ and organic anions, 
including glutamate, flow out of the neuronal cell and accumulate in the interstitial space 
(Vyskoeil et al., 1972; Somjen, 2001). Concomitantly, a predominant influx of cations (i.e., Na+ 
and Ca2+) but also Cl- elicit a net gain of solutes, resulting in osmotic cell swelling and 
reduction of the interstitial space (Somjen & Aitken, 1984).  
Dahlem et al. (2003) described the propagation of SD using a simplified model of a reaction-
transport mechanism. According to this model, high concentration of a so-called activator in 
the extracellular space provokes marked membrane depolarization, resulting in autocatalytic 
release of the activator – potentially glutamate (Van Harreveld, 1978) or K+ (Grafstein, 1956). 
Both lead to the efflux of K+ ions, which are partially cleared by reuptake, diffusion and 
redistribution throughout the gap junction-coupled glial network. Hence, high K+ concentrations 
in adjacent cell groups initiate the same excitation cycle and as a result, an excitation wave 
propagates along the neuronal tissue, followed by sustained depression of activity. 
In the brain, SD is usually initiated at a point source and then propagates in gray matter with a 
velocity of 2–5 mm/min (Marshall, 1959; Lauritzen, 1987). SD waves have been linked to the 
pathophysiology of ischemic stroke (Hossmann, 1996; Dohmen et al., 2008), where they are 
thought to account for the severity and extent of neuronal lesions (Nedergaard & Hansen, 
1993; Gido et al., 1994; Hossmann, 1994; Mies, 1997). Typically, adjacent brain tissue not 
affected by SD spread remains largely healthy (Andrew et al., 1999). Importantly, normoxic SD 
associated with migraine aura does not cause discernible neuronal damage (Lauritzen, 1994; 
Bolay et al., 2002). Furthermore, SD is supposed to play a role in concussion, postictal 
depression (after epileptic seizure), traumatic brain injury and subarachnoid as well as 
spontaneous/traumatic intracerebral hemorrhage (Strong et al., 2002; Rubaj et al., 2003; 
Fabricius et al., 2006; Rogawski, 2008; Dreier et al., 2009; Lauritzen et al., 2011). 
Interestingly, neuronal insults following hypoxia-induced spreading depression (HSD), e.g. 
during ischemic stroke, are found to predominantly affect the hippocampal part of the brain 
(Schmidt-Kastner & Freund, 1991). Due to its selective vulnerability, the hippocampus serves 
as a widely-used model structure to study ischemia or SD in general and will also serve as a 
model in this study. Notably, susceptibility to ischemia differs substantially when comparing 
discrete subregions of the hippocampus. While CA1 pyramidal neurons suffer from ischemic 
damage, the adjacent CA3 subfield and dentate gyrus remain mostly unaffected. In addition, 
interneurons appear quite resistant (Schmidt-Kastner & Freund, 1991). 
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1.7.2. Spreading depression-associated intrinsic optical signal 
SD can be characterized and identified by electrical as well as optical signals. The marked 
membrane depolarization of neurons and glial cells is usually accompanied by sudden 
negative field potential transients of 10–30 mV, which represent the electrophysiological 
hallmark of SD (Aitken et al., 1998; Müller & Somjen, 2000a). Furthermore, changes in light 
reflectance of the tissue can be detected and used to map SD spread. As they result from 
endogenous biological properties, they are termed “intrinsic” optical signals (IOSs).  
The characteristic IOS profile was first defined in isolated chick retina by Martins-Ferreira and 
de Castro (1966). Briefly, a short and weak decrease in tissue reflectance is followed by an 
abrupt and intense increase, which typically contains two maxima. A large number of studies 
aimed at identifying the molecular mechanisms which account for the IOS but, so far, they are 
not completely understood. However, the IOS is supposed to arise mainly from four dominant 
aspects: (I.) modified light scattering due to volume changes of neurons, glial cells and their 
corresponding organelles, (II.) changes in blood volume resulting from the lack of energy 
sources, (III.) activity-related changes in the oxygenation of hemoglobin and (IV.) modified 
absorption or fluorescence of intrinsic chromophores including cytochromes and cytochrome 
c-oxidases in mitochondria (Chance et al., 1962; Jöbsis et al., 1977; Mayevsky & Chance, 
1982; Andrew et al., 1999; Kawauchi et al., 2008). Cell swelling and shrinkage appear more 
pronounced in neuronal dendrites and glial processes than in somatic regions and are thought 
to trigger neuronal damage following excitotoxic and traumatic brain injury (Somjen, 2001; 
Rungta et al., 2015).  
1.8. The hippocampal formation 
The hippocampus is probably the most studied region in the brain due to its well-structured 
and defined neuronal composition. Together with the adjacent amygdala, it forms the central 
axis of the limbic system. The hippocampus is crucial for the formation and long-term storage 
of certain types of memories including episodic and spatial memory (Squire, 1992; Neves et 
al., 2008). Due to its interaction with emotion-related brain regions, the hippocampus is 
furthermore implicated in emotional behavior (Sahay & Hen, 2008). A prominent feature of 
hippocampal synapses is activity-dependent synaptic plasticity. Therefore, and owing to its 
well-defined anatomical structure, it serves as a major experimental model for the study of 
diverse neuronal functions using electrophysiological recordings. 
The hippocampal formation comprises four cortical regions, namely the dentate gyrus, the 
hippocampus proper – consisting of Cornu Ammonis subfields 3, 2 and 1 (CA3, CA2 and CA1, 
respectively), the subiculum and the entorhinal cortex, with the latter subdivided into medial 
and lateral parts (Figure 2) (Amaral & Witter, 1989). The cross-section of the hippocampus 
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has a defined laminal organization and depth-layers, in which pyramidal cells are arranged. 
Neuronal connections typically follow this laminar structure, are unidirectional and form closed 
loops originating mainly in the adjacent entorhinal cortex. The so-called “excitatory tri-synaptic 
pathway” describes information flow from the entorhinal cortex via the dentate gyrus to 
hippocampal subfields CA3 to CA1 (Figure 2, Neves et al., 2008). The major neuronal input 
arrives via the perforant pathway from axons mainly arising in layer II and III (and to a lesser 
extent in IV and V) of the entorhinal cortex, which projects to granule cells of the dentate 
gyrus, and pyramidal cells of CA3, CA1 and the subiculum. The axons of dentate gyrus 
granule cells (called mossy fibers) connect to CA3 pyramidal cells, which in turn project to the 
CA1 region through Schaffer collaterals. These inputs either arise from CA3 of the same 
hippocampus (ipsilateral; associational fibers) or the hippocampus of the other hemisphere 
(contralateral; commissural fibers). Finally, CA1 neurons send out their axons, which pass the 
subiculum and project onto deeper layers of the entorhinal cortex, representing the principal 
hippocampal output structure (Lavenex & Amaral, 2000; Neves et al., 2008). 
 
 
Figure 2: The neuronal circuitry in the rodent hippocampus. The excitatory tri-synaptic loop 
includes three major pathways: (I.) The perforant path connects the entorhinal cortex to all fields of 
the hippocampus proper, including granule cells of the dentate gyrus and pyramidal cells of CA3, 
CA1 and the subiculum, (II.) the mossy fiber pathway conveys information from the dentate gyrus 
to CA3 neurons, and (III.), CA3 pyramidal cells project to CA1 pyramidal cells through Schaffer 
collaterals. CA1 neurons can as well receive synaptic input from the contralateral CA3 region via 
the associational/commissural pathway. Distal apical dendrites of CA1 are connected with neurons 
from Layer III of the entorhinal cortex via the temporoammonic pathway. The hippocampus also 
comprises a diversity of inhibitory neurons, which are not shown in the figure. CA, Cornu Ammonis. 
Image adapted from (Neves et al., 2008). 
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1.9. Scope of the thesis 
DLG-MAGUKs, especially PSD-95 and PSD-93, are critical players in the core organization of 
the PSD and exhibit important roles in orchestrating synaptic function at developing and 
mature excitatory synapses. While PSD-95 is well-known to regulate the number of AMPA 
receptors at the postsynapse and therefore directly affect synaptic strength, changes in PSD-
95 expression have no influence on NMDAR-mediated transmission (Migaud et al., 1998; 
Schnell et al., 2002; Elias et al., 2006; Schlüter et al., 2006). Nevertheless, PSD-95 is capable 
of interacting with NMDAR subunits (Kornau et al., 1995). This direct interaction between 
receptor and the – so far commonly known as – “structuring” protein has been linked to 
NMDAR-dependent synaptic plasticity, thereby assigning an additional role to PSD-95, which 
exceeds its role as a structuring molecule (Migaud et al., 1998; Béïque & Andrade, 2003; Stein 
et al., 2003). Specifically, PSD-95 is assumed to serve as a mediator between NMDAR 
activation and downstream signal transduction pathways required for the induction of synaptic 
plasticity (Xu et al., 2008).  
On the contrary, studies on PSD-93 function in basal synaptic transmission are controversial, 
presumably because the role of PSD-93 depends on brain region and developmental state 
(Elias et al., 2006; Carlisle et al., 2008; Krüger et al., 2013). Like PSD-95, PSD-93 can interact 
with NMDARs, but does not regulate basal NMDAR-mediated transmission in the 
hippocampus. However, studies indicate contrary roles of PSD-93 in synaptic plasticity as 
compared to PSD-95 (Migaud et al., 1998; Béïque & Andrade, 2003), while the molecular 
mechanisms for either similar, or opposing, functions of the two paralogs still need to be 
clarified. 
1.9.1. Can the absence of PSD-95 and/or PSD-93 provide 
protection against hypoxic insults? 
The interaction of PSD-95 and PSD-93 with NMDARs has been implicated in neuronal 
excitotoxicity – a state, which is linked to diverse neuropathologies including one of the leading 
causes of long-term disability and death worldwide: ischemic stroke (Lai et al., 2014). 
Interestingly, while the functions of the two paralogs appear to differ with respect to synaptic 
transmission and plasticity, both PSD-95 and PSD-93 have been suggested to provide 
neuronal protection in the context of excitotoxicity (Huang et al., 1994; Sattler et al., 1999; 
Zhang et al., 2010, 2014). Nevertheless, some studies obtained conflicting results, especially 
for the role of the less studied paralog PSD-93 (Jiang et al., 2003). Despite the lack of studies 
on PSD-95 KO mice, showing a protective effect against excitotoxicity due to germ-line KO, 
PSD-95 has already served as a target of newly designed drugs for stroke prevention (Cook et 
al., 2012a; Hill et al., 2012). Specifically, interfering molecules have been synthesized to 
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prevent the complex formation of PSD-95 with NMDAR and an excitotoxicity-mediator, nNOS. 
However, whether and, if so, how these peptides actually target the ternary complex is still 
unclear and controversially discussed (Cui et al., 2007; Bach et al., 2015). 
Therefore, the main goal of this study is to decipher a potential role of PSD-95 and PSD-93 in 
mediating toxic pathways in neuronal networks undergoing metabolic compromise. 
Specifically, I used transgenic adult mice, in which either one paralog (PSD-95 or PSD-93) or 
both paralogs were knocked out. This genetic approach enables investigation on the individual 
protein function, but also provides a state in which both proteins are absent, because 
MAGUKs are partly able to functionally compensate for each other. In order to investigate 
whether the absence of PSD-93 and/or PSD-95 can be protective against stroke-like 
conditions, I used a model of transient hypoxia (but with normoglycemia), containing intact 
neuronal networks, but excluding system factors such as cerebral vascularization. Due to the 
reported selective vulnerability of the hippocampus to ischemia and hypoxia-induced 
spreading depression (HSD), I prepared acute hippocampal brain slices of WT and KO mice. 
To address possible genotype-related effects on initiation and propagation of HSD, I used a 
combination of extracellular field potential recording and intrinsic optical imaging. The ability to 
visualize HSD in the whole brain slice enabled spatial and temporal mapping of HSD wave 
propagation. By concurrently recording of evoked synaptic responses, I could monitor synaptic 
function during and after the hypoxic state, providing evidence for the occurrence and extent 
of hypoxia-induced neuronal damage. Furthermore, I examined basal synaptic transmission 
and short-term plasticity, in order to gain deeper insight in PSD-95 and PSD-93 function in 
mature neuronal networks.   
1.9.2. How does the synaptic composition change upon KO of 
PSD-95 and/or PSD-93? 
We have previously shown that PSD-95 and PSD-93 have opposite roles in the experience-
dependent maturation of AMPAR-silent synapses during early development, with PSD-95 KO 
mice maintaining high proportions of silent synapses into adulthood (D. Favaro et al., in press; 
Huang et al., 2015a). Higher silent synapse number mimics an immature synaptic state and 
has been shown to preserve certain plasticity capabilities (Huang et al., 2015a). As stroke 
susceptibility is known to be highly influenced by aging, I included the aspect of altered 
number of immature synapses following MAGUK KO into my study.  
Due to the fact that the exact molecular composition of silent synapses, especially the 
occurrence and/or localization of non-transmitting AMPARs, is still elusive, I aimed to dissect 
the synaptic composition of excitatory neurons in MAGUK KO mice. This time, I used cortical 
brain slices, since the cortex provides more organic material and was shown to be similarly 
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affected by MAGUK KO with respect to silent synapse levels compared to hippocampus. A 
combination of a biochemical protein crosslinking approach, together with immuno-
fluorescence imaging served as tools to address this question. 
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2. MATERIALS AND METHODS 
2.1. Materials 
The chemicals and reagents used in the present study are listed in Table 1, the devices in 
Table 2 and software information is provided in Table 3.  
 
Table 1: List of chemicals and reagents.  
 
Chemical / reagent Supplier 
3-(N-morpholino)propanesulfonic acid 
(MOPS) 
Sigma-Aldrich, St. Louis, USA 
5-Fluoro-2'-deoxyuridine (FUDR) Sigma-Aldrich, St. Louis, USA 
Agarose Invitrogen, Carlsbad, USA 
AMBA, Rotiphorese Gel 30 Carl Roth, Karlsruhe, Germany 
Ammoniumchloride (NH4Cl)  Carl Roth, Karlsruhe, Germany 
Ammonium peroxodisulfate (APS) Serva, Heidelberg, Germany 
Bissulfosuccinimidylsuberate (BS3) AppliChem, Darmstadt, Germany 
Bovine serum albumin (BSA, Fraction V, 
pH 7.0) 
Serva, Heidelberg, Germany 
Bromphenol blue Carl Roth, Karlsruhe, Germany 
Calciumdichloride dihydrate (CaCl2 ∙ 2 H2O) Carl Roth, Karlsruhe, Germany 
Choline Chloride Sigma-Aldrich, St. Louis, USA 
DABCO  Sigma-Aldrich, St. Louis, USA 
Deoxycholic acid sodium salt (DEO) Fluka, Buchs, Switzerland 
Diethylether Sigma-Aldrich, St. Louis, USA 
Dimethylformamide (DMF) Merck, Kenilworth, USA 
Dithiothreitol (DTT) Carl Roth, Karlsruhe, Germany 
DNase I Sigma-Aldrich, St. Louis, USA 
dNTP Bioline, Luckenwalde, Germany 
Dulbecco's Modified Eagle Medium/Ham's 
F-12 Nutrient Mixture (DMEM/Ham's F12) 
Sigma-Aldrich, St. Louis, USA 
EDTA disodium salt (Na2-EDTA) Carl Roth, Karlsruhe, Germany 
Ethidium bromide Carl Roth, Karlsruhe, Germany 
Ethylene diamine tetraacetic acid (EDTA) Carl Roth, Karlsruhe, Germany 
Ethylene glycol tetraacetic acid (EGTA) Carl Roth, Karlsruhe, Germany 
Fetal bovine serum (FBS) Biowest, Riverside, USA 
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Gelatine Carl Roth, Karlsruhe, Germany 
GeneRuler 100 bp Plus DNA Ladder Thermo Fischer Scientific, Waltham, USA 
Glucose D(+) Merck, Kenilworth, USA 
Glucose D(+) monohydrate Carl Roth, Karlsruhe, Germany 
GlutaMax (L-Alanyl-L-Glutamine) Biochrom, Berlin, Germany 
Glycerol Carl Roth, Karlsruhe, Germany 
Glycine Carl Roth, Karlsruhe, Germany 
Goat serum Sigma-Aldrich, St. Louis, USA 
HEPES Carl Roth, Karlsruhe, Germany 
Isoflurane 'Forene' AbbVie, North Chicago, USA 
L-Arginine (L-Arg) Carl Roth, Karlsruhe, Germany 
L-Aspartate (L-Asp) Carl Roth, Karlsruhe, Germany 
L-Cysteine (L-Cys) Carl Roth, Karlsruhe, Germany 
L-Glutamate (L-Glu) Carl Roth, Karlsruhe, Germany 
L-Lysine monohydrochloride (L-Lys) Fluka, Buchs, Switzerland 
Magnesium dichloride hexahydrate 
(MgCl2 ∙ 6 H2O) 
Carl Roth, Karlsruhe, Germany 
Magnesium sulfate heptahydrate 
(MgSO4 ∙ 7 H2O) 
Sigma-Aldrich, St. Louis, USA 
Mango Taq DNA Polymerase (5 U/µl) Bioline, Luckenwalde, Germany 
MEM vitamin solution Sigma-Aldrich, St. Louis, USA 
Methanol Sigma-Aldrich, St. Louis, USA 
Midori Green Nippon Genetics Europe, Düren, Germany 
MITO+ serum extender BD Biosciences, Franklin Lakes, USA 
Modified Minimum Essential Eagle (MEM) 
medium (w/o L-glutamine) 
Sigma-Aldrich, St. Louis, USA 
MOWIOL AppliChem, Darmstadt, Germany 
Neurobasal Medium (custom-made DMEM/F-
12) 
Life Technologies, Carlsbad, USA 
Neuronal Supplement NS21 Homemade (Chen et al., 2008) 
Nonident P40 (NP40) Fluka, Buchs, Switzerland 
Papain CellSystems, Troisdorf, Germany 
Paraformaldehyde (PFA) Carl Roth, Karlsruhe, Germany 
Phosphate buffered saline (PBS) 
(w/o Ca2+ and Mg2+) 
Sigma-Aldrich, St. Louis, USA 
Poly-D-lysine hydrobromide (PDL) Sigma-Aldrich, St. Louis, USA 
Ponceau S dye Sigma-Aldrich, St. Louis, USA 
Potassium chloride (KCl) Carl Roth, Karlsruhe, Germany 
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Primers MPI-EM, Göttingen, Germany 
Protease inhibitor cocktail tablet 'cOmplete' 
(EDTA free) 
Roche, Basel, Switzerland 
Proteinase K (20 mg/ml) Ambion, Foster City, USA 
Sodium chloride Carl Roth, Karlsruhe, Germany 
Sodium dihydrogen phosphate monohydrate 
(NaH2PO4 ∙ H2O) 
Sigma-Aldrich, St. Louis, USA 
Sodium dodecyl sulfate (SDS) Carl Roth, Karlsruhe, Germany 
Sodium fluoride (NaF) Sigma-Aldrich, St. Louis, USA 
Sodium hydrogen carbonate (NaHCO3) Sigma-Aldrich, St. Louis, USA 
Sodium hydrogen phosphate (Na2HPO4) Sigma-Aldrich, St. Louis, USA 
Sodium hydroxide (NaOH) Carl Roth, Karlsruhe, Germany 
Sodium L-ascorbate Sigma-Aldrich, St. Louis, USA 
Sodium orthovanadate (Na3VO4) Sigma-Aldrich, St. Louis, USA 
Sodium phosphate dibasic (NaH2PO4) Sigma-Aldrich, St. Louis, USA 
Sodium pyruvate (C3H3NaO3) Carl Roth, Karlsruhe, Germany 
Sodium tetraborate decahydrate 
(Na2B4O7 ∙ 10 H2O) 
Sigma-Aldrich, St. Louis, USA 
Sucrose Carl Roth, Karlsruhe, Germany 
Tetramethylethylenediamine (TEMED) Carl Roth, Karlsruhe, Germany 
Tetrodotoxin (TTX) Abcam, Cambridge, UK 
Trichlormethiazide (TCM) Sigma-Aldrich, St. Louis, USA 
Tris Carl Roth, Karlsruhe, Germany 
Tris hydrochloride (Tris-HCl) Carl Roth, Karlsruhe, Germany 
Triton X-100 Carl Roth, Karlsruhe, Germany 
Tween 20 Carl Roth, Karlsruhe, Germany 
Uridine Sigma-Aldrich, St. Louis, USA 
 
Table 2: List of devices.  
 
Device Supplier 
Biofuge stratos, Heraeus ThermoFischer Scientific, Waltham, USA 
Bioruptor sonication device Diagenode, Denville, USA 
Biosafety cabinet Herasafe ThermoFischer Scientific, Waltham, USA 
BlueCube 300 (gel documentation system) Serva Electrophoresis, Heidelberg, Germany 
Centrifuges 5417R, 5424, 5804R, 5810R Eppendorf, Hamburg, Germany 
Electrophoresis power supply EV2310 Consort Medical, Hemel Hempstead, UK 
Electroporation System ECM 399 Harvard Apparatus, Cambridge, UK 
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FastGene Ultra Cycler Gradient (FG-TC01, 
PCR cycler) 
Nippon Genetics Europe, Düren, Germany 
Incubator Panasonic Corporation, Osaka, Japan 
Incubator C200 Labotect Labortechnik, Rosdorf, Germany 
Mastercycler proS, vapo protect (PCR cycler) Eppendorf, Hamburg, Germany 
Odyssey Infrared Imager (WB scanner) LI-COR Biosciences, Lincoln, USA 
Osmometer Vapor Pressure 5520 Wescor, Logan, USA 
pH professional PP-15 (pH meter) Sartorius, Göttingen, Germany 
PowerPac 300 (Power supply SDS-PAGE) Bio-Rad Laboratories, Hercules, USA 
Rotator SB3, Stuart (rotation wheel) ThermoFischer Scientific, Waltham, USA 
Scanvac Coolsafe (freeze dryer) Labogene, Lynge, Denmark 
Shaking Incubator GFL 3032 GFL (Gesellschaft für Labortechnik), 
Burgwedel, Germany 
Thermomixer comfort Eppendorf, Hamburg, Germany 
Thermoshaker TS1 Biometra, Jena, Germany 
UV-illuminator (gel documentation) INTAS Science Imaging Instruments, 
Göttingen, Germany  
Vibratome VT1200 S Leica Microsystems, Wetzlar, Germany 
  
Microscopes  
Inverted microscope DM IL Leica Microsystems, Wetzlar, Germany 
LSM 710 confocal microscope Carl Zeiss Microscopy, Jena, Germany 
Objective 40x, oil Carl Zeiss Microscopy, Jena, Germany 
Stereo microscope SZX7 Olympus, Tokio, Japan 
  
Electrophysiological Setup  
Charge-coupled device (CCD) camera 
SensiCam Imago QE 
TILL Photonics, Gräfelfing, Germany 
Amplifier Electronics workshop, Physiology, UMG 
Digitizer 1322A (Data Aquisition System) Axon Instruments, Union City, USA 
Imaging Control Unit (ICU) TILL Photonics, Gräfelfing, Germany 
Light source KL 1500 LCD Schott, Mainz, Germany 
Micropipette Puller P-97 Sutter Instruments, Novato, USA 
Microscope Axiotech, epifluorescent Carl Zeiss Microscopy, Jena, Germany 
Objective 5x, 0.13NA Epiplan 442920 Carl Zeiss Microscopy, Jena, Germany 
Oscilloscope TDS, digital storage  Tektronix, Beaverton, USA 
Peristaltic pump 205S Watson-Marlow Flow Smart/ Bredel, 
Cheltenham, UK 
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Polychrome V (imaging system) TILL Photonics, Gräfelfing, Germany  
Stimulator S88 (photoelectric stimulus 
isolation unit PSIU 6) 
Technologies, West Warwick, USA 
Temperature controller Electronics workshop, Physiology, UMG 
Vibroslice 752M Campden Instruments, Loughborough, UK 
 
Table 3: List of software.  
 
Software Company 
Axon Clampfit 9.2 Molecular Devices LLC, San Jose, USA 
Axon pCLAMP 9.2 Molecular Devices LLC, San Jose, USA 
Image Studio Lite (2014) LI-COR Biosciences, Lincoln, USA 
MetaMorph 6.1 Universal Imaging, New York, USA 
SPSS Statistics IBM, Armonk, USA 
TILL Vision 4.0 TILL Photonics, Gräfelfing, Germany 
ZEN black (2012) Carl Zeiss Microscopy, Jena, Germany 
 
Table 4: List of other material.  
 
Material Company 
Borosilicate glass capillaries (type GC150TF-
10) 
Harvard Apparatus, Holliston, USA 
Cyanoacrylate glue (type 401) Loctite, Düsseldorf, Germany 
Microscope coverslips 10 x 10 mm, round, 
glass 
Menzel/Thermo Fischer Scientific, Waltham, 
USA 
Microscope slides Labsolute/Th. Geyer, Höxter, Germany 
Stimulation electrode (stainless steel 
microwire, 50 µm diameter) 
AM-Systems, Carlsborg, USA 
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2.2. Laboratory Animals 
2.2.1. Housing conditions  
Animals used in this study were of the species mus musculus and housed in the animal facility 
of the European Neuroscience Institute in Göttingen, Germany. The mice were kept in groups 
up to 5 in macrolon type II L cages (32.5 x 17.0 x 14.0 cm) under standard conditions of a 
12 hours light/dark cycle with controlled temperature and humidity. Access to food and water 
was provided ad libitum. Mice were weaned at 3 weeks of age, followed by separate housing 
of males and females.  
2.2.2. Genetic background 
Transgenic mouse lines with the background of Charles River C57BL/6J mice (The Jackson 
Laboratory, Bar Harbor, USA) were backcrossed for at least 10 generations. Experiments 
were performed with PSD-93 knockout (KO) (McGee et al., 2001), PSD-95 KO (Yao et al., 
2004; Abbas et al., 2009) and PSD-93/95 double knockout (DKO) mice. PSD-93 KO and PSD-
95 KO mice furthermore contained up to two floxed SAP97 alleles. Floxed SAP97 mice (Zhou 
et al., 2008) served as controls and are defined as wildtype (WT) mice in the present study. 
2.2.3. Genotyping of transgenic mice 
Animals were genotyped using a protocol according to Malumbres et al. (1997) before and 
after the experiment. For this purpose, genomic DNA was isolated either from a small tail 
biopsy (1 to 3 mm of the tail tip) taken after weaning, or from ear punches. The biopsies were 
lysed in PBND buffer (10 mM Tris, 50 mM KCl, 2.5 mM MgCl2 ∙ 6 H2O, 0.1 mg/ml gelatine, 
0.45% (v/v) Nonident P40 (NP40) and 0.45% (v/v) Tween 20; pH 8.3) supplemented with 
1:100 Proteinase K solution (20 mg/ml, Ambion) at 55°C for at least 3 hours with constant 
shaking. The enzyme was inactivated by incubation at 99°C for 10 min and the supernatant 
collected and stored at 4°C after centrifugation (14680 rpm for 2 minutes).  
Genotypes were determined by polymerase chain reaction (PCR) (Mullis et al., 1986; Saiki et 
al., 1988) and subsequent agarose gel electrophoresis. The gene specific PCR conditions and 
primers are listed in Table 5 to Table 8. 10x TNK (Tris (T), ammonium (N), potassium (K)) 
buffer contained 100 mM Tris, 15 mM MgCl2 ∙ 6 H2O, 500 mM KCl and 50 mM NH4Cl (pH 
8.5). 
 
Materials and Methods 
 
33 
 
Table 5: PCR conditions for SAP97 genotyping.  
 
PCR mixture PCR programme 
  Cycle step Temp. Time Cycles 
10x TNK buffer 2.2 µl     
10 mM dNTP 
(Bioline)  
2 µl 
Initial denaturation 94°C 2 min 
 
50 µM primer 1 0.2 µl Denaturation 94°C 30 s  
35x 50 µM primer 2 0.2 µl Annealing 60°C  45 s 
ddH2O ad 19.8 µl Extension 72°C 1 min 
Mango Taq DNA 
Pol (5 U/µl, Bioline) 
0.2 µl Final extension 72°C 10 min  
Lysed biopsy 2 µl     
 
 
Table 6: PCR conditions for PSD-95 genotyping.  
 
PCR mixture PCR programme 
  Cycle step Temp. Time Cycles 
10x TNK buffer 2.2 µl     
10 mM dNTP 
(Bioline) 
2 µl 
Initial denaturation 94°C 5 min 
 
50 µM primer 1 0.2 µl Denaturation 94°C 45 s  
35x 50 µM primer 2 0.2 µl Annealing 60°C  45 s 
ddH2O ad 19.8 µl Extension 72°C 1 min 
Mango Taq DNA 
Pol (5 U/µl, Bioline) 
0.2 µl Final extension 72°C 10 min  
Lysed biopsy 2 µl     
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Table 7: PCR conditions for PSD-93 genotyping.  
 
PCR mixture PCR programme 
  Cycle step Temp. Time Cycles 
10x TNK buffer 2.2 µl     
10 mM dNTP 
(Bioline) 
2 µl 
Initial denaturation 94°C 5 min 
 
50 µM primer 1 0.2 µl Denaturation 94°C 45 s  
35x 50 µM primer 2 0.2 µl Annealing 61°C  1 min 
50 µM primer 3 0.2 µl Extension 72°C 2 min 
ddH2O ad 19.8 µl Final extension 72°C 10 min  
Mango Taq DNA 
Pol (5 U/µl, Bioline) 
0.2 µl     
Lysed biopsy 2 µl     
 
Table 8: List of genotyping primers.   
 
Gene Primer sequence (5'-3') 
SAP97  CCT CTA CAG AAT CTG AGT TGG CTC 
 TAA GAA GAA TCA ACT GGC AAA GGT G 
PSD-95  CAG GTG CTG CTG GAA GAA GG 
 CTA CCC TGT GAT CCA GAG CTG 
PSD-93  GTG CGG AAT GTT GTT GTG CAG TG 
 CAC AAC AGT CTC CAA TAT GGG TCG C 
 GCC TTC TAT CGA CTT CTT GAC GAG 
 
The PCR product with a total volume of 22 µl was analyzed by agarose gel electrophoresis 
after the addition of 10 µl loading dye containing 5 mM sodium tetraborate, 60% glycerol and 
bromophenol blue. The gel was prepared with 1% agarose in sodium tetraborate buffer (1.9 g/l 
Na2B4O7) and electrophoresed at constant voltage of 140 mV for approximately 35 minutes. 
To visualize the DNA, ethidium bromide (Carl Roth) or Midori Green (Nippon Genetics) was 
added to the gel solution. Exposure under UV light with either the UV-illuminator by INTAS 
imaging system or the BlueCube 300 (Serva) visualized DNA bands. The respective lengths 
were determined according to a DNA ladder (GeneRuler 100 bp Plus DNA Ladder, Thermo 
Scientific). Table 9 shows the resulting band sizes for each genotype. 
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Table 9: Genotype specific lengths of DNA bands.   
 
Gene WT band [bp] 
Floxed band (SAP97)/ 
KO band (PSD-95, PSD-93) [bp] 
SAP97  600 900 
PSD-95  255 355 
PSD-93  330 750 
 
2.3. Cell culture 
2.3.1. Dissociated primary neuronal culture 
Solutions for dissociated neuronal culture: 
Feeding medium 
Neurobasal medium supplemented with 100 mM L-Arg/L-Lys, 2 mM GlutaMax and Neuronal 
Supplement NS21 (Chen et al., 2008) 
mGBSS solution 
130 mM NaCl, 22 mM HEPES, 11 mM MgCl2 ∙ 6 H2O, 5 mM glucose monohydrate, 4.9 mM 
KCl, 2.7 mM NaHCO3, 1.5 mM CaCl2 ∙ 2 H2O, 0.8 mM Na2HPO4, 0.3 mM MgSO4 ∙ 7 H2O and 
0.2 mM NaH2PO4 ∙ H2O; pH 7.32 
Enzymatic solution 
10 ml mGBSS supplemented with 50 mM EDTA disodium salt (Na2-EDTA, pH 8.0), 11.39 mM 
L-cysteine, 10 mM CaCl2 ∙ 2 H2O, 30 µl 1 N NaOH, 100 µl papain and 10 mg/ml DNase I 
Inactivation solution 
25 mg bovine serum albumin (BSA) and 10 mg/ml DNase I in 10 ml 5% serum medium I 
5% Serum medium I 
Neurobasal medium supplemented with 21 mM glucose, 2 mM GlutaMax, MEM vitamin 
solution, MITO+ serum extender and 5% fetal bovine serum (FBS) 
FUDR solution 
41 mM 5-Fluoro-2'-deoxyuridine (FUDR) and 20 mM uridine in ddH2O  
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Dissociated primary hippocampal culture was prepared from postnatal day 0 (P0) WT mice 
according to Huettner & Baughman (1986) and Schlüter et al. (2006). Therefore, round glass 
coverslips (10 x 10 mm, Menzel/Thermo Fischer Scientific) stored in 96% ethanol were treated 
with 1 M HCl overnight, washed twice with sterile water, again covered in 96% ethanol and 
flamed shortly to dry. Subsequently, 24-well plates were equipped with coverslips and coated 
with Poly-D-lysine hydrobromide (PDL) overnight at 37°C and 5% CO2. At least 2 hours before 
neuron plating, coverslips were washed in the plate with sterile water, dried at room 
temperature (RT) for approximately 30 minutes under the biosafety cabinet and covered with 
500 µl/well plating medium I (100 mM L-Asp/L-Glu in feeding medium). Newborn mice were 
anesthetized on ice for several minutes and quickly decapitated. Brains were cooled down in 
ice-cold mGBSS solution and hippocampi collected using the stereo microscope SZX7 
(Olympus). During dissection procedure, the hemispheres were separated with a spatula, 
meninges removed and the hippocampi carefully isolated from cortex and dentate gyrus. After 
papain and DNase I guided digestion of the hippocampi in enzymatic solution at 37°C and mild 
rotation (10 rpm) for 30 minutes, the solution was replaced with inactivation solution for short 
incubation. Subsequently, tissue was gently triturated in 5% serum medium I by pipetting up 
and down for at least 10 strokes with a fire-polished Pasteur pipette and the cell suspension 
excluding remaining tissue chunks filled-up with 5% serum medium I to 10 ml. Following 
centrifugation at 500 x g for 5 minutes, the cell pellet was resuspended in 5% serum medium I 
and neuronal concentration determined via a Neubauer counting chamber. 80000 cells were 
plated per well in a total volume of 1 ml and kept in the cell culture incubator (37°C and 5% 
CO2) until use at 15 days in vitro (DIV). Addition of FUDR solution at 4 DIV restricted the 
growth of astrocytes. Neuronal cultures were fed with fresh astrocyte-conditioned medium 
(section 2.3.2) at 7 DIV and 13 DIV. 
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2.3.2. Preparation of astrocyte-conditioned medium 
Solutions for conditioned medium preparation: 
5% Serum Medium II 
Modified Minimum Essential Eagle (MEM) medium (w/o L-glutamine) supplemented with 
21 mM glucose, 2 mM GlutaMax, MEM vitamin solution, MITO+ serum extender and 5% FBS 
Plating medium II 
Dulbecco's Modified Eagle Medium/Ham's F-12 Nutrient Mixture (DMEM/Ham's F12) 
supplemented with 2 mM GlutaMax and NS21  
 
Astrocyte culture was prepared from P0 WT mice and brain dissection conducted according to 
2.3.1 “Dissociated primary neuronal culture”. This time, murine cortices (not hippocampi) were 
collected, triturated and plated in medium size cell culture flasks with cells from 2 cortices 
each in 15 ml 5% serum medium II. Once per week, the culture was fed with 5% serum 
medium II. In order to generate conditioned medium for feeding of dissociated hippocampal 
cultures, astrocytes were washed with 5 ml plating medium II and cultured in additional 15 ml 
for 24 hours in the CO2 incubator at 37°C. After centrifugation at 1500 x g for 5 minutes, the 
supernatant (= conditioned medium) was collected and astrocytes fed with fresh 5% serum 
medium II. Between several conditioning steps, astrocyte culture was recovered in 5% serum 
medium II for at least 48 hours. 
2.4. Protein biochemistry 
2.4.1. Protein crosslinking assay 
For chemical crosslinking of surface proteins based on Boudreau et al. (2012), acute brain 
slices were prepared from mice of different age (P13–P32). Subsequently, cortical brain parts 
were isolated, incubated with the bifunctional crosslinker BS3 (Bis(sulfosuccinimidyl)suberate, 
Applichem) and further processed via SDS-PAGE and western blotting (section 2.4.2). 
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2.4.1.1. Acute brain slice preparation 
Solutions for acute brain slice preparation:  
Cutting buffer 
119 mM choline chloride, 30 mM glucose, 26 mM NaHCO3, 7 mM MgSO4 ∙ 7 H2O, 3 mM 
sodium pyruvate, 2.5 mM KCl, 1.3 mM sodium L-ascorbate, 1 mM CaCl2 ∙ 2 H2O, 1 mM 
NaH2PO4 ∙ H2O and 1 mM kynurenic acid (Makino et al., 2011) 
Artifical Cerebrospinal Fluid (ACSF) 
119 mM NaCl, 26 mM NaHCO3, 11 mM glucose, 2.5 mM KCl, 2.5 mM CaCl2 ∙ 2 H2O, 1.3 mM 
MgSO4 ∙ 7 H2O and 1 mM NaH2PO4 ∙ H2O  
 
Mice were anesthetized with isoflurane (Abbvie) and decapitated. Following dissection, the 
brain was cooled down in ice-cold cutting buffer for about 1 minute. After removal of 
cerebellum and olfactory lobe, the brain was glued to the cutting platform using cyanoacrylate 
glue (type 401, Loctite) and supported by a 2% agarose block. Coronal slices of 400 µm were 
cut using the vibratome VT1200 S (Leica Microsystems) and collected in the recovery 
chamber filled with ACSF for 30 minutes incubation at 35°C under continuous carbogen 
supply (95% O2 and 5% CO2). Thereby, the pH value was maintained at 7.4 and proper tissue 
oxygenation assured. 
2.4.1.2. BS3 crosslinking 
Solutions for BS3 crosslinking: 
HEPES buffer 
147 mM NaCl, 100 mM glucose, 20 mM HEPES and 1.2 mM CaCl2 ∙ 2 H2O; pH 7.4 
BS3 stock solution 
BS3 was dissolved in dimethylformamide (DMF) for preparation of 50 mM stock solution and 
vacuum dried using the Scanvac Coolsafe (Labogene) centrifuge. Right before the 
experiment, BS3 was dissolved freshly in water to 2 mM final concentration. 
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Lysis buffer 
15 mM NaCl, 1 mM Tris-HCl, 1 mM Na2-EDTA ∙ 2 H2O, 1 mM EGTA, 150 mM NaF, 1 mM 
Na3VO4, 1% NP-40, 0.5% DEO, 0.1% SDS and 1 protease inhibitor tablet; pH 7.4  
 
After recovery, slices were transferred into ice-cold HEPES buffer for cortical sample isolation 
by preparing similar sizes of crosslinked and control samples. Crosslinking of surface proteins 
was achieved by incubation with 2 mM BS3 for 30 minutes at 4°C during continuous rotation 
(4 rpm) of the sample tube. For additional 10 minutes, 100 mM glycine was added to quench 
the reaction. After removal of the supernatant following centrifugation at 14000 x g for 
2 minutes at 4°C, lysis buffer was added to homogenize the cortex sample via pipetting up and 
down. For further analysis, the tissue was processed using the Bioruptor sonication device 
(Diagenode) with cycles of 30 seconds on/off for 10 minutes at 4°C and directly prepared for 
SDS-PAGE and western blot procedure (section 2.4.2). 
2.4.2. SDS-PAGE and Western blotting 
For protein identification and analysis, samples extracted from acute brain slices were applied 
on a denaturing SDS-PAGE (Shapiro et al., 1967) after 1:1 addition of 2x SDS sample buffer 
(Sambrook et al., 1989). 4x SDS sample buffer (400 g/l glycerol, 68.2 g/l Tris, 40 g/l Tris-HCl, 
80 g/l SDS, 0.6 g/l EDTA and 0.75 g/l bromphenol blue; pH 8.5) was diluted and 
supplemented with 13.5 g/l DTT and 2.5% SDS right before the experiment. Freshly prepared 
samples were boiled at 99°C for 5 minutes, directly loaded on the gel or stored at -20°C. 
Before using, frozen samples were heated up to 60°C for another 5 minutes. A volume of 
12/28 µl protein sample was loaded in pockets of a 15-/10-well comb, respectively. Table 10 
shows the composition of SDS gels.  
 
Table 10: Gel composition for SDS-PAGE.  
 
 10% Separating gel 3.75% Stacking gel 
AMBA 6.7 ml 1.0 ml 
3.5x Bis-Tris buffer, pH 6.7 6.0 ml 0.8 ml 
10% SDS 100 µl - 
TEMED 25 µl 20 µl 
10% APS 60 µl 48 µl 
ddH2O 7.3 ml 6.2 ml 
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Electrophoresis was performed in SDS running buffer (0.05 M MOPS, 0.05 M Tris, 1 mM 
EDTA and 0.1% SDS) at 60 V until the samples reached the interface of the two gel 
components (approx. 20 min) and completed at 150 V for 45 minutes to 1 hour.  
The subsequent protein transfer onto nitrocellulose membranes (0.2 µm, GE Healthcare) was 
achieved via wet western blotting (WB) (Towbin et al., 1992) in an upright chamber. After 
2 hours of transfer (250 mA, 4°C) in Tris-glycine buffer (3 g/l Tris, 14.4 g/l glycine, 20% 
methanol) the proteins were stained with Ponceau S dye (Sigma Aldrich) to confirm the 
successful transfer. The dye was washed away with Tris-Buffered Saline-Tween 20 (TBS-T, 
20 mM Tris-HCl, 140 mM NaCl, 0.1% Tween 20; pH 7.6) and unspecific binding sites blocked 
with 5% BSA in TBS-T for 30 minutes at RT. After overnight incubation at 4°C and constant 
shaking with the primary antibody (diluted in 2.5% BSA/TBS-T; Table 11), the membrane was 
washed 2 times for 10 minutes with TBS-T and incubated with the respective secondary 
antibody diluted in TBS-T for approximately 1 hour at RT under light exclusion.  
Table 11: Antibodies used for immunoblotting.  
 
Antibody Host 
Approx. MW of 
protein [kDa] 
Working 
dilution 
Manufacturer* 
Primary antibody     
GABA-A 1 mouse 52 1:2000 Neuromab 
GAPDH mouse 38 1:2000 Merck Millipore 
GluA1 rabbit 110 1:2000 Merck Millipore 
GluA2 mouse 100 1:2000 Neuromab 
Mortalin mouse 75 1:8000 Neuromab 
Munc13-1 rabbit 200 1:2000 Synaptic 
Systems 
GluN2A rabbit 180 1:2000 Merck Millipore 
GluN2B mouse 166 1:2000 Neuromab 
β-Tubulin rabbit 55 1:1000 LI-COR 
Biosciences 
Secondary antibody     
anti-mouse 
IRDye 800CW 
goat  1:10000 LI-COR 
Biosciences 
anti-rabbit 
IRDye 680CW 
goat  1:10000 LI-COR 
Biosciences 
 
*Manufacturer information: Merck Millipore (Burlington, USA), Neuromab (Davis, USA), LI-COR 
Biosciences (Lincoln, USA) 
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Following additional washing steps (3 times for 8 minutes with TBS-T and once with TBS), the 
membrane was scanned with the Odyssey Infrared Imaging System from LI-COR Biosciences. 
Protein band quantification was conducted by the Image Studio Lite (LI-COR Biosciences) and 
ImageJ software using integrated band intensities. 
2.4.3. Antibody uptake assay 
Antibody feeding buffer 
139 mM NaCl, 10 mM HEPES, 10 mM glucose, 2.5 mM CaCl2 ∙ 2 H2O, 2.5 mM KCl, 1.3 mM 
MgCl2 ∙ 6 H2O and 1 µM tetrodotoxin (TTX); pH 7.3, 290 mOsm (Fredj & Burrone, 2009)  
 
Synaptotagmin 1 (Syt1) antibody uptake assay was performed in dissociated primary 
hippocampal culture (2.3.1 “Dissociated primary neuronal culture”) at 15 DIV. Coverslips with 
hippocampal neurons were placed upside-down onto 50 µl-drops of reaction solution 
containing Syt1 antibody (Table 12) in antibody feeding buffer (see above). Depending on 
different conditions, the reaction solution was supplemented with 0.5 mM Trichlormethiazide 
(TCM), 20 mM KCl (total concentration) or 300 mM sucrose. After incubation at 37°C and 5% 
CO2 for 10 minutes, the neurons were recovered for 1 minute in conditioned medium and 
applied to immunofluorescence staining described in the following chapter 2.4.4. 
2.4.4. Immunofluorescence staining 
Solutions for immunofluorescence staining: 
Goat Serum Dilution Buffer (GSDB) 
450 mM NaCl, 20 mM Phosphate buffer (NaH2PO4 ∙ H2O/Na2HPO4) and 2% goat serum; 
pH 7.4 
Fixation solution 
4% sucrose and 4% paraformaldehyde (PFA) in phosphate buffered saline (PBS, w/o Ca2+ 
and Mg2+); pH 6.9–7.2  
Coverslips with primary neuronal culture were carefully transferred onto another 24-well cell 
culture plate containing 500 µl/well fixation solution and incubated at RT for 15 minutes. The 
fixative was rinsed twice with 500 µl PBS (w/o Ca2+ and Mg2+) followed by blocking and 
permeabilization using 0.3% Triton X-100 solution in GSDB at RT for 30 minutes. In general, 
permeabilization of cell membranes allows detection of intracellular antibodies like the Syt1 
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antibody, which was taken up by the neurons. Additionally, intracellular antigens were labeled 
with primary antibodies in the subsequent overnight (4°C) incubation of coverslips placed 
upside-down on 50 µl-drops of antibody solutions in GSDB. For different primary and 
secondary antibodies see Table 12.  
 
Table 12: Antibodies used for immunofluorescence staining.  
 
Antibody Host 
Working 
dilution 
Manufacturer* 
Primary antibody    
Ankyrin B mouse 1:5 Santa Cruz 
MAP2 chicken 1:2000 Biosensis 
Munc13-1 guinea pig 1:500 Synaptic Systems 
Syt1 (luminal domain) rabbit 1:200 Synaptic Systems 
VGLUT1 mouse 1:300 Synaptic Systems 
    
Secondary antibody    
anti-chicken Alexa Fluor 647 goat 1:1000 Invitrogen 
anti-guinea pig Alexa Fluor 647 goat 1:1500 Invitrogen 
anti-mouse Alexa Fluor 488 goat 1:2000 Invitrogen 
anti-rabbit Alexa Fluor 555 goat 1:1500 Invitrogen 
 
*Manufacturer information: Santa Cruz (Santa Cruz, USA), Biosensis (Thebarton, Australia), 
Synaptic Systems (Göttingen, Germany), Invitrogen (Carlsbad, USA)  
 
Coverslips were then washed 3 times in GSDB (w/o goat serum) at RT for 10 minutes each 
and once with PBS (w/o Ca2+ and Mg2+) for 30 minutes. These and all the following washing 
steps were carried out during gentle shaking on a rocking plate. Primary antibodies were 
decorated with the respective secondary antibody conjugated to a fluorescent Alexa Fluor dye 
at RT for 2 hours under light exclusion. Afterwards, the coverslips were washed 3 times with 
GSDB (w/o goat serum) for 10 minutes each, once in PBS (w/o Ca2+ and Mg2+) for 30 minutes 
and once in 5 mM phosphate buffer (pH 7.4) for 15 minutes. Coverslip mounting was carried 
out with approximately 6 µl MOWIOL-DABCO mounting medium (10% MOWIOL, 25% 
DABCO, 25% glycerol and 0.1 M Tris) onto microscope slides (Labsolute/Th. Geyer), which 
were stored after consolidation at -20°C protected from light. 
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2.4.5. Image analysis and quantification 
Image acquisition was performed with the confocal microscope LSM 710 from Carl Zeiss 
Microscopy, combined with a 40x magnification oil-objective. Throughout the same 
experiment, images for every condition were obtained using identical acquisition parameters in 
ZEN black imaging software (Carl Zeiss Microscopy) and the same analysis parameters for 
exported raw images in Image J. Each experimental condition was represented by at least 5 
coverslips from 3 or more independently prepared hippocampal cultures. For each coverslip, 
5-10 neurons were analyzed using 3 dendritic regions of interests (ROIs) per neuron. To 
quantify intracellular Syt1 levels, dendritic ROIs of similar size were defined manually in 
Image J for fluorescence intensity calculation in this area. Intensity was normalized to the 
average fluorescence of untreated control samples. 
2.5. Electrophysiology 
2.5.1. Acute brain slice preparation for electrophysiology 
All electrophysiological recordings were performed in collaboration with the Institute of Neuro- 
and Sensory Physiology (University Medical Center Göttingen, Germany). Recordings were 
performed in acute hippocampal slices prepared from ~P60 mice. To this end, mice were 
decapitated under anesthesia with diethylether and the brains rapidly removed from the skull 
and cooled down in ice-cold ACSF for 1–2 minutes. ACSF contained 130 mM NaCl, 24 mM 
NaHCO3, 10 mM glucose, 3.5 mM KCl, 1.2 mM CaCl2 ∙ 2 H2O, 1.2 mM MgSO4 ∙ 7 H2O, 1.25 
mM NaH2PO4 ∙ H2O and was constantly aerated with carbogen (95% O2 and 5% CO2) for pH 
adjustment to 7.4. Coronal slices of 400 µm were cut using the vibroslice 752M (Campden 
Instruments), collected in cold ACSF and the hemispheres separated. Shortly thereafter, slices 
were placed in an Oslo style interface recording chamber and allowed to recover for around 
90 minutes. The interface chamber was maintained at 34–35°C and perfused with oxygenated 
and pre-warmed ACSF at a flow rate of 3–4 ml/min using a peristaltic pump (type 205S, 
Watson-Marlow). Slices were constantly supplemented with carbogen at a flow rate of 400 
ml/min to keep cells alive as long as possible (up to 6 hours). A lid covering the recording 
chamber with a small closable window to place the electrodes prevented the slices from 
draining. 
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2.5.2. Extracellular field potential recordings 
Acute hippocampal slices of WT, PSD-95 KO, PSD-93 KO and PSD-93/95 DKO mice were 
tested at 8–9 weeks of age (i.e., ~P60) with up to 6 slices being used from each animal. 
Extracellular field potential recordings were performed according to Müller & Somjen (1998) 
and Hepp et al. (2005). Electrodes were prepared from thin-walled borosilicate glass 
capillaries (type GC150TF-10, outer/inner diameter 1.5/1.17 mm, wall thickness 0.17 mm; 
Harvard Apparatus) using a horizontal micropipette puller (type P-97, Sutter Instruments). The 
recording electrode was filled with ACSF and its tip carefully trimmed to a resistance of 5–
10 MΩ. The stimulating electrode consisted of a stainless steel microwire (50 µm in diameter, 
AM Systems), which was soldered to a golden pin and thereby connected to the stimulator 
(S88 stimulator with photoelectric stimulus isolation units PSIU6, Grass Technologies). 
Position of both electrodes was controlled manually using micromanipulators.  
Field excitatory postsynaptic potentials (fEPSPs) were evoked by unipolar stimuli of 0.1 ms via 
the stimulating electrode placed at hippocampal CA3–CA1 junction to stimulate the Schaffer 
collateral (SC) pathway. Evoked orthodromic responses were recorded in st. (stratum) 
radiatum of CA1 with a sampling rate of 20 kHz using an extracellular direct current (DC) 
potential amplifier (electronics workshop, Physiology, UMG). The amplifier was controlled 
through the software Axon pCLAMP 9.2 (Molecular Devices LLC) and signals were visualized 
on the digital oscilloscope TDS 2014 (Tektronix). The Axon Instruments Digitizer (Digidata 
1322A) served as an analogue-to-digital converter between the amplifier and computer.  
2.5.3. Input-output curve 
Synaptic strength between SC and CA1 st. radiatum neurons was detected by measuring the 
input-output (I–O) curve via extracellular field potential recordings. To this end, SC neurons 
were stimulated with increasing stimulus intensities of 10–150 µA in 10 µA increments (= total 
of 15 different stimuli) and the resulting fEPSPs in CA1 st. radiatum recorded. fEPSP slopes 
were normalized to presynaptic fiber volley (FV) amplitudes as detected at maximal 
stimulation intensity. For each stimulus intensity, 4 consecutive traces were pooled and 
averaged. Electrophysiological analysis was performed using the Axon Clampfit 9.2 (Molecular 
Devices LLC) software. 
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2.5.4. Paired-pulse ratio 
In order to assess presynaptic neurotransmitter release probability at SC–to–CA1 synapses, 
paired-pulse ratio (PPR) recordings were performed. PPR is a type of short-term plasticity, in 
which two consecutive synaptic responses are evoked by paired, short-interval stimulation. In 
such a recording, the amplitude of the second synaptic response depends on the amplitude of 
the first, with the ratio of the two responses being assumed to depend on the presynaptic 
release probability (Pr) (Dobrunz & Stevens, 1997). The weaker the amplitude of the second 
fEPSP relative to the first, the higher is the presynaptic release probability (and vice versa). 
Stimulus intensity was set to the half-maximal response obtained during I–O curve 
measurements. 2 EPSCs were evoked with paired stimuli of 25–200 ms interpulse intervals in 
25 ms increments (= total of 8 different intervals). The PPR is defined as the ratio of the 
second EPSP amplitude to that of the first response. Paired pulse depression results in 
negative PPR values, whereas positive PPRs arise from paired pulse facilitation. 
2.5.5. Hypoxia induced spreading depression 
As mentioned above, viability of acute hippocampal slices was preserved by continuous 
carbogen supply of the interface chamber (95% O2 and 5% CO2) at a flow rate of 400 ml/min. 
For the induction of spreading depression (SD) according to Gerich et al. (2006), gas supply 
was switched from carbogen to nitrogen (95% N2 and 5% CO2) to create a severe hypoxic 
environment in the chamber, whereas carbogen aeration of ACSF was continued during 
hypoxia. This type of SD is called “hypoxia-induced spreading depression” (HSD). Specifically, 
oxygen withdrawal in the interface chamber induced HSD within 1–2 minutes and the slice 
was reoxygenated by switching back to carbogen 1 min, 2 min or 4 min after HSD onset. The 
HSD-accompanying negative deflection of the extracellular direct current (DC) potential was 
detected and its time to onset (∆t), amplitude (∆V) as well as duration (t1/2) calculated using 
Axon Clampfit 9.2 (Molecular Devices LLC) software. Along this, the amplitude was measured 
between pre-hypoxia baseline and the maximal DC potential change by considering only rapid 
shifts of at least -10 mV amplitude.  
To additionally visualize synaptic function throughout HSD induction and subsequent neuronal 
recovery, fEPSPs were measured upon continuous stimulation of 100 µA and 0.05 Hz (every 
20 s) (Hepp & Müller, 2008).  
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2.5.6. Intrinsic optical signal 
Concomitantly, the intrinsic optical signal (IOS) resulting from changes in tissue light 
reflectance was recorded in st. radiatum of CA1 hippocampus. The HSD-accompanied IOS 
provides information about HSD wave characteristics like its propagation velocity and the 
invaded hippocampal area. To this end, brain slices were illuminated by green light (460–
560 nm) (Mané & Müller, 2012) at an angle of ~45° (light source KL 1500 LCD, Schott) and 
monitored using a computer-controlled imaging system (Polychrome V, TILL Photonics) in 
combination with the sensitive charge-coupled device (CCD) SensiCam camera (Imago QE, 
TILL Photonics). The camera was attached to an upright epifluorescence microscope 
(Axiotech, Carl Zeiss Microscopy) using a 5x, 0.13NA objective (Epiplan 442920, Carl Zeiss 
Microscopy) (Gerich et al., 2006). Images were taken every 2 s with an exposure time of 
15 ms and reflectance changes visualized offline via image subtraction referring to an image 
taken before oxygen withdrawal (Müller & Somjen, 1999). Using a 256 gray-scale mode that 
covers a range of ±20% brightness variation, the intensity and temporal profile was analyzed 
within a rectangular ROI in CA1 st. radiatum close to the recording electrode. At the maximal 
increase in light scattering, tissue area invaded by HSD was calculated by referring to the total 
hippocampal area. The HSD propagation velocity was determined from the progression of the 
reflectance increase in CA1 st. radiatum parallel to st. pyramidale. Images were processed 
and analyzed via TILL Vision 4.0 (TILL Photonics) and MetaMorph 6.1 (Universal Imaging) 
software. 
2.6. Statistical data analysis 
Details of statistical analysis are provided in the respective figure legends and/or result 
sections and a summary of all statistical analysis in Table 17 (appendix). Data from repeated 
runs of the same experiment was pooled and statistically analyzed using two-tailed, unpaired 
Student's t-test. Comparison between genotype (gt) or age (ag) was tested with two-way 
analysis of variance (ANOVA) followed by least significant difference (LSD) post-hoc tests 
using IBM SPSS Statistics software. To additionally describe developmental protein profiles 
for a specific genotype, separate one-way ANOVAs followed by post-hoc LSD multiple 
comparison tests were performed. All data is given as mean values ± standard error of the 
mean (SEM) and significance is indicated as follows: ***p < 0.001; **p < 0.01 and *p < 0.05. 
For biochemical western blot analysis, the sample size (n) is shown as n = number of animals 
tested. For immunofluorescence staining, n represents the number of coverslips for one 
specific condition. The number of acute brain slices analyzed electrophysiologically (n), as well 
as the number of animals (m) in one group is indicated as n/m. 
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3. RESULTS 
 
3.1. Protective effect of PSD-95 KO against hypoxia-
induced synaptic dysfunction 
To investigate if the absence of PSD-93 or PSD-95 – as well as the lack of both proteins 
simultaneously – can be protective for neuronal networks against metabolic compromise, I 
performed a hypoxia-induced spreading depression (HSD) procedure in acute brain slices of 
the respective KO mice. Specifically, I recorded extracellular field potentials (fEPSPs) of 
hippocampal neurons in st. radiatum of the CA1 subfield in response to electrical stimulation of 
the Schaffer collateral (SC) – CA1 pathway in the hippocampal CA3–CA1 junction (Figure 3). 
Using this approach, I examined genotype differences in basal synaptic transmission and 
short-term plasticity of the hippocampal circuitry. Additionally, I assessed genotype effects on 
the network response to severe hypoxia using a combination of electrophysiological and 
optical parameters.  
 
 
Figure 3: Schematic illustration of fEPSP recordings in the hippocampus. fEPSPs were 
recorded in CA1 neurons of the st. radium (Erec) and evoked by stimulating the SC pathway (Estim). 
DG, dentate gyrus; sr, stratum radiatum. Image adapted from (Nasir et al., 2010). 
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3.1.1. Altered synaptic transmission and short-term plasticity 
in MAGUK KO mice 
At first, I tested basal synaptic function of hippocampal neurons in brain slices of WT, PSD-95 
KO, PSD-93 KO and PSD-93/95 DKO mice at two months of age (P58–65). fEPSPs were 
recorded upon single pulse stimulation with gradually increasing current intensities of 10–150 
µA using 10 µA increments. The resulting input-output (I-O) curves show characteristic 
progression with increasing fEPSP slopes for higher-intensity stimuli among all genotypes 
(Figure 4A; values in Table 15 (appendix); stimulus intensity effect: F14,700 = 33.078, p < 
0.001]. However, a genotype effect [F3,50 = 7.422, p < 0.001] dependent on the stimulus 
intensity [interaction effect: F42,700 = 5.827, p < 0.001] was detected. Notably, slices from PSD-
95 KO and PSD-93/95 DKO mice displayed lower strength of synaptic transmission compared 
to control mice as evidenced by fEPSP slope reduction of more than 50% [PSD-95 KO vs. 
WT, p = 0.012; PSD-93/95 DKO vs. WT, p = 0.004; PSD-95 vs. PSD-93/95 DKO, p = 0.458]. 
By contrast, PSD-93 deficient mice were undistinguishable from WT [PSD-93 KO vs. WT, 
p = 0.280] and exhibited strongly enhanced responses compared to PSD-95 KO and PSD-
93/95 DKO mice [PSD-93 KO vs. PSD-95 KO, p = 0.001; PSD-93 KO vs. PSD-93/95 DKO, p 
< 0.001].  
In order to evaluate a form of short-term synaptic plasticity, I measured paired-pulse ratios 
(PPRs). Specifically, pairs of EPSPs were evoked, from which the PPR was calculated as the 
amplitude ratio of the second to the first EPSP. The stimulus intensity was adjusted to half-
maximal response, gained from I-O curves and the interpulse interval progressively increased 
from 25 to 200 ms in 25 ms increments (8 steps in total). The resulting PPR is assumed to be 
inversely correlated with presynaptic release probability (Pr) at glutamatergic synapses 
(Dobrunz & Stevens, 1997). Upon electrical stimulation, calcium influx into the presynaptic 
terminal is triggered by the incoming action potential, which promotes vesicle fusion and 
subsequent neurotransmitter release. In case of low Pr many vesicles are not released and 
stay docked at the presynaptic membrane after the first action potential occurred. Hence, the 
residual calcium accumulates with calcium from the second action potential evoked shortly 
after, leading to elevated vesicle fusion events and a stronger postsynaptic response. This 
scenario causes increased amplitudes of the second EPSP, rendering synapses with low Pr 
more likely to exhibit paired-pulse facilitation (i.e., PPR values greater than one). By contrast, 
at synapses with high Pr, neuronal depolarization evokes more likely vesicle fusion, so that 
less vesicles stay docked at the membrane following the first action potential. These synapses 
typically show smaller amplitudes of the second EPSP and thus exhibit paired-pulse 
depression, in which the PPR is smaller than one. 
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PPR curves of all experimental groups exhibited amplitude ratios above one, thus indicating 
paired-pulse facilitation (Figure 4B; EPSP2/EPSP1 values are provided in Table 16, 
appendix). The characteristic decrease in PPR with longer interstimulus intervals [F7,371 = 
33.046, p < 0.001] can be explained by increasing duration until the second action potential, 
during which residual calcium can be cleared from the presynaptic terminal, resulting in lower 
secondary EPSP amplitudes and therefore lower PPRs. Interestingly, PSD-95 KO as well as 
PSD-93/95 DKO slices exhibited less pronounced facilitation compared to WT and PSD-93 
KO mice [F3,53 = 4.789, p = 0.005; PSD-95 KO vs. WT, p = 0.015; PSD-95 KO vs. PSD-93 KO, 
p = 0.003; PSD-93/95 DKO vs. WT, p = 0.036; PSD-93/95 DKO vs. PSD-93 KO, p = 0.009, all 
other p values > 0.05]. The genotype effect was especially strong for short interpulse intervals 
as indicated by the interaction effect [F21,371 = 2.107, p = 0.003].  
This result implies higher Pr in mice lacking PSD-95 or both PSD-95 and PSD-93, 
respectively, whereas in the absence of PSD-93, results were undistinguishable from control. 
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Figure 4: Changed hippocampal synaptic transmission and short-term synaptic plasticity 
in MAGUK KO mice. (A) The I-O curves showed decreased synaptic transmission in PSD-95 KO 
and PSD-93/95 DKO mice as compared to WT. In contrast, recordings from PSD-93 KO slices 
revealed significantly higher synaptic transmission than PSD-95 KO and PSD-93/95 DKO slices but 
were undistinguishable from WT mice. WT, n/m = 16/6; PSD-95 KO, n/m = 15/7; PSD-93 KO, n/m 
= 15/4; PSD-93/95 DKO, n/m = 9/3. (B) Positive PPR values (PPR, amplitude ratio EPSP2/EPSP1) 
indicated paired-pulse facilitation, which was decreased for PSD-95 KO and PSD-93/95 DKO mice. 
The PPR curve of PSD-93 KO samples was comparable to WT results. WT, n/m = 16/6; PSD-95 
KO, n/m = 15/7; PSD-93 KO, n/m = 16/4; PSD-93/95 DKO, n/m = 10/3. (C) Sample traces of 
fEPSP potential recordings with varying stimulus intensities (10–150 µA). Traces are shown for an 
interstimulus interval of 50 ms. (A-B) Two-way ANOVA followed by post-hoc LSD multiple 
comparison tests. ***p < 0.001; **p < 0.01; *p < 0.05. All data were given as means ± SEM.  
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3.1.2. Electrical and optical properties of HSD waves 
To examine if the MAGUK KO results in modified susceptibility to hypoxia, I triggered HSD 
episodes by severe extracellular oxygen withdrawal in hippocampal slices. Characteristic SD 
waves were evoked by massive neuronal and glial depolarization, propagating throughout the 
brain tissue by synchronization of neighboring cells. This phenomenon is also optically visible 
and can be monitored through the so-called intrinsic optical signal (IOS) which provides a 
spatiotemporal pattern of the SD wave (Aitken et al., 1999; Andrew et al., 1999). The 
characteristic increase in tissue light reflectance starting at HSD onset is illustrated in Figure 5. 
The HSD wave predominantly invaded CA1 region, which is consistent with previous studies 
(Schmidt-Kastner & Freund, 1991). Typically, it spread along the dentate gyrus and 
propagated through, but – if at all – just partly invaded the CA3 subfield. Granule cells of the 
dentate gyrus have been reported to be very resistant and just rarely show cell damage after 
relatively long ischemic periods (Schmidt-Kastner & Hossmann, 1988). Nevertheless, the here 
seen invasion of the dentate gyrus is in accordance with other studies showing similar HSD 
wave patterns using acute mouse (Fischer et al., 2008) or rat brain slices (Basarsky et al., 
1998). Notably, the reflectance increase was most pronounced in the dendritic layers (st. 
radiatum and st. oriens) but almost absent in st. pyramidale, in accordance with previous 
studies (Andrew et al., 1999). 
 
Figure 5: Intrinsic optical signal of the HSD wave in hippocampal slices. (A, B) The 
spatiotemporal IOS pattern shows an increase in tissue light reflectance starting at HSD onset 
(t=0). (A) Hippocampal tissue was illuminated with green light (460–560 nm) and HSD evoked 
following oxygen deprivation. Tissue light reflectance was detected in a small region of interest 
(ROI, indicated as a white square) in st. radiatum close to the recording electrode. Images result 
from subtraction as referred to normoxic baseline reflectance in order to visualize the changes in 
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light reflectance due to HSD (256 gray-scale covering a total range of ±20% brightness variation). 
The last image (+134 s) displays maximal spatial HSD spread. Time points relative to HSD onset at 
the recording electrode are provided in the left upper corner. (B) HSD-associated changes in tissue 
light reflectance normalized to prehypoxic baseline. In this example trace, HSD occurred 90 s after 
establishing a severe hypoxic environment. (C) Positions of the stimulation and recording electrode 
in the hippocampal slice. sr, stratum radiatum; SE, stimulation electrode; RE, recording electrode. 
 
Moreover, HSD is accompanied by an abrupt, massive decrease in the direct current (DC) 
potential and therefore also electrophysiologically detectable (Leão, 1947; Müller & Somjen, 
2000a). Figure 6 displays this negative DC shift – which occurs ~1–2 minutes after oxygen 
withdrawal – and its characteristic parameters. To test different severities of metabolic 
compromise, I varied the duration of the hypoxic state by initiating reoxygenation either from 
1 minute, 2 minute or 4 minutes after HSD onset, with the latter being defined as the starting 
point of the DC shift. Longer time periods until reoxygenation resulted in later recovery of the 
DC potential and therefore in prolonged HSD durations (Figure 6A–C). Each brain slice was 
exposed to hypoxic treatment only once to ensure similar health and neuronal activity 
conditions throughout all measurements. HSD was quantified using the following readouts: 
HSD amplitude (i.e. DC potential deflection), time to HSD onset, and duration of the half 
maximum amplitude (Figure 6D). 
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Figure 6: HSD-accompanied negative deflection of the DC potential. (A–C) The initial graph 
sections show baseline extracellular field potential recordings under continuous carbogen (95% O2 
and 5% CO2) supply, indicated as O2. At time point zero (t=0), gas supply was switched to nitrogen 
(95% N2 and 5% CO2) for hypoxia induction, indicated as N2. 1–2 min upon oxygen withdrawal, a 
rapid negative deflection of the DC potential marked the onset of HSD. 1 min (A), 2 min (B) or 
4 min (C) after this onset, oxygen was resubmitted to the brain slice which allows the DC potential 
to recover. (D) Example trace of DC potential recordings illustrating characteristic parameters of 
HSD-associated negative deflection such as amplitude, time to onset and the duration measured at 
half maximum amplitude.  
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3.1.3. Delayed onset of hypoxia-induced spreading depression 
in PSD-95 KO mice 
In the following, I analyzed HSD in WT and KO mice at 2 months of age (P55–65) and found 
that the onset upon oxygen withdrawal was strongly dependent on genotype [Figure 7A; F3,184 
= 5.787, p = 0.001]. Interestingly, HSD onset was delayed by ~20% in PSD-95 KO slices as 
compared to control [WT: 106.20 ± 3.43 s; PSD-95 KO: 126.85 ± 6.25 s; PSD-95 KO vs. WT, 
p = 0.002]. Moreover, PSD-95 KO mice exhibited later HSD onset compared to PSD-93 KO 
and PSD-93/95 DKO, both of which were undistinguishable from WT [PSD-93 KO: 113.81 ± 
4.04 s; PSD-93/95 DKO: 101.79 ± 3.80 s; PSD-95 KO vs. PSD-93 KO, p = 0.041; PSD-95 KO 
vs. PSD-93/95 DKO, p < 0.001; all other p values > 0.05]. Together, these results indicate 
reduced susceptibility to hypoxia in the absence of PSD-95 but not PSD-93. Notably, 
simultaneous deletion of PSD-93 counteracted the protective effects of PSD-95 KO, as 
evidenced by normal HSD onset in DKO slices. 
The DC potential drop in WT samples reached an amplitude of -17.14 ± 0.40 mV, which 
turned out to be not affected by genotype [Figure 7B; PSD-95 KO: -16.59 ± 0.45 mV; PSD-93 
KO: -16.97 ± 0.40 mV; PSD-93/95 DKO: -16.92 ± 0.34 mV; F3,184 = 0.327, p = 0.806]. 
I obtained similar results for the HSD duration, which was unchanged in the absence of either 
PSD-93 or PSD-95 and both proteins simultaneously (Figure 7C). The HSD durations for the 
three different time periods until reoxygenation were analyzed separately [1 min: F3,64 = 0.953, 
p = 0.420; 2 min: F3,59 = 0.670, p = 0.574; 4 min: F3,53 = 0.803, p = 0.498]. For early 
reoxygenation (after 1 min), HSD lasted 82.36 ± 2.76 s in WT hippocampi [PSD-95 KO: 93.10 
± 10.13 s; PSD-93 KO: 89.06 ± 3.27 s; PSD-93/95 DKO: 88.80 ± 2.58 s] and increased by an 
average of ~64% to 134.86 ± 4.47 s if the hypoxic phase was doubled in time [reoxygenation 
2 min after HSD onset: PSD-95 KO: 138.80 ± 1.93 s; PSD-93 KO: 138.31 ± 1.70 s; PSD-
93/95 DKO: 140.04 ± 1.77 s]. By again doubling the time for reoxygenation to 4 minutes, the 
HSD duration was lengthened by about 53% to 206.78 ± 17.68 s [PSD-95 KO: 212.07 ± 
15.96 s; PSD-93 KO: 213.60 ± 14.47 s; PSD-93/95 DKO: 235.96 ± 9.83 s].  
The profile of negative DC deflection mostly showed the characteristic inverted saddle shape, 
comprised of an early sharp peak followed by a second negative peak or lower plateau (Figure 
7D), with the latter reported to be mainly shaped by NMDAR-mediated currents (Marrannes et 
al., 1988; Herreras & Somjen, 1993; Krüger et al., 1999).  
HSD-induced DC potential changes are typically divided into three phases (Martin et al., 1994; 
Frenguelli, 1997). The initial short hyperpolarization is thought to result from enhanced 
membrane conductance to K+ via the activation of voltage-gated, ATP- and/or Ca2+-sensitive 
K+ channels. Subsequently, a rapid and marked depolarization (second phase) is mediated by 
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GluR currents and the inhibition of Na+/K+-ATPase, leading to disrupted ion homeostasis and 
near complete depolarization of neurons and glial cells. After reoxygenation, extracellular ion 
concentrations and neurotransmitter levels become reinstated mainly by the activity of Na+/K+-
ATPase and glutamate uptake (Martin et al., 1994). Typically, these processes transiently 
overshoot as seen by a posthypoxic hyperpolarization with a DC potential higher than baseline 
levels (Figure 7D) (Hansen & Zeuthen, 1981). 
 
Figure 7: Time to HSD onset was prolonged by loss of PSD-95. (A) Bar graph depicting the 
times to HSD onset following oxygen withdrawal. PSD-95 KO slices showed delayed HSD onset 
compared to WT, PSD-93 KO and PSD-93/95 DKO mice. (B) No significant changes were 
observed for the amplitude of negative DC potential deflection. (C) Bar graph displaying HSD 
duration which showed no genotype effect, irrespective of the reoxygenation condition (1 min, 
2 min and 4 min, respectively). (D) Sample traces of DC potential recordings with the arrow 
indicating gas supply switch from oxygen to nitrogen for hypoxia induction. In this sample trace, 
slices were reoxygenated 2 min after the onset of HSD. (A, B) WT, n/m = 44/9; PSD-95 KO, n/m = 
48/12; PSD-93 KO, n/m = 50/11; PSD-93/95 DKO, n/m = 46/11. (C) 1 min: WT, n/m = 16/9; PSD-
95 KO, n/m = 19/11; PSD-93 KO, n/m = 17/9; PSD-93/95 DKO, n/m = 16/11. 2 min: WT, n/m = 
15/9; PSD-95 KO, n/m = 15/10; PSD-93 KO, n/m = 18/11; PSD-93/95 DKO, n/m = 15/9. 4 min: WT, 
n/m = 13/9; PSD-95 KO, n/m = 14/10; PSD-93 KO, n/m = 15/8; PSD-93/95 DKO, n/m = 15/9. One-
way ANOVA followed by post-hoc LSD multiple comparison tests. ***p < 0.001; **p < 0.01; *p < 
0.05. All data were given as means ± SEM. 
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3.1.4. Modified intrinsic optical signals indicate a protective 
capacity of PSD-95 loss against hypoxia 
3.1.4.1. Loss of PSD-95 attenuates the increase of tissue light 
reflectance during HSD 
The protective effect of PSD-95 KO against hypoxia, as so far indicated by delayed HSD 
onset, was also observed on the level of HSD-accompanying change in tissue light reflectance 
(IOS). The IOS displayed a characteristic profile with a brief, weak decrease in tissue light 
reflectance (visible in Figure 8A and C), followed by a sharp and pronounced increase, which 
slowly declined after resubmission of oxygen. Frequently, a secondary increase during 
recovery was visible, which was likely caused by “undershoot” of the cell volume as cells 
recover from the preceding swelling (Figure 8, arrowheads) (Andrew et al., 1999; Somjen, 
2001). Furthermore, dendritic beading has been shown to occur in the brain following ischemia 
and might as well account for the increase in light scattering (Hori & Carpenter, 1994).  
As seen in Figure 8A and B, the increase in reflectance was markedly attenuated in PSD-95 
KO mice when oxygen was resupplied 1 or 2 minutes upon HSD onset. The same tendency 
was present for longer hypoxic periods (4 min, Figure 8C). Furthermore, PSD-93/95 DKO 
slices showed a somewhat lower reflectance change for early reoxygenation (1 minute) and a 
slowly developing, moderate secondary increase during recovery, which was absent in the 
other experimental groups. In contrast to affected intensities of tissue reflectance change, the 
time course seemed to be unaltered among the genotypes.  
In detail, by comparing the maximal tissue reflection (Figure 8D), control slices demonstrated 
20.40 ± 1.58% increase upon hypoxia for the 1 minute condition, whereas this signal was 
substantially reduced to 11.23 ± 1.52% in the absence of PSD-95 [F3,55 = 7.617, p < 0.001; 
PSD-95 KO vs. WT, p < 0.001]. The KO of PSD-93 as well as PSD-93 and PSD-95 
simultaneously did not have significant effects as compared to WT; however, reflectance 
increases were stronger than in PSD-95 KO mice [PSD-93 KO: 19.52 ± 1.51%; PSD-93/95 
DKO: 16.46 ± 1.46%; PSD-95 KO vs. PSD-93 KO, p < 0.001; PSD-95 KO vs. PSD-93/95 
DKO, p = 0.016].  
I obtained similar results for IOS intensities when the brain tissue was reoxygenated 2 minutes 
after HSD onset. WT hippocampi showed an increase of 19.68 ± 1.33%, whereas light 
reflectance augmented by only 14.82 ± 1.65% in PSD-95 KO mice [PSD-93 KO: 20.82 ± 
1.39%; PSD-93/95 DKO: 20.01 ± 1.27%; F3,58 = 3.720, p = 0.016; PSD-95 KO vs. WT, p = 
0.020; PSD-95 KO vs. PSD-93 KO, p = 0.003; PSD-95 KO vs. PSD-93/95 DKO, p = 0.015]. 
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Regarding the immense prolonged and stressful hypoxic period up to 4 minutes, no genotype 
differences were evident [WT: 18.47 ± 1.40%; PSD-95 KO: 16.74 ± 1.84%; PSD-93 KO: 
21.23 ± 1.72%; PSD-93/95 DKO: 21.21 ± 1.65%; F3,48 = 1.755, p = 0.168]. Nevertheless, 
tissue light reflectance recovered much slower and remained quite high after reoxygenation, 
especially in case of PSD-93 KO and PSD-93/95 DKO mice. Strikingly, the second increase 
was intensified and prolonged in all slices, irrespective of genotype (Figure 8C). All these 
observations point to a diminished or even absent recovery of neuronal tissue after the 
extensive time period of oxygen lack. This aspect, I will further examine in section 3.1.5.3 by 
assessing synaptic recovery via recording of evoked responses.  
In conclusion, when slices were reoxygenated within less than 4 minutes, the HSD-associated 
increase in tissue light reflectance was strongly attenuated in the absence of PSD-95. This 
effect was seen in slices reoxygenated either 1 or 2 minutes after HSD onset and thus 
replicable. In line with my previous findings on HSD onset, these data point to a protective 
effect of the PSD-95 loss against hypoxia-induced network dysfunction. Strikingly, this effect 
was abolished by simultaneous deletion of PSD-93. 
 
 
 
 
 
 
 
[figure on next page] 
Figure 8: Reduced light reflectance response of hippocampal tissue in PSD-95 KO mice 
after HSD induction. (A-C) Temporal pattern of the reflectance changes aligned to the onset of 
HSD (at t=0). Oxygen was resupplied 1 min (A), 2 min (B) and 4 min (C) after HSD onset, 
respectively. Arrowheads indicate a secondary increase in tissue light reflectance. (D) Bar graph 
depicting the corresponding maximal tissue reflectance rise shown in A-C. PSD-95 KO mice 
displayed reduced intensity changes as compared to all other genotypes in case of reoxygenation 
1 min or 2 min upon HSD onset. Diminished recovery was observed in all brain slices facing the 
longest hypoxic time period (4 min, C). 1 min: WT, n/m = 13/9; PSD-95 KO, n/m = 16/10, PSD-93 
KO, n/m = 15/10; PSD-93/95 DKO, n/m = 15/10. 2 min: WT, n/m = 15/9; PSD-95 KO, n/m = 16/10; 
PSD-93 KO, n/m = 17/11; PSD-93/95 DKO, n/m = 14/10. 4 min: WT, n/m = 15/9; PSD-95 KO, n/m 
= 16/11; PSD-93 KO, n/m = 17/9; PSD-93/95 DKO, n/m = 14/10. One-way ANOVA followed by 
post-hoc LSD multiple comparison tests. ***p < 0.001; **p < 0.01; *p < 0.05. All data were given as 
means ± SEM. 
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3.1.4.2. Trend to decelerated HSD wave propagation in PSD-95 KO 
slices 
Further analysis of the IOS provided information about HSD wave characteristics such as its 
propagation velocity and maximum spread throughout the brain slice.  
At light reflectance peak, the relative tissue area being invaded by an HSD episode was 
calculated with reference to total hippocampal size. In WT mice, 67.92 ± 0.013% of the 
hippocampus displayed IOS effects, which did not differ significantly from those areas 
obtained in KO mice [Figure 9A, PSD-95 KO: 64.48 ± 0.017%; PSD-93 KO: 65.88 ± 0.017%; 
93-95 DKO: 65.42 ± 0.014%; F3,170 = 0.864, p = 0.461]. Therefore, PSD-95 loss could not 
protect parts of the hippocampus from the hypoxic, depolarized state by supposably impaired 
synchronization of neighboring neurons, which could prevent further HSD wave propagation. 
In contrast, a trend towards a genotype effect was gained from the analyzed velocities of HSD 
wave propagation [Figure 9B; F3,175 = 2.508, p = 0.061]. Even though the main effect was not 
significant, I did an exploratory comparison among the genotypes. In control samples, the 
velocity averaged in 6.62 ± 0.27 mm/min, which was decelerated to 5.72 ± 0.26 mm/min in 
the absence of PSD-95, corresponding to a decrease of ~13.6% [PSD-95 KO vs. WT, p = 
0.036]. Again, propagation velocities of PSD-93 KO as well as PSD-93/95 DKO were similar to 
WT levels, but higher compared to PSD-95 KO [PSD-93 KO: 6.57 ± 0.28 mm/min; PSD-93/95 
DKO: 6.72 ± 0.22 mm/min; PSD-95 KO vs. PSD-93 KO, p = 0.039; PSD-95 KO vs. PSD-
93/95 DKO, p = 0.017; all other p values > 0.05]. These observations corroborate my previous 
results showing partly dampened hypoxia-induced impairments in PSD-95 KO neuronal 
networks. Specifically, in this case, by a decelerated transfer of the depolarized and non-
functional neuronal state onto the neighboring tissue. The effect of PSD-95 loss was again 
abrogated by simultaneous knockout of PSD-93. 
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Figure 9: The HSD wave proliferated more slowly in the absence of PSD-95. (A) Bar graph 
illustrating the HSD invaded area as referred to total hippocampus, which was undistinguishable 
among genotypes. WT, n/m = 41/9; PSD-95 KO, n/m = 46/12; PSD-93 KO, n/m = 44/11; 93-95 
DKO, n/m = 43/11. (B) Propagation of the HSD wave front detected in st. radiatum parallel to st. 
pyramidale was diminished due to loss of PSD-95 compared to all other genotypes. WT, n/m = 
41/9; PSD-95 KO, n/m = 46/12; PSD-93 KO, n/m = 45/11; PSD-93/95 DKO, n/m = 43/11. (A, B) 
One-way ANOVA followed by post-hoc LSD multiple comparison tests. *p < 0.05. All data were 
given as means ± SEM. 
 
3.1.5. Partly reduced hypoxia-induced synaptic dysfunction in 
PSD-95 KO and PSD-93/95 DKO mice 
Throughout optical and electrophysiological monitoring of hypoxia-treated brain slices, I 
evoked fEPSPs to visualize synaptic function of the neuronal network. To this end, I stimulated 
the SC–CA1 hippocampal pathway every 20 s with an intensity of 100 µA and analyzed 
changes in resulting fEPSP amplitudes.  
3.1.5.1. Reduced excitability of PSD-95 KO and PSD-93/95 DKO 
neuronal networks 
By screening fEPSPs of the normoxic baseline, amplitudes were reduced to approximately 
50% in PSD-95 KO and PSD-93/95 DKO mice as compared to control and as well PSD-93 KO 
slices (Figure 10) [WT: 100.00 ± 0.05%; PSD-95 KO: 52.38 ± 0.03%; PSD-93 KO: 111.37 ± 
0.07%; 93-95 DKO: 42.86 ± 0.02%; F3,184 = 53.246, p < 0.001; PSD-95 KO: vs. WT, 
p < 0.001, vs. PSD-93 KO, p < 0.001, vs. PSD-93/95 DKO, p = 0.150; PSD-93 KO: vs. PSD-
93/95 DKO, p < 0.001, vs. WT, p = 0.090; PSD-93/95 DKO vs. WT, p < 0.001]. This is in line 
with the genotype differences seen for the initial I-O curve measurements (3.1.1 and Figure 4) 
and indicates reduced basal synaptic transmission in PSD-95 KO and DKO mice. 
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Figure 10: PSD-95 KO and PSD-93/95 DKO fEPSP amplitudes showed 50% reduction. 
As part of DC potential recordings, hippocampal networks were stimulated every 20 s with an 
intensity of 100 µA. (A) The evoked fEPSP amplitudes are normalized to WT levels. In PSD-95 KO 
and PSD-93/95 DKO slices, fEPSP amplitudes were reduced to about 50% compared to control 
and PSD-93 KO. WT, n/m = 44/9; PSD-95 KO, n/m = 48/12; PSD-93 KO, n/m = 49/11; 93-95 DKO, 
n/m = 46/11. One-way ANOVA followed by post-hoc LSD multiple comparison tests. ***p < 0.001. 
All data were given as means ± SEM. (B) Sample traces of fEPSP potential recordings with a 
stimulus intensity of 100 µA. 
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3.1.5.2. Loss of synaptic function in acute brain slices due to oxygen 
deprivation 
The effects of hypoxia on synaptic function of the SC–CA1 hippocampal pathway are 
demonstrated in Figure 11. Approximately 40 s upon oxygen withdrawal, fEPSP amplitudes 
decreased within about 20 s to 50% as referred to normoxic baseline conditions. After 
~2 minutes following oxygen deprivation, total loss of synaptic function was indicated by the 
absence of fEPSP responses as seen in the recording traces. Following semi-automated 
analysis, amplitudes seem to remain 10–30% of their intensity due to noise peak detection. As 
baseline fEPSP amplitudes were about 50% decreased in PSD-95 KO and PSD-93/95 DKO 
mice (Figure 10), the noise effect was enhanced when normalized to baseline and therefore 
misleads to reduced synaptic loss compared to WT and PSD-93 KO. Thus, statistical analysis 
was neglected. On the descriptive level, I detected similar time courses for the experimental 
mouse groups of reoxygenation 1 minute, 2 minutes and 4 minutes after the onset of HSD. 
However, the loss of synaptic function seemed to be slightly delayed in PSD-95 KO mice, at 
least for the conditions where slices were reoxygenated after 1 minute and 4 minutes, 
respectively (Figure 11A and C, indicated by arrowheads). 
The early occurring synaptic failure represents a major difference of the HSD observed here, 
to normoxic SD (Somjen, 2001). While in normoxic SD, synapses continue to function until 
their ion channels get inactivated due to depolarization, synaptic failure in the present study 
was already seen around one minute before the actual HSD onset. Indeed, the earliest 
consequence of cerebral ischemia is the loss of synaptic activity (Hofmeijer et al., 2012). 
There are various mechanisms which might contribute to the early synaptic failure during 
hypoxia and can occur independently of the following depolarization-induced SD (Somjen et 
al., 1993). Most studies indicate presynaptic dysfunction such as impaired neurotransmitter 
release (Crépel et al., 1993; Frenguelli, 1997; Sun et al., 2002), most likely due to disturbed 
activity of voltage-dependent Ca2+ channels at the presynaptic terminal (Adams et al., 1985; 
Ouanonou et al., 1999). On the other hand, evidence for postsynaptic dysfunction was 
provided by enhanced K+ conductance of the postsynaptic membrane, in turn contributing to 
diminished excitatory transmission by raising the firing threshold (Somjen et al., 1993). 
Additionally, increased intracellular Ca2+ levels – similar to the presynapse – might arise from 
NMDAR overactivation and release from intracellular stores (Nowicky & Duchen, 1998), hence 
disturbing physiological ion gradients and contributing to synaptic failure as seen here. 
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Figure 11: Hypoxia-induced loss of synaptic function in acute hippocampal slices. 
(A-C) Line graphs depicting fEPSP amplitudes normalized to normoxic baseline conditions. 
Datasets for 1 min (A), 2 min (B) and 4 min (C) reoxygenation after HSD onset were analyzed 
separately. Neuronal synapses lost their function completely within about 120 s (2 min) after 
oxygen deprivation (t=0), as seen in the recording traces. Note that due to noise peak effect, zero-
amplitudes are not quiet reached in the line graphs. The absence of PSD-95 promoted a somewhat 
delayed drop of fEPSP amplitude intensities (indicated by arrowheads). (A) WT, n/m = 16/9; PSD-
95 KO, n/m = 19/11; PSD-93 KO, n/m = 15/9; PSD-93/95 DKO, n/m = 16/11. (B) WT, n/m = 15/9; 
PSD-95 KO, n/m = 17/10; PSD-93 KO, n/m = 18/11; 93-95 DKO, n/m = 15/9. (C) WT, n/m = 13/9; 
PSD-95 KO, n/m = 13/10; PSD-93 KO, n/m = 15/8; 93-95 DKO, n/m = 15/9. 
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3.1.5.3. PSD-95 KO and PSD-93/95 DKO mice display improved 
posthypoxic recovery  
More obvious KO effects were seen during synaptic recovery after reoxygenation as reflected 
by a return of fEPSP amplitudes. When oxygen was resubmitted 1 minute after the onset of 
HSD, PSD-95 KO as well as PSD-93/95 DKO slices recovered completely within 9 to 10 
minutes, whereas fEPSP amplitudes of WT and PSD-93 KO samples stagnated at about 70% 
(WT) to 90% (PSD-93 KO) below baseline, reaching a plateau thereafter (Figure 12A). Using 
two-way ANOVA to test for a genotype effect, I detected significant differences comparing 
PSD-95 KO and PSD-93/95 DKO to control samples, respectively [F3,63 = 4.204, p = 0.009; 
PSD-95 KO vs. WT, p = 0.004; PSD-93/95 DKO vs. WT, p = 0.003; all other p values > 0.05].
  
In case of reoxygenation after 2 minutes, synaptic recovery of PSD-95 KO and DKO mice was 
again higher compared to WT, and in addition to PSD-93 KO slices [Figure 12B; F3,61 = 8.458, 
p < 0.001; PSD-95 KO vs. WT, p = 0.003; PSD-95 KO vs. PSD-93 KO, p = 0.008; PSD-93/95 
DKO vs. WT, p < 0.001; PSD-93/95 DKO vs. PSD-93 KO, p < 0.001; all other p values > 0.05]. 
Full recovery was achieved slightly later, i.e. at minute 10 to 11, compared to earlier 
reoxygenation. In contrast, again WT and PSD-93 KO mice did not recover completely, this 
time even less by reaching 60 to 70% of baseline levels.  
When oxygen was deprived for 4 minutes upon HSD detection, the acute brain slices were not 
capable anymore to recover from metabolic stress – at least within the 20 minutes of recovery 
where recordings have been performed. In fact, synaptic responses of all genotypes remained 
under 50% and where hardly distinguishably from noise peaks in the raw traces (Figure 12C). 
Nonetheless, I obtained significantly stronger recovery for PSD-95 KO and DKO neuronal 
network [F3,52 = 18.391, p < 0.001; PSD-95 KO vs. WT, p < 0.001; PSD-95 KO vs. PSD-93 
KO, p < 0.001; PSD-93/95 DKO vs. WT, p < 0.001; PSD-93/95 DKO vs. PSD-93 KO, 
p < 0.001; all other p values > 0.05] which likely resulted from the higher noise impact on 
smaller EPSP amplitudes in these mice as specified before.  
The here detected impaired synaptic recovery after the longest hypoxic period was implied 
before by tissue light reflectance, which remained on very high levels even upon 
reoxygenation after 4 minutes (Figure 8). Accordingly, the recovery of both, synaptic function 
and physical properties of the brain tissue, was impaired after the extensive hypoxic period.  
Highlighted throughout Figure 12A–C is a marked and abrupt peak in synaptic responses 
shortly after oxygen resupply in DKO and to a smaller extent also in PSD-95 KO mice 
(indicated by arrowheads). In addition, PSD-93/95 DKO slices showed posthypoxic 
potentiation with fEPSP amplitudes transiently exceeding the baseline by 10% for 
reoxygenation after 1 minute, and 20% when reoxygenated after 2 minutes, followed by return 
to prehypoxic levels. These two observations were virtually absent in WT and PSD-93 KO 
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mice. Previous studies reported a similar phenomenon, which is referred to as “anoxic LTP” 
(Crépel et al., 1993; Gozlan et al., 1994). Anoxic LTP delineates hypoxia-induced selective 
potentiations of the NMDAR-mediated component of synaptic transmission. This persistent 
form of potentiation is assumed to partially account for delayed neuronal cell death (Crépel et 
al., 1993; Gozlan et al., 1994). In contrast, the potentiation in PSD-93/95 DKO mice seen here 
was transient and characterized by increased fEPSP amplitudes, representing both AMPAR- 
and, to a lesser extent, NMDAR-mediated transmission. A similar transient potentiation has 
been reported by Frenguelli (1997) and linked to strong activity of AMPARs and NMDARs 
during the hypoxic episode. Strong receptor activation is most likely caused by the excess of 
extracellular glutamate, since its uptake is impaired or even reversed by hypoxia (Szatkowski 
& Attwell, 1994). Indeed, the resulting high intracellular Ca2+ levels have been shown to 
provoke transient potentiations of synaptic transmission (Kauer et al., 1988). Furthermore, 
HSD-accompanied cell swelling might contribute to the observed potentiation as reported for 
hyptonia-induced reduction in the interstitial space (Ballyk et al., 1991; Chebabo et al., 1995). 
Thus, several mechanisms possibly account for transient potentiation in mice lacking both 
PSD-95 and PSD-93. They all imply a rather unstable neuronal network, in which synaptic 
activity and cell volume may easily under- and overshoot due to metabolic changes.  
Collectively, these results show improved synaptic recovery in PSD-95 KO mice for 
reoxygenation within less than 4 minutes, demonstrated by faster and more complete 
reinstatement of normoxic fEPSP amplitudes. This result further strengthens the observed 
enhanced hypoxia tolerance due to loss of PSD-95, as clearly seen by a delayed onset of 
HSD (Figure 7) and attenuated change of the HSD-accompanying tissue light reflectance 
(Figure 8). Additional evidence was given by a trend for decelerated HSD wave propagation 
(Figure 9) and slightly delayed hypoxia-induced loss of synaptic function in PSD-95 KO mice 
(Figure 11). Interestingly, all these effects were consistently abolished by additional knockout 
of the paralog PSD-93, but with the only exception of synaptic recovery. Indeed, mice with a 
loss of both proteins, PSD-93 and PSD-95, as well showed improved ability for posthypoxic 
recovery as seen in Figure 11. However, synaptic function in DKO mice seemed to be more 
unstable and susceptible for changes in oxygen levels as indicated by the abrupt and 
prominent increase in fEPSP amplitudes shortly after reoxygenation and by transient 
posthypoxic potentiation during recovery (Figure 12). 
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Figure 12: Brain slices from PSD-95 KO and PSD-93/95 DKO mice demonstrated earlier and 
increased posthypoxic recovery. (A-C) Displayed are time courses for fEPSP amplitudes 
normalized to prehypoxic baseline after reoxygenation at t=0. (A, B) PSD-95 KO and DKO slices 
showed complete synaptic recovery, whereas WT and PSD-93 KO slices recovered markedly 
slower and did not return to normoxic baseline levels. (C) When oxygen was resubmitted 4 min 
after HSD onset, acute brain slices failed to recover within the analyzed time period of 20 min. 
(A–C) Arrowheads indicate an abrupt amplitude increase detected in DKO and partially in PSD-95 
KO mice. Please note the before mentioned influence of noise peaks on the calculation of 
amplitude values, wherefore zero-amplitudes at t=0 are not quiet reached. (A) WT, n/m = 16/9; 
PSD-95 KO, n/m = 19/11; PSD-93 KO, n/m = 16/9; PSD-93/95 DKO, n/m = 16/11. (B) WT, n/m = 
15/9; PSD-95 KO, n/m = 17/10; PSD-93 KO, n/m = 18/11; PSD-93/95 DKO, n/m = 15/9. (C) WT, 
n/m = 13/9; PSD-95 KO, n/m = 13/10; PSD-93 KO, n/m = 15/8; PSD-93/95 DKO, n/m = 15/9. Two-
way ANOVA followed by post-hoc LSD multiple comparison tests. ***p < 0.001; **p < 0.01. All data 
were given as means ± SEM. 
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3.2. Synaptic composition of excitatory cortical neurons 
in MAGUK KO mice 
I then aimed to gain deeper insight into the consequences of PSD-93 and/or PSD-95 KO on 
synapse composition and function, in order to identify molecular candidates mediating the 
striking effect of PSD-95 loss on hypoxia susceptibility. PSD-93 as well as PSD-95 are known 
to play prominent roles in the organization of glutamatergic receptors. Indeed, we previously 
showed that single loss of PSD-95 or PSD-93 has opposing effects on developmental silent 
synapse maturation in a variety of cortical areas, including hippocampus (Huang et al., 2015a; 
D. Favaro et al., in press). Specifically, PSD-95 KO mice maintain a very high level (about 
50%) of synapses lacking AMPAR-mediated transmission – the so-called “silent synapses” – 
into adulthood, whereas silent synapses in WT mice almost mature completely (Huang et al., 
2015a). In contrast, their maturation was accelerated in mice lacking PSD-93, which altogether 
demonstrates a promoting effect of PSD-95 and an inhibiting effect of PSD-93 for the 
maturation of silent synapses (D. Favaro et al., in press). Interestingly, in mice lacking both 
paralogs, the fraction of silent synapses was similar to WT mice as reported until late critical 
period of primary visual cortex (V1) (D. Favaro et al., in press).  
Silent synapses have been proposed to serve as substrates for synaptic plasticity during early 
refinement of cortical networks (Isaac et al., 1995; Liao et al., 1995; Isaac & Crair, 1997). 
Hence, loss of PSD-95 and the resulting high proportion of silent synapses into adulthood 
virtually maintains this plasticity on the level of juvenile animals, which are known to possess 
increased capabilities of learning and neuronal network reorganization. Indeed, juvenile ocular 
dominance (jOD) plasticity was preserved in adult PSD-95 KO mice (Huang et al., 2015a). As 
younger animals are also known to exhibit higher neuronal regeneration capacities than 
adults, a plausible link between PSD-95 KO and enhanced hypoxia tolerance lies in the 
preserved plasticity due to higher number of silent synapses, possibly providing lower 
susceptibility for hypoxia-induced dysfunction and improved recovery potential. 
Since the exact molecular composition of silent synapses and its developmental changes still 
remain to be clarified, I addressed total as well as surface GluR levels in WT and MAGUK KO 
mouse brains in different developmental stages in order to reveal potential changes in PSD-
93- or PSD-95-mediated synaptic processes. 
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3.2.1. Similar cortical protein levels of glutamate and GABA 
receptors in WT and PSD-95 KO mice 
Huang et al. (2015a) showed that the fraction of V1 silent synapses declined from ~55% at 
P10–12 before eye opening to about 25% at the age of P25–30 but remained unchanged in 
the absence of PSD-95 even into adulthood.  
At first, I assessed the developmental change of total GluR and GABAA receptor subunit levels 
in whole-cortex brain slices of WT and PSD-95 KO mice starting from eye opening (P13–14) 
to 3 weeks (P20–21) and 4 weeks of age (P28–32) (Figure 13). The exact numbers of western 
blot analysis with normalization to P28–32 levels are provided in Table 13. In order to see the 
effect of PSD-95 KO on receptor expression, I performed a direct comparison of the absolute 
values obtained from western blot quantification (Figure 14). At P13–14, protein levels in PSD-
95 KO did not differ from control samples in any of the assessed proteins (i.e., GluA1, GluA2, 
GluN2A, GluN2B and GABAα1; Figure 14). Indeed, Huang et al. (2015a) showed in V1 that the 
expression of PSD-95 only starts by the age of eye opening. Therefore, PSD-95 KO is unlikely 
to have pronounced effects on synaptic protein levels at P13–14 since it is barely expressed at 
this developmental stage. 
 
Table 13: Developmental profile of glutamatergic and GABAergic receptor subunits in WT 
and PSD-95 KO cortex.  
 
Genotype Age [P] Total protein level [norm. to P28–32]; mean ± SEM 
 
  GluA1 GluA2 GluN2A GluN2B GABAα1 
WT 
13-14 0.80 ± 0.06 1.01 ± 0.05 0.68 ± 0.04 1.38 ± 0.02 0.50 ± 0.09 
20-21 1.16 ± 0.17 1.27 ± 0.14 0.89 ± 0.06 1.49 ± 0.14 0.15 ± 0.03 
28-32 1.00 ± 0.12 1.00 ± 0.09 1.00 ± 0.07 1.00 ± 0.11 1.00 ± 0.06 
PSD-95 
KO 
13-14 0.74 ± 0.08 1.19 ± 0.11 0.53 ± 0.04  1.06 ± 0.06 0.42 ± 0.04 
20-21 0.91 ± 0.23 1.16 ± 0.27 0.82 ± 0.08 1.01 ± 0.11 0.49 ± 0.07 
28-32 1.00 ± 0.13 1.00 ± 0.08 1.00 ± 0.23 1.00 ± 0.09 1.00 ± 0.11 
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Figure 13: Developmental profile of cortical protein expression in WT and PSD-95 KO brain 
slices. (A) Western blot analysis showing total levels of receptor subunits in three developmental 
stages (P13–14, P20–21 and P28–32) of WT and PSD-95 KO mice. Band intensities were 
normalized to Munc13-1 as a loading control, which also showed a developmental increase but 
was not different among genotypes. (B, C) Quantified protein levels were normalized to P28–32 as 
demonstrated in Table 13 and plotted against age for WT (B) and PSD-95 KO (C), respectively. 
(A–C) WT P13-14, n = 4; WT P20-21, n = 3; WT P28-32, n = 6; PSD-95 KO P13-14, n = 4; PSD-95 
KO P20-21, n = 4; PSD-95 KO P28-32, n = 5; for all subunits. One-way ANOVA followed by post-
hoc LSD multiple comparison tests. ***p < 0.001; **p < 0.01; *p < 0.05. All data were given as 
means ± SEM. 
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Figure 14: Comparison of glutamate and GABAA receptor levels in WT and PSD-95 KO 
cortices. (A–C) Quantified protein levels were normalized to WT P28–32 and plotted against age 
for the GABAα1 subunit (A), NMDAR subunits (B) and AMPAR subunits (C). Significant 
developmental changes are indicated, and no genotype effect detected. (A-C) WT P13-14, n = 4; 
WT P20-21, n = 3; WT P28-32, n = 6; PSD-95 KO P13-14, n = 4; PSD-95 KO P20-21, n = 4; PSD-
95 KO P28-32, n = 5; for all subunits. One-way ANOVA followed by post-hoc LSD multiple 
comparison tests. ***p < 0.001; **p < 0.01; *p < 0.05. All data were given as means ± SEM. 
 
As demonstrated in Figure 13, GABAα1 subunit levels in inhibitory synapses showed the 
steepest rise with 40–50% at P13–14 to reference level of 100% at P28–32, in WT as well as 
in PSD-95 KO mice [age (ag): WT, Fag(2,10) = 35.650, pag < 0.001; PSD-95 KO, Fag(2,10) = 
15.623, pag = 0.001]. However, WT samples displayed a minimum of 15% protein expression 
at 3 weeks of age (P20–21), which was absent in PSD-95 KO mice [WT: P13-14 vs. P20-21, p 
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= 0.011, P13-14 vs. P28-32, p < 0.001, P20-21 vs. P28-32, p < 0.001; PSD-95 KO: P13-14 vs. 
P20-21, p > 0.05, P13-14 vs. P28-32, p = 0.001, P20-21 vs. P28-32, p = 0.001]. The observed 
sharp increase of subunit expression starting at P20–21 is in parallel to the reported pivotal 
role of inhibitory interneurons in triggering the onset of critical period plasticity in the visual 
cortex (Huang et al., 1999; Fagiolini & Hensch, 2000). Comparison of both genotypes among 
all developmental stages showed a trend for generally higher GABAα1 levels in PSD-95 KO 
mice, while the developmental trajectories were highly comparable [Figure 14A; genotype (gt): 
Fgt(1,20) = 4.271, pgt = 0.052 (trend); Fag(2,20) = 44.529, pag < 0.001; pgtxag > 0.05].  
Expression of the NMDAR subunit GluN2A increased progressively with age, possibly due to 
growth and/or linkage of new excitatory synapses after eye opening. The developmental 
increase reached significance for WT mice but not for PSD-95 KO mice, presumably due to 
the relatively small n-number and high variance [Figure 13B/C; WT: Fag(2,10) = 6.348, 
pag = 0.017; P13-14 vs. P28-32, p = 0.005, all other p values > 0.05; PSD-95 KO: pag > 0.05 
(note high SEM for P28-32)]. By comparing both genotypes, GluN2A expression was 
unaffected in the absence of PSD-95 [Figure 14B; pgt > 0.05; Fag(2,20) = 4.972, pag = 0.018; 
pgtxag > 0.05].  
In contrast to the developmental increase of GluN2A levels, GluN2B subunits declined 
markedly in WT mice from ~140% at P13–14 to P28–32 reference levels with a slight peak at 
P20–21, whereas in PSD-95 KO mice, the developmental change was absent [Figure 14B; 
pgt > 0.05; Fag(2,20) = 3.455, pag = 0.051 (trend), pgtxag > 0.05; WT:  Fag(2,10) = 6.651, pag = 0.015; 
P13-14 vs. P20-21, p > 0.05, P13-14 vs. P28-32, p = 0.021, P20-21 vs. P28-32, p = 0.009; 
PSD-95 KO: pag > 0.05]. The GluN2B drop is in accordance with the reported developmental 
switch of GluN2B- to GluN2A-containing NMDARs in the cerebral cortex – triggered by 
receptor activity and sensory experience (Monyer et al., 1994; Sheng et al., 1994). As the 
GluN2B expression remained unchanged in PSD-95 KO samples, the subunit exchange 
seemed to be impaired, which is presumably linked to the lack of silent synapse maturation 
after eye opening. This observation is in consistent with a previous study showing that PSD-95 
is essential for the replacement of GluN2B- with GluN2A-containing NMDARs (Elias et al., 
2008).  
GluA1 levels non-significantly increased from ~80% as shown in Figure 13B/C and did not 
differ significantly among the genotypes (Figure 14C), though displaying a slight peak at 
~115% in WT cortices [pgt > 0.05; pag > 0.05; pgtxag > 0.05; one-way ANOVA: pag > 0.05 for WT 
and PSD-95 KO]. Descriptively, GluA2 already reached the expression level of P28–32 at eye 
opening in control slices, also peaked at P20–21 and declined afterwards (Figure 13B). Levels 
in PSD-95 KO slices stayed virtually stable, showing a slight decrease starting at ~120% 
(Figure 13C). However, these changes were not significant [pag > 0.05 for WT and PSD-95 
KO]. As displayed in Figure 14C, also no significant differences among genotypes were 
detected [pgt > 0.05; pag > 0.05; pgtxag > 0.05]. Therefore, these results suggest similar cortical 
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AMPAR expression in WT and PSD-95 KO mice. Taking into account the reported 50% of 
AMPAR transmission-lacking synapses in P25–30 PSD-95 KO mice compared to only 25% in 
WT samples (V1, Huang et al., 2015a), the question arises as to whether AMPAR subunits are 
still expressed to normal levels in the absence of PSD-95 but are not transported to the cell 
surface. To further address this question, I analyzed the surface levels of glutamate receptors. 
3.2.2. Slight effects on GluR surface expression due to the 
absence of PSD-95 
In order to identify the receptor fraction being expressed on the cell surface, cortical brain 
slices were incubated with the membrane-impermeable, bifunctional crosslinker BS3 (Figure 
15). The BS3 reagent covalently crosslinks extracellular lysine residues of surface-expressed 
proteins, hence increasing their apparent molecular weight on immunoblots (Boudreau et al., 
2012). On the contrary, intracellular receptors remain unmodified and can be detected as 
monomers. Since the crosslinked protein fraction did not enter the SDS-resolving gel, I directly 
calculated the protein surface levels from the intracellular pool as follows: 
𝑃𝑟𝑜𝑡𝑒𝑖𝑛 𝑠𝑢𝑟𝑓𝑎𝑐𝑒 𝑙𝑒𝑣𝑒𝑙 = 1 − 
𝑖𝑛𝑡𝑒𝑟𝑛𝑎𝑙 𝑙𝑒𝑣𝑒𝑙 (𝑚𝑜𝑛𝑜𝑚𝑒𝑟 𝑏𝑎𝑛𝑑 𝑖𝑛 𝑠𝑎𝑚𝑝𝑙𝑒 + 𝐵𝑆3)
𝑡𝑜𝑡𝑎𝑙 𝑙𝑒𝑣𝑒𝑙 (𝑚𝑜𝑛𝑜𝑚𝑒𝑟 𝑏𝑎𝑛𝑑 𝑤 𝑜⁄ 𝐵𝑆3)
  
 
 
 
Figure 15: Molecular structure of the crosslinker BS3. BS3 (Bis(sulfosuccinimidyl)suberate) 
covalently binds to primary amines of extracellular lysine side chains and/or N-terminals via its two 
reactive NHS (N-hydroxysuccinimide)-ester groups. Therefore, BS3 crosslinks proteins such as 
receptors expressed on the cell surface. Image adapted from Shi et al. (2017). 
 
At first, I compared AMPAR as well as NMDAR surface levels in cortical slices of WT, PSD-95 
KO, PSD-93 KO and PSD-93/95 DKO mice at 4 weeks of age (P28–32). The corresponding 
surface protein levels are provided in Table 14.  
 
 
Results 
 
73 
 
Table 14: Cortical surface levels of AMPAR and NMDAR subunits in WT and MAGUK KO 
mice.  
 
Genotype 
Age 
[P] 
Surface protein level [%]; mean ± SEM 
 
  GluA1 GluA2 GluN2A GluN2B GABAα1 
WT 
13-14 63.44 ± 4.71 53.97 ± 3.85 43.81 ± 3.58 35.15 ± 4.13 63.01 ± 1.54 
20-21 70.79 ± 2.86 79.83 ± 0.71 28.67 ± 3.47 41.60 ± 1.35 54.22 ± 1.88 
28-32 63.09 ± 2.90 73.60 ± 1.08 49.29 ± 2.30 35.22 ± 4.20 62.48 ± 2.22 
PSD-95 
KO 
13-14 56.20 ± 1.59 55.04 ± 0.91 46.96 ± 6.34 41.10 ± 10.1 64.60 ± 4.26 
20-21 62.57 ± 2.84 67.77 ± 1.41 50.62 ± 5.42 42.24 ± 7.92 68.88 ± 1.07 
28-32 53.68 ± 3.49 70.33 ± 3.07 37.37 ± 4.96 41.13 ± 4.71 61.71 ± 1.06 
PSD-93 
KO 
28-32 52.39 ± 5.12 69.79 ± 2.61 41.55 ± 2.69 36.21 ± 2.05 - 
93/95 
DKO 
28-32 52.67 ± 4.14 68.38 ± 4.04 39.92 ± 3.86 33.32 ± 6.03 - 
 
The AMPAR subunits GluA1 and GluA2 were expressed on the membrane with 60–70% of 
total in WT mice at 4 weeks of age, whereas only ~50% of GluN2A and ~35% of GluN2B were 
membrane-located. As demonstrated in Figure 16B/C, MAGUK KO mice did not exhibit 
significantly altered surface levels neither of the NMDAR, nor of AMPAR subunits as 
compared to WT mice [P28-32: GluA1, Fgt(3,22) = 1.341, pgt = 0.287; GluA2, Fgt(3,22) = 0.348, pgt 
= 0.791; GluN2A, Fgt(3,22) = 1.770, pgt = 0.182; GluN2B, Fgt(3,19) = 0.636, pgt = 0.601]. On the 
descriptive level, the surface expression of GluA1, GluA2 and GluN2B was slightly reduced in 
all KO mice compared to WT.  
Notably, the beforehand reported total AMPA receptor levels (section 3.2.1) were expressed to 
similar amounts on the cell surface among the genotypes, therefore providing no explanatory 
hints for the ~25% more AMPAR-transmission deficient synapses in PSD-95 KO mice at this 
developmental stage. 
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Figure 16: Surface levels of AMPAR and NMDAR subunits in WT and MAGUK KO mice at 
P28–32. (A) Representative western blots of total and BS3-crosslinked GluA1 and GluA2. 
Crosslinked proteins are visible in the “BS3” lane as smears of approximately > 400 kDa, a result in 
line with crosslinked subunits (each ~100 kDa) of a GluR tetramer and possible inclusions of small 
auxiliary proteins (Boudreau et al., 2012). On the other hand, intracellular receptors were detected 
as monomers at the indicated characteristic height (100/110 kDa) and their bands quantified for 
surface level calculation. β-Tubulin was used as a loading control. (B) Resulting surface levels of 
GluA1 and GluA2 in cortex of WT and MAGUK KO mice at P28–32. (C) Bar graph displaying the 
fractions of GluN2A and GluN2B expressed on the cell surface at P28–32. (B-C) WT, n = 5-6; 
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PSD-95 KO, n = 6-8; PSD-93 KO, n = 7; PSD-93/95 DKO, n = 4. One-way ANOVA, p > 0.05. All 
data were given as means ± SEM. 
 
To assess putative differences in the developmental profile of the surface expression between 
WT and PSD-95 KO, I also determined AMPAR, NMDAR and GABAA receptor surface levels 
at P13–14 (~eye opening) and 3 weeks of age (P20–21). The respective values are provided 
in Table 14.  
The GluA1 proportion on the cell surface of PSD-95 KO neurons demonstrated exactly the 
same developmental trace as in WT mice, though with significantly reduced surface levels by 
7–10% among all age groups [Figure 17A; Fgt(1,24) = 8.021, pgt = 0.009; pag > 0.05; pgtxag > 0.05; 
one-way ANOVA: pag > 0.05 for WT and PSD-95 KO]. Despite the reduced GluA1 surface 
levels by loss of PSD-95, a reduction of solely 7–10% is much lower than the 25% 
discrepancy in silent synapse levels reported, at least for P28–32. In case of GluA2, a 
developmental increase in surface localization was detected for both genotypes [WT: Fag(2,10) = 
32.085, pag < 0.001; P13-14 vs. P20-21, p < 0.001, P13-14 vs. P28-32, p < 0.001, P20-21 vs. 
P28-32, p > 0.05; PSD-95 KO:  Fag(2,14) = 9.267, pag = 0.003; P13-14 vs. P20-21, p = 0.010, 
P13-14 vs. P28-32, p = 0.001, P20-21 vs. P28-32, p > 0.05]. Again, GluA2 surface levels were 
only slightly – but significantly – decreased in PSD-95 KO mice, mainly at P20–21 with ~12% 
difference [Fgt(1,24) = 4.697, pgt = 0.040; Fag(2,24) = 31.256, pag < 0.001; pgtxag > 0.05]. By 
considering the similar amount of silent synapses in WT and PSD-95 KO mice before eye 
opening, only reaching the 25% difference by the age of P25 (in V1, Huang et al., 2015a), one 
would have assumed that AMPAR surface levels remained constant in the KO mice while 
increasing in WT by surface-incorporation during silent synapse maturation.  
No such diminished surface levels among all age groups were found in PSD-95 KO mice 
compared to WT by assessing NMDA or GABA subunits (Figure 17B/C). In contrast, surface 
expression of GluN2A as well as GABAα1 was slightly enhanced in PSD-95 KO slices at 3 
weeks of age, while showing a significant minimum in the control samples [(i) GluN2A: 
pgt > 0.05; pag > 0.05; Fgtxag(2,23) = 5.898, pgtxag = 0.009; one-way ANOVA, WT: Fag(2,10) = 
11.116, pag = 0.003; P13-14 vs. P20-21, p = 0.010, P13-14 vs. P28-32, p > 0.05, P20-21 vs. 
P28-32, p = 0.001; PSD-95 KO: pag > 0.05. (ii) GABAα1: Fgt(1,24) = 6.816, pgt = 0.015; pag > 0.05; 
Fgtxag(2,24) = 5.359, pgtxag = 0.012; one-way ANOVA, WT:  Fag(2,10) = 4.207, pag = 0.047; P13-14 
vs. P20-21, p = 0.027, P13-14 vs. P28-32, p > 0.05, P20-21 vs. P28-32, p = 0.025; PSD-95 
KO: pag > 0.05]. The surface levels of GluN2B were mostly stable and did not differ among the 
genotypes [pgt > 0.05; pag > 0.05; pgtxag > 0.05; one-way ANOVA: pag > 0.05 for WT and PSD-
95 KO]. 
Together, these data suggest that silent synapses likely contain similar levels of AMPA 
receptors with only partly and minimal surface reductions depending on the developmental 
stage, but clearly not reaching 25% reduction at 4 weeks of age. Therefore, another possibility 
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is that surface AMPARs are either located extrasynaptically or inactivated (or both), resulting 
in the lack of AMPAR-transmission in silent synapses.  
 
 
Figure 17: Developmental profile of AMPAR, NMDAR and GABAA receptor surface 
expression in WT and PSD-95 KO cortices. Surface levels of AMPAR subunits (A), NMDAR 
subunits (B) and the GABA-A α1 subunit (C) among three developmental stages as indicated at 
the x-axis. Ratios were obtained by quantification of immunoblot monomer bands as exemplarily 
shown in (D). Crosslinked proteins were visible as smears of higher molecular weight in the “BS3” 
lanes. (A–D) WT P13-14, n = 4; WT P20-21, n = 3; WT P28-32, n = 5-6; PSD-95 KO P13-14, n = 4-
5; PSD-95 KO P20-21, n = 4; PSD-95 KO P28-32, n = 6-8. Two-way ANOVA (genotype)/ one-way 
ANOVA (age) followed by post-hoc LSD multiple comparison tests, ***p < 0.001; **p < 0.01; *p < 
0.05. All data were given as means ± SEM. 
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3.2.3. Investigation of the TCM effect on AMPAR-mEPSC 
frequency  
As mentioned above, the molecular characteristics of silent synapses still remain elusive. 
Since the total and surface expression of AMPA receptors seemed to be virtually unaltered in 
PSD-95 KO mice (section 3.2.1 and 3.2.2), which yet show high levels of AMPAR-silent 
synapses (Huang et al., 2015a), such AMPARs might be rather inactive or located 
extrasynaptically. The latter assumption is supported by lower levels of the AMPAR subunits 
GluA1, GluA2 and GluA3 in PSD fractions of adult PSD-95 KO mice detected in V1 (Huang et 
al., 2015a). In detail, synaptic levels were reduced to about 50%, which is equal to the ~50% 
silent synapse number in adult PSD-95 KO mice, therefore implicating that these synapses do 
not contain PSD-located AMPARs at all. 
Considering the developmental decrease of silent synapse number in WT mice and by 
assuming that silent synapses mature to AMPAR-transmitting synapses, one would expect a 
correlating increase in AMPAR miniature-EPSC (mEPSC) frequency. mEPSCs result from 
spontaneous vesicle release and are directly proportional to the number of AMPAR-positive 
synapses, because presumably one synapse just releases one vesicle at a time without 
electric stimulation (Frerking et al., 1997). As expected, mEPSC frequency in V1 of PSD-95 
KO mice is reduced as compared to WT mice and remains stable after eye opening – due to 
the lack of silent synapse maturation (Supporting Figure 21A, appendix). Surprisingly, we and 
others (Han et al., 2017) found that mEPSC frequency as well remains stable in WT mice, 
although silent synapses mature to AMPAR-transmitting synapses. This finding indicates 
another mechanism for the homeostasis of AMPAR transmission in the WT brain. We 
therefore previously investigated a possible role of AMPAR desensitization and found that the 
desensitization blocker TCM (trichlormethiazide) promoted a more than three-fold increase in 
mEPSC frequency in WT mice at the age of P31, while this effect was lower in an earlier 
developmental stage (P16) (Supporting Figure 21B, Appendix). Hypothetically, AMPAR 
homeostasis could be achieved by a specific mechanism accompanying silent synapse 
maturation, which results in a proportion of spontaneously non-active AMPARs. These non-
active or “permanently desensitized” AMPARs might be re-activated due to TCM treatment. 
This effect could in general be pre- or postsynaptic. To address its localization, I used TCM in 
a Synaptotagmin 1 (Syt1) antibody uptake assay in dissociated hippocampal mouse culture for 
monitoring presynaptic vesicle release as illustrated and mechanistically described in Figure 
18.   
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Figure 18: Molecular mechanism of the Synaptotagmin 1 uptake assay for monitoring 
presynaptic activity. The release of presynaptic vesicles can be monitored by an uptake or 
“feeding” assay of Syt1, a membrane-trafficking protein acting as a calcium sensor (Südhof, 2002). 
As illustrated here, intracellular calcium ions trigger vesicle fusion with the presynaptic membrane 
in order to release neurotransmitters into the synaptic cleft. As soon as the N-terminus of Syt1 is 
exposed to the extracellular space, the primary antibody can bind and gets incorporated into the 
vesicle following recycling. Therefore, permeabilization of the cell membranes (using Triton X-100) 
was necessary in order to couple the primary antibody with a fluorescence-labeled secondary 
antibody. In case of a high fusion rate of presynaptic vesicles, strong fluorescence signals were 
detected and vice versa. 
 
3.2.3.1. Synaptotagmin 1 co-localizes with the presynaptic markers 
Munc13, VGLUT1 and Ankyrin-B 
Apart from its localization in presynaptic vesicle membranes, Syt1 was also reported to be 
present at the postsynaptic, dendritic site and linked to AMPAR exocytosis during LTP (Wu et 
al., 2017). Hence, I first sought to confirm that the assay demonstrates presynaptic (but not 
postsynaptic) activity by immunofluorescence co-staining of Syt1 with specific synaptic 
markers in primary mouse hippocampal culture at 15 days in vitro (DIV).  
As demonstrated in Figure 19A, Syt1 co-localized with the active zone marker Munc13-1, 
while both proteins were separated but in close contact to postsynaptic dendrites visualized by 
staining of the microtubule-associated protein (MAP) 2. Furthermore, Syt1 signals were co-
localized with the vesicular glutamate transporter (VGLUT) 1 in synaptic vesicle membranes of 
excitatory neurons (Figure 19B). Together with the co-localization of Syt1 and Ankyrin B, 
which is reported to be highly enriched in axons (Kunimoto, 1995; Engelhardt et al., 2013) 
(Figure 19C), these results show that the Syt1 uptake assay can be used to determine a 
possible presynaptic origin of the TCM effect.  
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Figure 19: Immunofluorescence staining showed co-localization of Synaptotagmin 1 with 
diverse presynaptic markers. Dissociated primary hippocampal cultures prepared from WT P0-
mice were immunolabeled at 15 DIV with specific primary antibodies, followed by fluorescent 
secondary antibodies. (A1–C1) Schematic illustration of the respective protein localizations at the 
pre- or postsynapse. As shown in the merged pictures, Syt 1 co-localized with the active zone 
marker Munc13-1 (A2), the presynaptic vesicle-bound transporter VGLUT1 (B2) and axonal 
enriched Ankyrin B (C2), whereas MAP2 visualized the neighboring dendritic compartment. 
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3.2.3.2. The TCM-evoked increase in AMPAR-mEPSC frequency is not 
a presynaptic effect 
After validating the presynaptic localization of immunofluorescent Syt1 signals, I performed the 
Syt1 antibody uptake assay to test the TCM effect on presynaptic vesicle release using 
primary hippocampal cultures. Throughout the experiment, the voltage-gated sodium channel 
blocker TTX (1 µM) was added to prevent action potential firing in order to exclusively monitor 
spontaneous vesicle release. As shown in Figure 20, TCM (0.5 mM; 92.17 ± 6.59%) did not 
affect the turnover of synaptic vesicles compared to control (100 ± 4.50%), whereas high 
potassium chloride concentration evoked an increase in Syt1 signals (20 mM KCl; 134.59 ± 
13.48%) [TCM vs. control, p > 0.05; KCl vs. control, p = 0.014]. High extracellular potassium 
levels result in increased depolarization of the neuronal cell and were therefore used as a 
control for the stimulation of presynaptic activity. Interestingly, hypertonic sucrose showed no 
effect on Syt1 incorporation [0.3 M sucrose; 87.87 ± 9.61%; sucrose vs. control, p > 0.05], 
although being reported to trigger vesicle exocytosis from the readily releasable pool and 
thereby leading to a higher number of mEPSC events (Rosenmund & Stevens, 1996; Lonart & 
Südhof, 2000).  
Nevertheless, since TCM exhibited no effect on synaptic vesicle turnover, the TCM-evoked 
increase in mEPSC frequency is unlikely to result from presynaptic effects on spontaneous 
vesicle fusion. Thus, the effect is most likely originated at the postsynapse, where TCM might 
recruit additional transmission sites such as “permanently desensitized” AMPARs which had 
been inactive before and whose underlying mechanism remains to be investigated. 
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Figure 20: Synaptotagmin 1 uptake assay did not reveal an effect of TCM on presynaptic 
activity. (A) Dissociated hippocampal culture prepared from P0 WT mice was applied to Syt1 
uptake assay at 15 DIV. The resulting Syt1 fluorescence signals are displayed for control samples, 
treatment with the desensitization blocker trichlormethiazide (TCM; 0.5 mM), sucrose treatment 
(0.3 M) and with high concentrations of potassium chloride (KCl; 20 mM) as indicated. Throughout 
all conditions, TTX (1 µM) was supplemented to prevent action potentials in order to exclusively 
monitor spontaneous vesicle fusions. (B) Bar graphs illustrating the amount of Syt1 uptake as 
normalized to WT with respective n numbers indicated. Only high potassium chloride 
concentrations enhanced the presynaptic vesicle turnover. Two-tailed, unpaired Student’s t-test. 
*p < 0.05. Data were given as means ± SEM. (C) Schematic illustration of the performed Syt1 
uptake assay with 10 minutes of drug incubation, recovery for 1 minute in the conditioned cell 
culture medium, followed by fixation and immunostaining.  
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4. DISCUSSION 
4.1. Knockout of PSD-95 leads to reduced excitatory 
synaptic strength 
In the present study, I aimed at investigating the function of the DLG-MAGUKs PSD-95 and 
PSD-93 in basal synaptic transmission by performing fEPSP recordings in hippocampal slices 
of adult PSD-95 KO, PSD-93 KO and PSD-93/95 DKO mice. 
The absence of either PSD-95 alone or both PSD-95 and PSD-93 substantially reduced the 
strength of synaptic transmission as indicated by shifted input-output curves (Figure 4A). In 
contrast, loss of PSD-93 alone had no effect, with input-output curves being undistinguishable 
from WT (Figure 4A). The paired-pulse ratio (PPR) again showed changes in PSD-95 KO and 
DKO mice, but not in PSD-93 KO mice. Specifically, PPR was reduced in PSD-95 KO and 
DKO mice, indicating higher probability of presynaptic vesicle release (Pr) (Figure 4B). Since 
both – synaptic strength and Pr – remained unchanged upon PSD-93 KO, the decrease in 
strength and increase in Pr observed in DKO mice were most likely mediated by the absence 
of PSD-95 alone. Collectively, these results clearly demonstrate that loss of PSD-95 
influences basal synaptic transmission by reducing its strength and enhancing the Pr. Given 
the stargazin-mediated interaction of PSD-95 with AMPARs (Fukata et al., 2005) and its direct 
interaction with NMDARs (Kornau et al., 1995), PSD-95 could possibly regulate synaptic 
transmission via both glutamate receptors. On one side, PSD-95 could tether AMPARs at the 
synaptic membrane and on the other side, PSD-95 might regulate AMPAR trafficking through 
NMDAR-dependent signaling cascades as it has been shown for synaptic plasticity (Xu et al., 
2008). 
In support of the unchanged basal synaptic transmission in PSD-93 KO mice seen here, 
previous studies showed that genetic deletion of PSD-93 did not affect synaptic transmission 
in hippocampus (Elias et al., 2006) and cerebellum (McGee et al., 2001). In contrast, findings 
for PSD-95 KO mice are puzzling. While some studies found unaltered excitatory synaptic 
transmission in adult PSD-95 KO mice (Migaud et al., 1998; Elias et al., 2006), others  showed 
substantially reduced synaptic transmission in young (Béïque et al., 2006) and in adult PSD-
95 deficient mice (Carlisle et al., 2008). In support of reduced excitatory synaptic strength, 
further studies demonstrated ~50% reduced AMPAR-mediated EPSCs upon KD of PSD-95 
(Nakagawa et al., 2004; Elias et al., 2006; Schlüter et al., 2006). Hence, the majority of studies 
demonstrates diminished strength of synaptic transmission due to loss of PSD-95, which is 
also consistent with the present data. While some authors postulated that PSD-95 functions to 
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anchor AMPARs at synaptic sites (Schnell et al., 2002; Ehrlich & Malinow, 2004), Huang et al. 
(2015a) have linked PSD-95 to experience-dependent maturation of silent synapses. 
Specifically, PSD-95 KO mice maintain ~50% AMPAR-silent synapses into adulthood in all 
cortical areas investigated so far, including hippocampus, nucleus accumbens, V1 and medial 
prefrontal cortex (D. Favaro et al., in press; Huang et al., 2015a; Shukla et al., 2017). Notably, 
the high number of silent synapses can even be reinstated by acute KD of PSD-95 in V1 of 
adult mice (Huang et al., 2015a). The function of PSD-95 in silent synapse maturation has 
additionally been indicated by other studies showing that manipulations of PSD-95 levels 
mainly affects mEPSC frequency, but not the amplitude, thus indicating selective changes in 
the number of AMPAR-positive synapses (Béïque & Andrade, 2003; Stein et al., 2003; Béïque 
et al., 2006; Carlisle et al., 2008). Given that silent synapses do not transmit at resting 
potential, the reduced strength of synaptic transmission in PSD-95 KO mice as detected in the 
present study via fEPSP recordings most likely resulted from high levels of silent synapses. As 
silent synapses are thought to mature in an LTP-like manner (Liao et al., 1995; Durand et al., 
1996; Isaac & Crair, 1997), PSD-95 presumably couples NMDAR activation to downstream 
cascades involved in silent synapse maturation. 
Conversely, silent synapse maturation has been shown to be accelerated in the absence of 
PSD-93, resulting in an adult-like state of <10% silent synapses in the hippocampus at P20 (D. 
Favaro et al., in press). By the age of ~P60, as analyzed in the present study, hippocampal 
synapses in WT mice are probably also matured, thus showing similar levels as PSD-93 KO 
mice (Huang et al., 2015a). Hence, the unchanged strength of basal synaptic transmission in 
PSD-93 KO mice is most likely due to comparable low levels of silent synapses. 
The impaired synaptic transmission in PSD-93/95 DKO mice (Figure 4A) is consistent with 
Elias et al. (2006), also demonstrating a shift in the input-output curve. In consideration of 
decreased synaptic AMPAR levels in PSD-enriched fractions and reduced mEPSC frequency 
in the hippocampus of P30–P40 DKO mice (Elias et al., 2006), these findings possibly indicate 
enhanced silent synapse levels in DKO mice. Contrary to this view, silent synapse levels in V1 
of DKO mice have been shown to be unchanged until late critical period (P28) (D. Favaro et 
al., in press). However, this result does not rule out that the level of silent synapses differs 
from WT at later developmental stages in a different brain region (i.e. hippocampus) of DKO 
mice. Excitatory synapses in DKO mice may also differ in other respects, especially by 
considering the mechanistical difference in silent synapse maturation between DKO and WT 
mice. Specifically, while silent synapses matured with similar pace in WT and DKO mice until 
P28, maturation in DKO mice was not anymore regulated by visual experience (D. Favaro et 
al., in press), possibly resulting in unfavorable connection patterns. Consistent with this notion, 
DKO mice displayed severely impaired visual acuity (D. Favaro et al., in press). In addition, 
quantal size was reduced in DKO mice as indicated by reduced mEPSC amplitudes (D. 
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Favaro et al., in press), which likely also account for diminished strength of synaptic 
transmission observed here. 
Similar to the altered strength of synaptic transmission in PSD-95 KO and DKO mice, both 
genotypes exhibited changes in release probability, i.e. reduced PPR und thus higher Pr, while 
PPR in PSD-93 KO mice was unchanged (Figure 4B). Such a higher Pr at AMPAR-
transmitting synapses, as measured through fEPSP recordings in the present study, likely 
enhances mEPSC frequency and therefore likely leads to an overestimation of the number of 
AMPAR-positive synapses derived from mEPSC recordings. Thus, the ~50% reduction in 
mEPSC frequency reported by Béïque et al. (2006) might be even stronger without such a 
presynaptic effect being present. This would indicate that numbers of silent synapses might be 
underestimated in PSD-95 KO mice and would support the more than 50% reduction in fEPSP 
slope in PSD-95 KO mice (Figure 4A). Given that MAGUKs are mainly located at the 
postsynapse and that maturation of silent synapses is further thought to occur postsynaptically 
(Liao et al., 1995, 2001; Malinow & Malenka, 2002), changes in Pr might be caused by 
retrograde signaling to the presynaptic terminal (Futai et al., 2007). Accordingly, MAGUKs 
could affect Pr via their interaction with neuroligin (Irie et al., 1997), which can in turn bind to 
presynaptic β-neurexin through its extracellular domain (Ichtchenko et al., 1995). Such 
coupling with β-neurexin could induce changes to the vesicle release machinery (Dean & 
Dresbach, 2006). 
However, the following comparison with previous studies is conflicting and likely results from 
the use of different mouse lines and/or different developmental states, since PPR has been 
shown to be age-dependent (Chavis & Westbrook, 2001). While the unchanged PPR in PSD-
93 KO mice is consistent with D. Favaro et al. (in press) using the same mouse line, Carlisle et 
al. (2008) reported an increase in PPR in the hippocampus of adult PSD-93 KO mice. 
Moreover, PPR in DKO mice was found to be unchanged in hippocampus by the age of P30–
40 (Elias et al., 2006). Surprisingly, even an enhanced PPR in PSD-95 KO mice has been 
reported before (Migaud et al., 1998; Carlisle et al., 2008). Since most of the mentioned 
studies performed fEPSP recordings like I did, results mainly rely on AMPAR-mediated 
responses, but are also influenced by NMDAR-mediated currents. Given that silent synapses 
do not transmit at resting potential, they just get activated and thus detected upon membrane 
depolarization, e.g. resulting from adjacent AMPAR-positive synapses. Thereby, the obtained 
PPR mainly characterizes presynaptic terminals of mature, AMPAR-transmitting synapses. By 
considering a rather immature neuronal network in PSD-95 KO and DKO mice, higher Pr 
might result from the “attempt” of the network to compensate for the reduced synaptic strength 
in order to be able to transmit information. Interestingly, previous studies proposed a higher Pr 
for silent synapses by separate analysis of AMPAR- and NMDAR-PPRs. Specifically, high Pr 
during early synapse development – when silent synapse levels are high – and a subsequent 
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gradual decrease in Pr have been reported for hippocampus (Bolshakov & Siegelbaum, 1995; 
Chavis & Westbrook, 2001) and thalamocortex (Yanagisawa et al., 2004). As stated earlier, 
the here analyzed fEPSP responses are likely to mainly display AMPAR-mediated currents. 
However, silent synapses primarily contain GluN2B-NMDARs (Béïque et al., 2006; Huang et 
al., 2009; Brown et al., 2011), which have slower decay kinetics (Cull-Candy & Leszkiewicz, 
2004) and are thus able to integrate synaptic currents across broader time intervals. 
Therefore, it is possible that GluN2B-NMDARs in silent synapses are more easily activated 
and thus stronger contribute to the higher Pr as detected in the absence of PSD-95.  
4.2. Partly altered synaptic composition in MAGUK KO 
mice 
The development of excitatory synapses can be subdivided into two phases: synaptogenesis, 
followed by synaptic maturation. Synaptogenesis involves formation of cell-to-cell contacts and 
recruitment of synaptic proteins required for synaptic transmission such as AMPARs and 
NMDARs (Waites et al., 2005). Throughout subsequent synapse maturation, the strength of 
AMPAR-mediated transmission increases due to gradual AMPAR incorporation, and the 
NMDAR subunit composition changes from primarily GluN2B- to GluN2A-containing NMDARs 
(Monyer et al., 1994; Sheng et al., 1994; Wu et al., 1996; Petralia et al., 1999). As excitatory 
synapse maturation is impaired in PSD-95 KO mice, which are maintaining high levels of silent 
synapses into adulthood (Huang et al., 2015a), I aimed at examining whether such impaired 
maturation is linked to altered expression levels of AMPARs and NMDARs. 
4.2.1. Evidence for extrasynaptic AMPARs in silent synapses  
In order to investigate the molecular composition of AMPAR-silent synapses, I analyzed total 
and surface GluA1 and GluA2 levels of cortical slices in WT and PSD-95 KO mice. Surface 
levels ranged from ~60–70% and were comparable with previously reported levels in 
hippocampal cultures (i.e. 60–70% of GluA1 and 40–50% of GluA2) (Hall & Soderling, 1997). 
While total expression of GluA1 and GluA2 was unchanged in the absence of PSD-95 (Figure 
14C), GluA1 (but not GluA2) surface levels were slightly (7–10%) reduced at P30 (Figure 
17A). Taken together, these data show that loss of PSD-95 has, if any, only minimal effects on 
AMPAR expression levels. Thus, this effect cannot account for the difference of ~50% vs. 
~25% silent synapses in PSD-95 KO and WT mice, respectively, observed at this age (Huang 
et al., 2015a). Therefore, these data indicate that the AMPAR number in silent synapses and 
(mostly) mature AMPAR-transmitting synapses is highly comparable. Hence, silent synapses 
might contain inactivated or extrasynaptic AMPARs, resulting in abolished AMPAR-
transmission. By additionally taking into account the reported reduction of ~50% in GluA1 and 
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GluA2 levels in the core PSD fraction of PSD-95 KO mice (Bonnet et al., 2013; Huang et al., 
2015a), AMPARs in silent synapses might rather be located extrasynaptically, since synaptic 
levels are reduced, whereas total levels, including those at extrasynaptic sites, are not or only 
minimally affected. Together, these findings support the role of PSD-95 in silent synapse 
maturation, rather than in clustering AMPARs at the neuronal surface in general. 
Analysis of the developmental profile of AMPAR expression from P13 to P30 in WT mice 
revealed different mechanisms of AMPAR maintenance and turnover between subunits GluA1 
and GluA2. While total GluA1 levels showed an increase of ~20%, GluA2 levels remained 
constant (Figure 14C). Conversely, surface expression of GluA1 did not change, while GluA2 
surface levels increased by ~20% (Figure 17A). Collectively, a net increase of both subunits 
by 20% from P13 to P30 was detected. These results indicate that, regarding GluA1, total 
protein expression increases during development while maintaining a constant ratio of intra- to 
extracellular amount. In contrast, total GluA2 is expressed in a relatively stable manner (with a 
peak at P20), but progressively gets incorporated into the surface membrane during neuronal 
development. Hence, transport of GluA1 to the surface membrane at earlier developmental 
stages seems to be more efficient as compared to GluA2 subunits.  
In V1, a developmental increase in total levels of both AMPAR subunits has been reported 
earlier (Huang et al., 2015a). Specifically, GluA1 levels increased by ~15% between P14 and 
P30, which is highly comparable to the results obtained from whole cortex samples, i.e. an 
increase of 20%. In contrast, while total GluA2 levels remained constant in whole cortex and 
just increased in terms of surface expression, total GluA2 increased by ~40% in V1. This 
discrepant data most likely results from differences in the time course of area-specific critical 
periods (Hensch, 2004), which all contribute to the results obtained from whole cortex. For 
example, maturation of the somatosensory system through tactile stimulation probably occurs 
earlier in life than V1 maturation, which is triggered only after eye opening (~P13). Thus, rather 
drastic changes at the level of individual cortical circuits might have been masked by using 
whole cortex homogenates due to asynchronous synapse maturation in different sensory 
systems. To enable more detailed comparison between the two studies, information about the 
developmental change in surface levels of AMPARs in V1 are needed. In addition, the 
biological material differed: While Huang et al. (2015a) used P2 crude synaptosomal fractions, 
I used whole cortex homogenates. 
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4.2.2. Impaired GluN2B to GluN2A switch in PSD-95 KO mice 
Further analysis of the cortical brain samples revealed differences in NMDAR expression by 
comparing WT with PSD-95 KO mice. Regarding GluN2A, I detected a developmental 
increase in cortical expression but constant surface levels between P13 and P30, even in the 
absence of PSD-95 (Figure 14B, Figure 17B). This increase likely results from growth and 
linkage of new excitatory synapses during early development. Interestingly, GluN2A surface 
levels displayed a minimum in P20 WT mice, which was absent in PSD-95 KO mice (Figure 
17B). The detected variation might be due to the dynamic process of silent synapse 
maturation, which is impaired in PSD-95 KO mice. However, it needs further investigation and 
higher sample size in order to confirm this finding.  
In contrast to the increase in GluN2A expression, GluN2B levels decreased in WT mice, but 
remained constant in the absence of PSD-95 (Figure 14B). Analysis of surface GluN2B 
expression did not reveal any changes when comparing P13 with P30 levels (Figure 17B). 
Together, these data indicate that loss of PSD-95 impairs the developmental switch of 
GluN2B- to GluN2A-containing NMDARs. Due to the fact that this subunit switch occurs during 
early development (Monyer et al., 1994; Sheng et al., 1994) and thus in parallel to silent 
synapse maturation, such a switch lacking in PSD-95 KO mice is consistent with impaired 
silent synapse maturation in these mice (Huang et al., 2015a). This finding is supported by a 
previous study in young (<P25) PSD-95 KO mice, which showed greater contribution of 
GluN2B-containing receptors to the NMDAR-mediated synaptic current, thereby also 
indicating an impaired (or delayed) subunit switch (Béïque et al., 2006). On the contrary, a 
study on cortical PSD fractions reported comparable levels of synaptic GluN2B between adult 
WT and PSD-95 KO mice (Bonnet et al., 2013). Since I detected a difference in the 
developmental profile of total GluN2B, but not by comparing absolute levels at ~P30, the 
difference between genotypes might biochemically just be detectable by investigation of the 
developmental profile. Furthermore, the age of the analyzed mice strongly differs between the 
two studies (P13–P30 in the present study vs. adult, >P60 (Bonnet et al., 2013)). 
Similar deficits in the GluN2A/2B subunit switch seen here in PSD-95 KO mice, have also 
been reported in PSD-93/95 DKO mice (at the age of P30–P40) (Elias et al., 2008). 
Interestingly, they were shown to be fully rescued by the expression of PSD-95. These 
findings are partly in line with the somewhat dysfunctional silent synapse maturation in DKO 
mice (D. Favaro et al., in press), possibly lacking NMDAR subunit switch and therefore not 
reaching a fully functional state. Rescue of the subunit switch in DKO mice by PSD-95 
expression (Elias et al., 2008) clearly points towards a PSD-95-dependent mechanism 
accounting for the switch. In contrast, other studies indicated a mechanism rather dependent 
on silent synapse maturation, as dark-rearing of WT mice, which prevents silent synapse 
maturation, also prevented the GluN2B/2A switch in V1 (although PSD-95 is expressed) (D. 
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Favaro et al., in press.; Quinlan et al., 1999). Indeed, dark-rearing maintains high levels of 
silent synapses by depriving mice of visual experience, which normally triggers silent synapse 
maturation during critical period plasticity. Importantly, while silent synapse maturation in DKO 
mice follows the same developmental trajectory as in WT mice, it is not anymore regulated by 
visual experience (D. Favaro et al., in press). This might indicate that specifically experience-
dependent synapse maturation requires a switch from GluN2B to GluN2A expression. 
4.2.3. Unchanged inhibitory tone in PSD-95 KO mice 
The GABAα1 subunit is particularly enriched at the postsynaptic site of inhibitory synapses 
formed by parvalbumin-positive (PV+) interneurons on pyramidal cells (Klausberger et al., 
2002). While GABAα1 levels were maintained at a constant extra- to intracellular ratio, as 
evidenced by largely stable surface levels (Figure 17C), total expression strongly increased by 
~50% between P13 and P30 (Figure 14A), showing the steepest developmental rise in both 
WT and PSD-95 KO mice compared to all other receptor subunits assessed. This indicates 
that membrane expression of GABAα1 receptors strongly increases during the critical period. 
Interestingly, this process is not affected by loss of PSD-95.  
These data are consistent with a study by Huang et al. (2015a), showing a developmental 
increase in V1 but unaltered levels of GABAα1 and gephyrin – a scaffolding protein of inhibitory 
synapses – in V1 PSD fractions of PSD-95 KO mice (Huang et al., 2015a). Consistently, 
developmental maturation (~P28 to P65) of the inhibitory tone of PV+ interneurons onto 
pyramidal neurons as measured by patch-clamp recordings was similar between WT and 
PSD-95 KO, indicating that GABAergic inhibition is not changed in adult PSD-95 KO mice 
(Huang et al., 2015a). These results are at odds with the prevailing view that critical period 
plasticity is mainly regulated by the local inhibitory tone (Hensch, 2005; Levelt & Hübener, 
2012). Specifically, it is thought that cortical disinhibition enables ocular dominance (OD) 
plasticity following monocular deprivation (Wu & Sun, 2015; Sun et al., 2016). Accordingly, 
loss of excitatory inputs to PV+ interneurons would lead to decreased inhibition, thereby 
enabling excitatory OD plasticity. Given that PSD-95 KO mice maintain juvenile-like OD 
plasticity into adulthood (Huang et al., 2015a) and do not show decreased GABAα1 levels as 
presented here, or decreased inhibitory tone as reported earlier (Huang et al., 2015a), the 
model of regulating critical period plasticity has to be refreshed by assigning an important role 
to PSD-95, in addition to inhibitory interneurons. 
Total and surface GABAα1 even showed slightly higher levels in PSD-95 KO mice as 
compared to WT at the age of three weeks (P20–21) (Figure 14A and Figure 17C). This 
possibly indicates some kind of transient compensatory regulation, which is absent by 
reaching P30. Since pharmacological increase of the GABAergic tone in adult PSD-95 KO 
mice did not abolish OD plasticity as seen in WT mice (following 7 days of monocular 
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deprivation) (Huang et al., 2015a), the transiently increased GABAα1 level probably do not 
affect the maintenance of juvenile-like plasticity, possibly because of being cancelled out by 
the high level of silent synapses. Further investigation by measuring the inhibitory tone in 
pyramidal neurons of WT and PSD-95 KO mice at the age of P20 could clarify if the difference 
in GABAα1 expression leads to altered inhibitory input.  
4.2.4. Homeostasis of spontaneous synaptic transmission is 
primarily a postsynaptic mechanism 
Despite the developmental maturation of silent synapses into AMPAR-transmitting ones, 
mEPSC frequency – which is thought to be directly proportional to silent synapse number if 
the vesicle fusion propensity is unchanged – remains stable in WT mice (Supporting Figure 
21A, appendix and Han et al., 2017). PSD-95 KO mice display a similar developmental profile, 
but have been shown to maintain ~50% silent synapses after eye opening (Huang et al., 
2015a). Hence, the constant level of mEPSC frequency after eye opening was expected in the 
absence of PSD-95, but unexpected in WT. The similarity of WT and PSD-95 KO trajectories 
indicates that AMPAR transmission is homeostatically maintained on a stable level during 
silent synapse maturation in the WT brain. In support of that view, the AMPAR desensitization 
blocker TCM increases mEPSC frequency in ~P30 WT mice more than three-fold, while this 
effect is reduced in an earlier developmental stage (i.e. at P16) (Supporting Figure 21B, 
appendix), leading to the hypothesis that some AMPAR transmission sites get “permanently 
desensitized” and thus locked during development, but can be released again by TCM. These 
sites most likely do not belong to silent synapses, since application of cyclothiazide, which is 
an AMPAR desensitization blocker similar to TCM (Mitchell & Fleck, 2007), did not reveal any 
AMPAR-mediated responses in silent synapses (Montgomery et al., 2001). As it is not clear 
yet how receptors at these sites are maintained in an inactive state, they will be referred to as 
“idle sites” in the following.  
In idle sites, AMPARs might be desensitized by glutamate, e.g. due to glutamate spillover from 
adjacent terminals (Kullmann & Asztely, 1998). In turn, TCM application could block the 
desensitization, leading to activation of these idle sites. On the other hand, TCM could act at 
the presynapse by increasing Pr. The presynaptic vesicle population has been reported to be 
heterogenous and consist of two distinct pools: An evoked and a spontaneous releasable pool 
(Nosyreva et al., 2013; Crawford & Kavalali, 2015). While these pools usually interact with 
each other through vesicular, cytosolic and plasma membrane proteins (Crawford & Kavalali, 
2015), this crosstalk might be impaired in idle sites (or idle synapses), leading to an absence 
of spontaneous transmitter release. Thus, a conceivable mechanism of TCM might be to 
unlock the crosstalk between these two vesicle pools. However, by using the Syt1 uptake 
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assay, I could rule out that TCM affects presynaptic vesicle release due to an absent effect of 
TCM on Syt1 incorporation (Figure 20). This result indicates that the homeostasis of 
spontaneous synaptic transmission is likely to be regulated by a postsynaptic mechanism.  
While performing the Syt1 uptake assay, I obtained a rather unexpected result for the effect of 
high sucrose solution. Whereas high extracellular potassium levels increased vesicle turnover 
as expected, hyperosmotic sucrose (0.3 M) did not. This is at odds to previous studies 
reporting that 0.5 molar sucrose solution triggers vesicle exocytosis from the readily releasable 
pool (Rosenmund & Stevens, 1996; Lonart & Südhof, 2000). However, differences due to 
varying sucrose concentrations cannot be excluded (0.3 M vs. 0.5 M). Importantly, sucrose 
(0.45 M) has also been reported to inhibit clathrin-dependent endocytosis by preventing 
clathrin and adaptors from interacting, which results in empty microcages of “trapped” clathrin 
(Heuser & Anderson, 1989; Hansen et al., 1993). This effect could possibly counteract the 
sucrose-mediated stimulation of spontaneous vesicle release. One might argue that Syt1 in 
vesicles, which cannot be endocytosed and are kind of stuck at the membrane, would still be 
detectable by its immunofluorescence. Anyhow, it is likely that, if too many vesicles are stuck, 
the vesicle recycling machinery gets out of balance and adjusts its activity in form of a 
negative feedback mechanism. Furthermore, it cannot be excluded that sucrose affects the 
binding affinity of the Syt1-specific antibody to its target. 
The hypothesis of a TCM-mediated increase in spontaneous synaptic transmission at idle 
sites requires more detailed analysis. However, the present result leads to the conclusion that 
further investigations should focus on a possible postsynaptic mechanism. Idle sites could 
account for the homeostatic regulation of AMPAR transmission during progressive silent 
synapse maturation, thereby providing a balancing function. Hence, the more silent synapses 
have matured, the more idle sites might exist. 
4.3. Knockout of PSD-95 protects against hypoxia 
The interaction of DLG-MAGUKs with NMDARs is thought to mediate the activation of several 
downstream signaling pathways in response to Ca2+ influx, thus affecting processes such as 
synaptic plasticity (Xu et al., 2008). Importantly, both PSD-95 and PSD-93 have been 
implicated in NMDAR-mediated excitotoxicity, which contributes to neuronal dysfunction and 
cell damage in diverse neuropathologies including ischemic stroke, Alzheimer’s disease and 
acute brain injury (Dawson & Dawson, 1998; Lai et al., 2014; Parsons & Raymond, 2014). 
However, the specific role of PSD-95 and PSD-93 in this context is elusive and, notably, 
studies on PSD-95 KO mice are still lacking. In order to shed some light on possibly similar or 
opposing functions of PSD-95 and PSD-93, I induced excitotoxicity in acute brain slices of the 
respective KO and DKO mice by hypoxia, leading to spreading depression (HSD).  
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Importantly, only the KO of PSD-95 but not PSD-93 provided protection against hypoxia. This 
finding indicates that only PSD-95 is involved in NMDAR-mediated excitotoxicity following 
metabolic compromise. Furthermore, simultaneous KO of both PSD-95 and PSD-93 showed 
partly reduced susceptibility to hypoxia, most likely due to the absence of PSD-95 and not 
PSD-93. The protective effect of PSD-95 KO was demonstrated by multiple parameters. First 
of all, the onset of HSD was delayed in absence of PSD-95, as indicated by a delayed HSD-
accompanied DC shift (Figure 7A). Second, KO of PSD-95 resulted in a markedly attenuated 
IOS change, as displayed by reduced tissue light reflectance (Figure 8D). Third, PSD-95 KO 
mice exhibited a trend towards decelerated HSD wave propagation (Figure 9) and slightly 
delayed synaptic failure (Figure 11). Finally, the most obvious evidence for reduced 
susceptibility to hypoxia in PSD-95 deficient mice was their substantially improved recovery of 
synaptic function (Figure 12A and B). By contrast, single KO of PSD-93 had no effect in all of 
these parameters. Interestingly, the protective effects in PSD-95 KO mice were consistently 
abolished by additional KO of PSD-93 in DKO mice, except for improved synaptic recovery. 
The only parameters which were not altered and therefore did not indicate protection by the 
absence of PSD-95, were the amplitude and duration of the HSD-associated DC shift (Figure 
7B/C) and the size of affected hippocampal area (Figure 9). Whereas a reduced HSD-invaded 
area would have been expected, the amplitude and duration of the DC shift depend on the 
synchronization of underlying neuronal and glial depolarizations, and therefore not necessarily 
provide evidence for the vulnerability to hypoxia. Specifically, while an improved 
synchronization could shorten the DC shift, the amplitude would be enhanced. Consistent with 
the lack of differences in the invaded area between genotypes observed in the present study, 
no morphological alterations in hippocampal structures of PSD-93 KO and PSD-95 KO mice 
have been detected so far (Migaud et al., 1998; McGee et al., 2001). Detailed morphological 
investigations in PSD-93/95 DKO mice are still lacking, but the here presented unchanged DC 
parameters do not indicate alterations.  
The delayed occurrence of HSD (Figure 7A) seen in PSD-95 KO mice might have been 
influenced by the decreased neuronal excitability (Figure 4A), since neuronal excitability is an 
important parameter defining the vulnerability of brain tissue to HSD generation (Aitken et al., 
1991; Müller, 2000; Müller & Somjen, 2000b). However, HSD onset was unchanged in DKO 
mice, which also presented reduced strength of basal synaptic transmission (Figure 4A). 
Therefore, the protective effect seen in PSD-95 mice is more likely to be genotype-specific, 
rather than due to reduced excitability. 
The here demonstrated protection due to loss of PSD-95 against ischemia-like insults is 
consistent with several previous studies. Sattler et al. (1999) reported protective effects of 
antisense RNA-mediated KD of PSD-95 in cortical cultures against NMDAR-dependent 
excitotoxicity as indicated by reduced cell death after NMDA-treatment. These authors 
addressed delayed neuronal death, while my results indicate short-term protective effects 
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such as delayed HSD onset and improved synaptic recovery. Sattler et al. (1999) furthermore 
linked the interaction of PSD-95 with NMDARs to toxic NO production, in which PSD-95 
serves to couple nNOS-activity to NMDAR-mediated Ca2+ influx. Consequently, following 
studies used small interfering peptides, which were synthesized to disrupt the NMDAR-PSD-
95-nNOS interaction and tested them in stroke models. In support of the present data, these 
so-called “PSD-95 inhibitors” provided protection against ischemic stroke in rodents (Aarts et 
al., 2002; Sun et al., 2008; Zhou et al., 2010), macaques (Cook et al., 2012a), as well as 
humans tested in phase II clinical trials, which suffered from fewer infarcts following treatment 
(Hill et al., 2012). Specifically, the peptides reduced neuronal deficits following MCAO (Aarts et 
al., 2002; Sun et al., 2008; Zhou et al., 2010), which is comparable to the present study 
showing improved reinstatement of neuronal function upon hypoxia in PSD-95 KO mice 
(Figure 12A and B).  
In contrast to the unchanged size of the HSD-invaded hippocampal area in PSD-95 KO mice 
seen here (Figure 9), previous studies, testing PSD-95 inhibitors in MCAO models, reported 
reduced infarct volumes (Aarts et al., 2002; Sun et al., 2008; Zhou et al., 2010; Cook et al., 
2012a). However, using a different lesion model which typically does not result in a penumbra 
region like MCAO, i.e. photothrombotic stroke, another study did not detect reduced lesion 
sizes in PSD-95 KO mice (Greifzu et al., 2016). This is consistent with the present data, 
indicating similarities between impairments induced by photothrombotic stroke and the here 
addressed hypoxia-induced dysfunctions. Nevertheless, various other parameters including 
the reduced IOS change and improved functional recovery in PSD-95 KO mice are pointing 
towards diminished brain damage and an enhanced ability to recover from hypoxia such as in 
a penumbra region following MCAO, if appropriate treatment is performed (Ferrer & Planas, 
2003). The extent and severity of delayed neuronal damage and/or cell death can, however, 
not be investigated here, due to the given time-limit of acute brain slices. 
There are two main possibilities, which could account for the protective effect in absence of 
PSD-95. On the one hand, loss of PSD-95 might result in reduced activation of excitotoxicity 
pathways such as toxic NO production (Sattler et al., 1999). On the other hand, high levels of 
silent synapses in PSD-95 KO mice (D. Favaro et al., in press; Huang et al., 2015a) may 
“reinstate” a juvenile, more plastic state, possibly promoting synaptic reorganization following 
hypoxia. Both possibilities will be further discussed in the following sections (4.4 and 4.5). 
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4.4. Neuronal protection due to high levels of silent 
synapses? 
Silent synapses represent opportunities for activity- and experience-dependent synaptic 
connections, therefore consolidating final wiring patterns (Liao et al., 1995; Durand et al., 
1996; Itami et al., 2003). Critical periods in early development show especially high levels of 
neuronal plasticity, enabling sensory cortical networks to adapt to their environment and 
optimize functional output (Fagiolini & Hensch, 2000).  
In the maturing brain, silent synapse levels gradually decrease during early development 
(Kerchner & Nicoll, 2008; Huang et al., 2015a). Thus, neuronal networks lose their state of 
high plasticity and the ability to rapidly adjust to new experience. Intriguingly, genetic KO of 
PSD-95 prevented the experience-dependent maturation of silent synapses and maintained 
high plasticity levels as shown for juvenile-like OD plasticity in V1 (Huang et al., 2015a). 
Furthermore, acute KD of PSD-95 increased silent synapse levels, facilitates LTP induction 
(Migaud et al., 1998; Béïque et al., 2006; Carlisle et al., 2008) and reinstates juvenile-like OD 
plasticity in adult mice (Huang et al., 2015a). Thus, the absence of PSD-95 preserves (or 
reinstates) a premature, more plastic state of neuronal networks, which is physiologically 
present only in the “young” brain. 
In the present study, a model of transient hypoxia served as a tool to examine the response 
and vulnerability of neuronal networks to metabolic compromise occurring in diverse neuronal 
disorders such as ischemic stroke. Ischemic stroke mainly occurs in elderly people and age is 
known to strongly influence the patients’ outcome (Chen et al., 2010; Liu & McCullough, 
2012). In fact, aging emerges as the most important independent risk factor for the incidence 
and prevalence of stroke with over 80% of strokes occurring in people aged >65 years (Rojas 
et al., 2007; Rosamond et al., 2008). In line with these epidemiological data, stroke also 
appears to be age-dependent in diverse animal models (Popa-Wagner et al., 2007; Liu et al., 
2009a). Thus, age – or, the maturational synaptic state – plays an important role in 
susceptibility to stroke and the severity of stroke-induced neuronal impairments. I analyzed the 
response and neuronal impairments following hypoxia, which is an important aspect of stroke, 
in WT mice at 2 months of age (~P60) and compared them to age-matched KO mice lacking 
PSD-93, PSD-95 or both paralogs. Throughout the study, adult PSD-93 KO mice, which 
contain very low levels of silent synapses (D. Favaro et al., in press), were undistinguishable 
from WT. Thus, no beneficial or disadvantageous effect on hypoxia-susceptibility due to loss 
of PSD-93 was found. In contrast, PSD-95 deficiency indeed provided protection in a variety of 
parameters. 
Given the high level of silent synapses in adult PSD-95 KO mice, it is well conceivable that 
silent synapses account (at least in part) for the detected protection in metabolic compromise. 
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Silent synapses might be particularly beneficial for the reinstatement of synaptic function by 
providing substrates for reorganization of the neuronal network. Comparable effects of PSD-
95 deficiency have been shown in V1 as evidenced by preserved OD plasticity after a distant 
stroke lesion (Greifzu et al., 2016). Since many of the parameters, which indicated protection 
in PSD-95 KO mice, were unaltered in the DKO, both genotypes lacking PSD-95 were 
affected differently. Given that high silent synapse levels have been (so far) only detected in 
PSD-95 KO mice (Huang et al., 2015a), the present results point towards silent synapses 
being likely important to mediate protection against hypoxia, rather than distracted PSD-95/ 
NMDAR-mediated excitotoxicity. Whether the PSD-95 inhibitors, which provided protection 
against ischemic insults in various studies (Aarts et al., 2002; Sun et al., 2008; Zhou et al., 
2010; Cook et al., 2012a), also rejuvenates the synapses, as does PSD-95 KD in adult mice 
(Huang et al., 2015a), is not known yet. However, it is likely that PSD-95-binding to NMDARs 
and possibly other PDZ-mediated interactions of PSD-95, which might be impaired due to the 
interfering peptides, are required to maintain a mature synaptic state in the adult brain. 
Since DKO mice showed improved synaptic recovery and assuming that silent synapses are 
an important substrate for the protective effects seen in PSD-95 KO mice, this finding points 
towards uncomplete synaptic maturation in DKO mice as well. So far, silent synapse levels 
have only been determined in V1 of younger DKO mice, showing no alterations in the pace of 
silent synapse maturation, but a distinct mechanism which is experience-independent (D. 
Favaro et al., in press). Therefore, an increased number of silent synapses in the 
hippocampus of adult DKO mice cannot be excluded and would be consistent with the 
reported reduction in mEPSC frequency in the hippocampus of P30–P40 DKO mice, as well 
as reduced AMPAR levels in PSD-enriched fractions (Elias et al., 2006). Nonetheless, either 
partly silent as reported for the hippocampus (Elias et al., 2006), or inadequately matured 
leading to reduced quantal size and partly impaired functional outcome as shown in V1 (D. 
Favaro et al., in press), these data suggest that synapses lacking both PSD-95 and PSD-93 
can facilitate functional recovery following hypoxia.  
4.4.1. CaMKII as a possible target to inhibit silent synapse 
maturation 
In order to confirm that the protective effect seen in PSD-95 KO (and partly in DKO) mice is 
mediated by high levels of silent synapses, a possible approach would be to prevent silent 
synapse maturation independently of PSD-95 deletion. In V1, this can be achieved by dark-
rearing (Funahashi et al., 2013) or dark-exposure (Guo et al., 2012), but this model is not 
transferable to the hippocampus. Instead, a molecular mediator for silent synapse maturation 
has to be addressed and blocked.  
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Such a candidate is the Ca2+/calmodulin-dependent protein kinase II (CaMKII). CaMKII is a 
signal transduction molecule with developmentally regulated expression and shows specific 
abundance at the PSD of excitatory synapses (Kennedy et al., 1983; Schulman, 1993). 
CaMKII has been implicated in synaptogenesis, neuronal growth and is known to be an 
important player in synaptic plasticity (Soderling, 2000; Lisman et al., 2002). Indeed, inhibition 
or genetic modification of CaMKII impairs LTP in CA1 hippocampus (Silva et al., 1992; Hinds 
et al., 1998) and V1 (Kirkwood et al., 1997), most likely by preventing CaMKII-mediated 
phosphorylation of the AMPAR subunit GluA1 (Barria et al., 1997; Mammen et al., 1997). In 
line with the broad consensus that silent synapses mature in a LTP-like manner (Liao et al., 
1995; Durand et al., 1996), CaMKII has also been implicated in silent synapse maturation. 
Early studies on retinotectal synapses from Xenopus tadpoles revealed that overexpression of 
a Ca2+/calmodulin-independent form of CaMKII mimics silent synapse maturation – as 
indicated by the appearance of AMPAR-mediated synaptic responses (Wu et al., 1996). 
Further studies on the visual system of mice identified α-CaMKII as an essential kinase for OD 
plasticity, together with its indispensable ability to autophosphorylate (Gordon & Stryker, 1996; 
Taha et al., 2002). Therefore, inhibiting CaMKII activity or its autophosphorylation might 
prevent – or impair – silent synapse maturation and possibly show similar protective effects 
against hypoxia-induced metabolic compromise as PSD-95 KO. This would support the idea 
that decreased susceptibility in PSD-95 KO mice is largely due to the presence of high silent 
synapse levels. 
4.5. Neuronal protection due to attenuated NMDAR-
mediated excitotoxicity? 
Another conceivable reason for the protective effect seen in mice lacking PSD-95 is the 
disruption of NMDAR-mediated excitotoxicity cascades. Hypothetically, due to loss of PSD-95 
as a linker protein, key proteins involved in these cascades get uncoupled from NMDAR 
overactivation and subsequent Ca2+ overload. Excess of Ca2+ has been shown to trigger 
diverse toxic downstream pathways including activation of the neuronal NO synthase (nNOS), 
which has been especially implicated in neuronal disorders such as ischemic stroke (Dawson 
et al., 1992; Huang et al., 1994; Volbracht et al., 2005). Indeed, inhibition of nNOS activity 
reduced infarct volumes and neurological deficits in mice subjected to cerebral ischemia 
(Huang et al., 1994). 
As stated earlier, the proposed role of PSD-95 in mediating toxic NO production resulted from 
studies on neuronal cultures, demonstrating that suppressed PSD-95 expression attenuates 
NMDAR-mediated NO synthesis as well as excitotoxicity (Sattler et al., 1999). Interestingly, 
PSD-93 has also been implicated in providing protection against ischemic injury. Specifically, 
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PSD-93 deletion also prevented NMDAR/nNOS-dependent toxicity in cortical cultures (Xu et 
al., 2004; Zhang et al., 2010). Furthermore, KO of PSD-93 in a mouse stroke model resulted in 
reduced infarct size and diminished neurological deficits (Zhang et al., 2014). However, 
another study showed that loss of PSD-93 did not provide neuroprotection in the hippocampus 
of neonatal mice subjected to hypoxia-induced ischemia (Jiang et al., 2003), which is similar to 
the present study not detecting any protection of PSD-93 KO against hypoxia. Collectively, 
these studies strongly implicate PSD-95 in stroke-induced neurotoxicity pathways, while the 
effect of PSD-93 KO needs further investigation. 
The structural similarity of PSD-95 and PSD-93 (Cho et al., 1992) and the ability of both to 
directly interact with NMDARs (Kornau et al., 1995; Niethammer et al., 1996) suggests that 
both paralogs are capable of mediating NMDAR-dependent excitotoxicity. They interact with 
NMDARs by binding of their N-terminal PDZ1 and PDZ2 domains to the C-terminal 
cytoplasmatic tail of GluN2A and GluN2B (Kornau et al., 1995; Niethammer et al., 1996). 
These first two PDZ repeats are highly conserved throughout all DLG-MAGUK family 
members, showing 80–90% amino acid sequence identity (Niethammer et al., 1996). 
Interaction of PSD-95 or PSD-93 with nNOS has further been shown to be mediated by PDZ2 
of the MAGUKs, in turn binding to the PDZ domain of nNOS (Brenman et al., 1996).  
4.5.1. Reduced activity of the NMDAR-nNOS pathway in PSD-95 
KO mice? 
Given the structural similarity of PSD-95 and PSD-93, the binding specificity of the PSD-95 
inhibitors can be questioned. These small molecules – including Tat-NR2B9c (NA-1), ZL006 
and Tat-N-dimer – are assumed to prevent the interaction of PSD-95 with either GluN2B or 
nNOS (Sun et al., 2008; Zhou et al., 2010; Bach et al., 2012). They have aroused much 
attention in the past years with one of them (NA-1) having already been tested in a clinical trial 
of ischemic stroke (Hill et al., 2012).  
In addition to stroke-related studies, the same (or similar) interfering molecules have even 
been used in other contexts of neuronal disorders. Interestingly, two peptides (i.e. IC87201 
and Tat-nNOS) – in vitro interfering with the nNOS-PSD-95 interaction – showed protection in 
mouse models of NMDA-induced acute and chronic pain (Florio et al., 2009). Furthermore, 
nNOS-PSD-95 interaction has been proposed as a novel target for fear-related disorders such 
as posttraumatic stress disorder, since the peptide ZL006 attenuated fear memory in the 
amygdala (Li et al., 2018). Despite the well-known involvement of nNOS in mechanisms of 
depression (Wegener & Volke, 2010), the same peptide (ZL006) did not induce 
antidepressant-like effects in rodent depression models (Tillmann et al., 2017). Notably, in a 
mechanistical in vitro study, ZL006 and IC87201 were unable to interact with the PDZ domains 
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of PSD-95 or nNOS, nor inhibited the PDZ-PDZ binding interface of the two proteins (Bach et 
al., 2015). This is in sharp contrast to the previously reported in vitro interference capability of 
IC87201 by Florio et al. (2009). Additional doubt on the proposed mechanism of action was 
generated by a finding of Cui et al. (2007), that Tat-NR2B9c contains higher potency of 
affecting the interaction of PSD-95PDZ2 with GluN2A, rather than with GluN2B. This finding 
seems surprising, since GluN2A is implicated in pro-survival pathways located at the synapse, 
while extrasynaptic GluN2B mainly mediates excitotoxicity (Hardingham & Bading, 2003). On 
top of that, despite the assumed interference of Tat-NR2B9c with GluN2B-PSD-95 interaction 
(Aarts et al., 2002), the peptide is much more effective at disrupting nNOS-PSD-95 by means 
of the half maximal inhibitory concentrations (IC50, 8 µM for PSD-95PDZ2-GluN2B vs. 0.2 µM for 
PSD-95PDZ2-nNOS, respectively) (Cui et al., 2007). Hence, these controversial studies on the 
synthetic peptides do not allow any clarification about their in vivo mechanism of action that 
mediates the protection against ischemic injury. 
By taking into account the high structural similarity of PSD-95 and PSD-93 and the reported 
ability of Tat-NR2B9c to bind both paralogs (Cui et al., 2007), it is likely that the interaction of 
PSD-93 with GluN2B or nNOS is also affected. Nevertheless, the present study clearly 
implicates PSD-95 – rather than PSD-93 – in mediating hypoxia-induced excitotoxicity, as 
evidenced by substantial protection provided by genetic loss of PSD-95 but not PSD-93. 
The here obtained results indicate either higher levels of silent synapses or reduced 
excitotoxicity such as impaired NO production to account for the protective effects seen in 
PSD-95 KO mice, while both mechanisms do not have to be mutually exclusive. However, the 
fact that the DKO mice, in which PSD-95-mediated excitotoxicity is abolished as well, showed 
almost no protection, clearly points towards a key role of high silent synapse levels in PSD-95 
KO mice in providing protection against hypoxia.  
A possible approach to further investigate a potential reduction in nNOS activity by PSD-95 
deficiency is the targeting of NO substrates. NO (or NO-derived reactive oxygen species) 
account for the nitration of tyrosine, or nitrosylation of free cysteine residues of diverse 
proteins (Ischiropoulos, 1998; Lai et al., 2014). Especially the nitrosylation of free cysteine 
residues (S-nitrosylation), which can arise from broken disulfide bonds due to oxygen 
deprivation, has been linked to downstream cascades of excitotoxic nNOS activity. In turn, 
nitrosylation of these proteins activates death signaling or inhibits pro-survival cascades. 
Reported targets of S-nitrosylation include GAPDH (Hara et al., 2005), the GluR6 subunit of 
the kainate receptor (Yu et al., 2008) and the src homology 2 domain-containing phosphatase 
(SHP-2) (Shi et al., 2013). Hence, specific antibodies could be used to detect possible 
differences in the level of nitration or nitrosylation between WT and PSD-95 KO following the 
hypoxic event as an indicator for nNOS activity and thus, for excitotoxicity. 
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4.6. How do PSD-95 and PSD-93 mediate different 
signaling cascades? 
While both PSD-95 and PSD-93 have a specialized role in determining the number of 
AMPARs at excitatory synapses, they show quite differing roles in synaptic plasticity. PSD-93 
deletion enhances the threshold for LTP, but has no influence on LTD (Carlisle et al., 2008). In 
contrast, PSD-95 counteracts LTP, but promotes LTD (Migaud et al., 1998; Béïque & 
Andrade, 2003). Furthermore, the paralogs exhibit opposite functions in cortical network 
maturation and stabilization during early development (Huang et al., 2015; D. Favaro et al., in 
press).  
The present study adds an additional aspect to this scheme of similar vs. differing or even 
opposing functions. Specifically, only PSD-95 was found to mediate hypoxia-induced 
excitotoxicity, as evidenced by lower susceptibility of PSD-95 KO mice. On the contrary, PSD-
93 deficiency did not provide any protection in the hippocampal tissue. For most parameters, 
simultaneous KO of PSD-93 even abolished the beneficial effects of PSD-95 deletion as seen 
in the DKO mice, except for improved recovery of synaptic function. Thus, future studies 
should further aim at identifying different signaling cascades coupled to NMDAR activation. 
4.6.1. PSD-95 and PSD-93 might be localized at different 
neuronal sites 
The main question regarding individual functions is, if PSD-95 and PSD-93 are expressed at 
the same synapses and, if so, if they are located at similar sites. If the paralogs are positioned 
in high vicinity, they might compete for the same signaling cascade. On the other hand, if they 
are expressed more distantly (e.g. synaptic vs. peri- or extrasynaptic sites), they might affect 
different downstream pathways. While earlier studies reported a co-localization of 33% in the 
hippocampus (Sans et al., 2000), others demonstrated high levels of co-localization at the 
same synapse in the cortex (DeGiorgis et al., 2006) and in V1 (D. Favaro et al., in press). 
Hence, it is most likely that PSD-95 and PSD-93 are expressed at the same synapse, but – so 
far – their precise localization remains elusive.  
It is widely accepted that NMDAR-dependent excitotoxicity relies on extrasynaptic NMDARs, 
whereas synaptic NMDARs are suggested to have a protective function (Hardingham & 
Bading, 2003). Early after birth, most synaptic NMDARs contain GluN2B subunits, which get 
gradually replaced by GluN2A during synapse maturation (Monyer et al., 1994; Sheng et al., 
1994). This subunit switch results in the predominant location of GluN2A at synaptic sites and 
GluN2B at extrasynaptic sites in matured neurons.  
The present study confirms previous observations that the subunit switch is abolished in the 
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absence of silent synapse maturation in PSD-95 KO mice (or due to lack of PSD-95 itself) (D. 
Favaro et al., in press.; Quinlan et al., 1999; Béïque et al., 2006). Thus, PSD-95 lacking mice 
contain a reduced number of synapses with extrasynaptically located GluN2B-containing 
NMDARs, which likely mediate neurotoxic cascades. This aspect could provide a link between 
the two seemingly incoherent ways of lowering susceptibility to hypoxia in PSD-95 deficient 
mice: (I.) High levels of silent synapses and (II.) reduction of NMDAR-dependent excitotoxic 
signaling. Furthermore, this study implicates PSD-95 to be located at the extrasynaptic region 
to higher levels than PSD-93. This hypothesis is supported by a study of Xu et al. (2004), 
reporting co-localization and complex formation of PSD-93 with GluN2A (not GluN2B) and 
nNOS in cortical cultures. Hypothetically, PSD-93 rather couples nNOS to synaptic GluN2A-
NMDARs, resulting in physiological NO production, while PSD-95 mediates extrasynaptic toxic 
nNOS overactivation. 
4.6.2. Potential interaction partners of PSD-95 and PSD-93 
There have been several attempts to identify unique protein binding partners of either PSD-95 
or PSD-93 in order to provide evidence for differentially affected signaling cascades. One 
candidate is the synaptic GTPase activating protein (SynGAP). SynGAP has been shown to 
interact with the PDZ-domains of PSD-95 and SAP102 via its C-terminus and to co-locate with 
PSD-95 and NMDAR in vitro using immunocytochemistry and in vivo via Co-
immunoprecipitation (Kim et al., 1998; Rumbaugh et al., 2006). A possible interaction of 
SynGAP with PSD-93 has not been reported yet. Functionally, SynGAP is involved in Ras 
kinase activity and subsequent activation of MAPK-mediated pathways such as activity of the 
pro-survival kinase Erk and the pro-apoptotic kinase p38 (Rumbaugh et al., 2006). Notably, 
altered expression levels of SynGAP have been detected in PSD-93 KO mice following 
MCAO-induced ischemia (Rong et al., 2016). Moreover, Rong et al. (2016) showed reduced 
infarct volumes and neurological deficits in PSD-93 deficient mice, which is in odds to my 
results lacking any effect in mice of the same genotype. However, as stated before, the 
interaction and/or co-localization of PSD-93 and SynGAP has not been proved yet. 
Interestingly, we also found differing phosphorylation levels – indicating a change in activity – 
of SynGAP by comparing total brain extracts of PSD-93 KO and PSD-95 KO mice via a 
quantitative phospho-tyrosine (pY) proteomic approach (in collaboration with Dr. Wilhelm Haas 
and Weifeng Xu, Massachusetts, USA). A second candidate protein appearing in both studies 
with altered expression and phosphorylation levels, respectively, is the protein kinase C (PKC) 
β. PKCβ also acts in Ca2+ signaling pathways and has been shown to associate with GluN1 
and GluN2B subunits (Lipp & Reither, 2011; Rong et al., 2016).  
Accordingly, both SynGAP and PKCβ provide promising targets for further investigation on the 
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role of PSD-95 and PSD-93 in mediating signaling specificity due to individual protein binding 
partners and, presumably, specific neuronal localization. 
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6. APPENDIX 
Table 15: fEPSP slope/FV amplitude ratios of I-O curves.  
 
Stimulus 
intensity [µA] 
fEPSP slope/FV amplitude [ms-1]; mean ± SEM 
 WT PSD-95 KO PSD-93 KO 93-95 DKO 
10 0.05 ±   0.03 0.03 ±   0.02 0.06 ± 0.03 0.03 ± 0.03 
20 0.28 ±   0.06 0.17 ±  0.06 0.18 ± 0.05 0.07 ± 0.03 
30 0.47 ±   0.10 0.35 ±  0.10 0.39 ± 0.08 0.14 ± 0.05 
40 0.90 ±   0.18 0.26 ±  0.07 0.66 ± 0.12 0.25 ± 0.13 
50 1.09 ±   0.22 0.33 ±  0.06 1.20 ± 0.33 0.15 ± 0.03 
60 1.31 ±   0.29 0.53 ±  0.17 1.31 ± 0.29 0.23 ± 0.07 
70 1.42 ±   0.23 0.56 ±  0.17 1.53 ± 0.36 0.19 ± 0.02 
80 1.60 ±   0.30 0.59 ±  0.21 1.85 ± 0.43 0.17 ± 0.04 
90 1.63 ±   0.31 0.60 ±  0.14 1.97 ± 0.49 0.20 ± 0.05 
100 1.86 ±   0.35 0.67 ±  0.22 2.27 ± 0.52 0.35 ± 0.08 
110 2.00 ±   0.38 0.68 ±  0.18 2.51 ± 0.61 0.31 ± 0.09 
120 1.93 ±   0.35 0.73 ±  0.20 2.50 ± 0.55 0.35 ± 0.07 
130 2.03 ±   0.37 0.78 ±  0.18 2.66 ± 0.60 0.34 ± 0.09 
140 2.09 ±   0.38 0.79 ±  0.25 2.64 ± 0.61 0.33 ± 0.07 
150 2.06 ±   0.36 0.73 ±  0.23 2.74 ± 0.59 0.36 ± 0.07 
 
 
Table 16: EPSP2/EPSP1 amplitude ratios of paired-pulse facilitation.  
 
Interstimulus 
interval [ms]  
Paired-pulse ratio; mean ± SEM 
 WT PSD-95 KO PSD-93 KO 93-95 DKO 
25 3.62 ±  0.54 2.15 ±  0.11 3.40 ±  0.40 2.16 ±  0.16 
50 2.91 ±  0.41 1.80 ±  0.11 2.90 ±  0.39 1.73 ±  0.11 
75 2.24 ±  0.19 1.64 ±  0.10 2.42 ±  0.30 1.58 ±  0.08 
100 2.16 ±  0.26 1.54 ±  0.09 2.22 ±  0.20 1.61 ±  0.11 
125 1.90 ±  0.21 1.48 ±  0.05 2.04 ±  0.18 1.60 ±  0.08 
150 1.81 ±  0.16 1.40 ±  0.06 2.08 ±  0.24 1.34 ±  0.15 
175 1.52 ±  0.07 1.35 ±  0.05 2.04 ±  0.29 1.36 ±  0.09 
200 1.63 ±  0.12 1.33 ±  0.07 1.92 ±  0.22 1.39 ±  0.10 
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Figure 21: Developmental profile of AMPAR-mEPSC frequency and effect of TCM. Data was 
provided from (A) Man Ho Wong (PhD thesis, 2017) and (B) Yue Yang (Pittsburgh, 
unpublished). (A) AMPAR-mEPSC recording of pyramidal neurons in layer II/III of V1 (holding 
potential of -60 mV; 500 nM TTX to prevent spontaneous action potentials by blocking of voltage-
gated sodium channels). Graphs show mEPSC frequency during development in WT and PSD-95 
KO mice. Welch’s t-test: WT P11 vs. P13: p = 0.028; PSD-95 KO P11 vs. P13: p = 0.007. *p < 
0.05; **p < 0.01. Data were given as means ± SEM. (B) Experimental set-up according to (A) with 
additional TCM-treatment of 0.5 mM. Bar graphs display the effect of the desensitization blocker 
TCM on AMPAR-mEPSC frequency in WT mice. TCM provoked a greater increase in mEPSC 
frequency at P31 (n = 27; 3.15-fold change) than at P16 (n = 27; 2.34-fold change). Welch’s t-test: 
P16 vs. P31, p = 0.0025. **p < 0.01. Data were given as means ± SEM. 
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Table 17: Statistical analysis.  
 
  Statistical test  Comparison F value P value 
Figure 4A: I-O curve    
  2-way ANOVA Stimulus  F14,700 = 33.078 p < 0.001 
   Genotype F3,50 = 7.422  p < 0.001 
   Interaction F42,700 = 5.827 p < 0.001 
  Post-hoc LSD PSD-95 KO vs. WT  p = 0.012 
   PSD-93 KO vs. WT  p = 0.280 
   DKO vs. WT  p = 0.004 
   PSD-95 KO vs. PSD-93 KO  p = 0.001 
   PSD-95 KO vs. DKO  p = 0.458 
   PSD-93 KO vs. DKO  p < 0.001 
      
Figure 4B: Paired-pulse ratio    
  2-way ANOVA Interstimulus interval F7,371 = 33.046 p < 0.001 
   Genotype F3,53 = 4.789 p = 0.005 
   Interaction F21,371 = 2.107 p = 0.003 
  Post-hoc LSD PSD-95 KO vs. WT  p = 0.015 
   PSD-93 KO vs. WT  p = 0.535 
   DKO vs. WT  p = 0.036 
   PSD-95 KO vs. PSD-93 KO  p = 0.003 
   PSD-95 KO vs. DKO  p = 0.935 
   PSD-93 KO vs. DKO  p = 0.009 
      
Figure 7A: Time to HSD onset    
  1-way ANOVA Genotype F3,184 = 5.787 p = 0.001 
  Post-hoc LSD PSD-95 KO vs. WT  p = 0.002 
   PSD-93 KO vs. WT  p = 0.241 
   DKO vs. WT  p = 0.504 
   PSD-95 KO vs. PSD-93 KO  p = 0.041 
   PSD-95 KO vs. DKO  p < 0.001 
   PSD-93 KO vs. DKO  p = 0.062 
      
Figure 7B: HSD amplitude    
  1-way ANOVA Genotype F3,184 = 0.327 p = 0.806 
      
Figure 7C: HSD duration    
 1 min 1-way ANOVA Genotype F3,64 = 0.953 p = 0.420 
 2 min 1-way ANOVA Genotype F3,59 = 0.670 p = 0.574 
 4 min 1-way ANOVA Genotype F3,53 = 0.803 p = 0.498 
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  Statistical test  Comparison F value P value 
Figure 8D: Reflectance increase   
 1 min 1-way ANOVA Genotype F3,55 = 7.617 p < 0.001 
  Post-hoc LSD PSD-95 KO vs. WT  p < 0.001 
   PSD-93 KO vs. WT  p = 0.691 
   DKO vs. WT  p = 0.080 
   PSD-95 KO vs. PSD-93 KO  p < 0.001 
   PSD-95 KO vs. DKO  p = 0.016 
   PSD-93 KO vs. DKO  p = 0.157 
 2 min 1-way ANOVA Genotype F3,58 = 3.720 p = 0.016 
  Post-hoc LSD PSD-95 KO vs. WT  p = 0.020 
   PSD-93 KO vs. WT  p = 0.566 
   DKO vs. WT  p = 0.874 
   PSD-95 KO vs. PSD-93 KO  p = 0.003 
   PSD-95 KO vs. DKO  p = 0.015 
   PSD-93 KO vs. DKO  p = 0.689 
 4 min 1-way ANOVA Genotype F3,48 = 1.755 p = 0.168 
      
Figure 9A: HSD-invaded area   
  1-way ANOVA Genotype F3,170 = 0.864 p = 0.461 
      
Figure 9B: HSD propagation velocity   
  1-way ANOVA Genotype F3,175 = 2.508 p = 0.061 
  Post-hoc LSD PSD-95 KO vs. WT  p = 0.036 
   PSD-93 KO vs. WT  p = 0.934 
   DKO vs. WT  p = 0.798 
   PSD-95 KO vs. PSD-93 KO  p = 0.039 
   PSD-95 KO vs. DKO  p = 0.017 
   PSD-93 KO vs. DKO  p = 0.730 
      
Figure 10: EPSP amplitude: baseline   
  1-way ANOVA Genotype F3,184 = 53.246 p < 0.001 
  Post-hoc LSD PSD-95 KO vs. WT  p < 0.001 
   PSD-93 KO vs. WT  p = 0.090 
   DKO vs. WT  p < 0.001 
   PSD-95 KO vs. PSD-93 KO  p < 0.001 
   PSD-95 KO vs. DKO  p = 0.150 
   PSD-93 KO vs. DKO  p < 0.001 
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  Statistical test  Comparison F value P value 
Figure 12: EPSP amplitude: posthypoxic recovery   
A. 1 min 2-way ANOVA Genotype F3,63 = 4.204 p = 0.009 
  Post-hoc LSD PSD-95 KO vs. WT  p = 0.004 
   PSD-93 KO vs. WT  p = 0.132 
   DKO vs. WT  p = 0.003 
   PSD-95 KO vs. PSD-93 KO  p = 0.169 
   PSD-95 KO vs. DKO  p = 0.798 
   PSD-93 KO vs. DKO  p = 0.118 
B. 2 min 2-way ANOVA Genotype F3,61 = 8.458 p < 0.001 
  Post-hoc LSD PSD-95 KO vs. WT  p = 0.003 
   PSD-93 KO vs. WT  p = 0.642 
   DKO vs. WT  p < 0.001 
   PSD-95 KO vs. PSD-93 KO  p = 0.008 
   PSD-95 KO vs. DKO  p = 0.220 
   PSD-93 KO vs. DKO  p < 0.001 
Figure 12C. 4 min 2-way ANOVA Genotype F3,52 = 18.391 p < 0.001 
  Post-hoc LSD PSD-95 KO vs. WT  p < 0.001 
   PSD-93 KO vs. WT  p = 0.744 
   DKO vs. WT  p < 0.001 
   PSD-95 KO vs. PSD-93 KO  p < 0.001 
   PSD-95 KO vs. DKO  p = 0.463 
   PSD-93 KO vs. DKO  p < 0.001 
      
Figure 13: Total protein level    
Figure 13B: WT     
 GABAα1 1-way ANOVA Age Fag(2,10) = 35.650 pag < 0.001 
  Post-hoc LSD P13-14 vs. P20-21  p = 0.011 
   P13-14 vs. P28-32  p < 0.001 
   P20-21 vs. P28-32  p < 0.001 
 GluN2A 1-way ANOVA Age Fag(2,10) = 6.348 pag = 0.017 
  Post-hoc LSD P13-14 vs. P20-21  p = 0.078 
   P13-14 vs. P28-32  p = 0.005 
   P20-21 vs. P28-32  p = 0.285 
 GluN2B 1-way ANOVA Age Fag(2,10) = 6.651 pag = 0.015 
  Post-hoc LSD P13-14 vs. P20-21  p = 0.500 
   P13-14 vs. P28-32  p = 0.021 
   P20-21 vs. P28-32  p = 0.009 
 GluA1 1-way ANOVA Age Fag(2,10) = 1.697 pag = 0.232 
 GluA2 1-way ANOVA Age Fag(2,10) = 2.289 pag = 0.152 
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  Statistical test  Comparison F value P value 
Figure 13C: PSD-95 KO    
 GABAα1 1-way ANOVA Age Fag(2,10) = 15.623 pag = 0.001 
  Post-hoc LSD P13-14 vs. P20-21  p = 0.553 
   P13-14 vs. P28-32  p = 0.001 
   P20-21 vs. P28-32  p = 0.001 
 GluN2A 1-way ANOVA Age Fag(2,10) = 2.165 pag = 0.165 
 GluN2B 1-way ANOVA Age Fag(2,10) = 0.146 pag = 0.866 
 GluA1 1-way ANOVA Age Fag(2,10) = 0.724 pag = 0.508 
 GluA2 1-way ANOVA Age Fag(2,10) = 0.430 pag = 0.662 
      
Figure 14: Total protein level: WT vs. PSD-95 KO   
AFigure 
14 
GABAα1 2-way ANOVA Genotype Fgt(1,20) = 4.271 pgt = 0.052 
   Age Fag(2,20) = 44.529 pag < 0.001 
   Interaction Fgtxag(2,20) = 3.106 pgtxag = 0.067 
B GluN2A 2-way ANOVA Genotype Fgt(1,20) = 0.613 pgt = 0.443 
   Age Fag(2,20) = 4.972 pag = 0.018 
   Interaction Fgtxag(2,20) = 0.357 pgtxag = 0.704 
 GluN2B 2-way ANOVA Genotype Fgt(1,20) = 0.296 pgt = 0.592 
   Age Fag(2,20) = 3.455 pag = 0.051 
   Interaction Fgtxag(2,20) = 2.443 pgtxag = 0.112 
C GluA1 2-way ANOVA Genotype Fgt(1,20) = 0.068 pgt = 0.797 
   Age Fag(2,20) = 6.348 pag = 0.017 
   Interaction Fgtxag(2,20) = 0.365 pgtxag = 0.699 
 GluA2 2-way ANOVA Genotype Fgt(1,20) = 0.997 pgt = 0.330 
   Age Fag(2,20) = 1.449 pag = 0.258 
   Interaction Fgtxag(2,20) = 0.631 pgtxag = 0.542 
      
Figure 16: Protein surface level (P28-32)   
B GluA1 1-way ANOVA Genotype Fgt(3,22) = 1.341 pgt = 0.287 
 GluA2 1-way ANOVA Genotype Fgt(3,22) = 0.348 pgt = 0.791 
C GluN2A 1-way ANOVA Genotype Fgt(3,22) = 1.770 pgt = 0.182 
 GluN2B 1-way ANOVA Genotype Fgt(3,19) = 0.636 pgt = 0.601 
      
Figure 17: Protein surface level: WT vs. PSD-95 KO   
A GluA1 2-way ANOVA Genotype Fgt(1,24) = 8.021 pgt = 0.009 
   Age Fag(2,24) = 2.796 pag = 0.081 
   Interaction Fgtxag(2,24) = 0.055 pgtxag = 0.946 
  1-way ANOVA Age, WT Fag(2,10) = 1.167 pag = 0.350 
  1-way ANOVA Age, PSD-95 KO Fag(2,14) = 1.781 pag = 0.205 
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 GluA2 2-way ANOVA Genotype Fgt(1,24) = 4.697 pgt = 0.040 
   Age Fag(2,24) = 31.256 pag < 0.001 
   Interaction Fgtxag(2,24) = 2.605 pgtxag = 0.095 
  1-way ANOVA Age, WT Fag(2,10) = 32.085 pag < 0.001 
   P13-14 vs. P20-21  p < 0.001 
   P13-14 vs. P28-32  p < 0.001 
   P20-21 vs. P28-32  p = 0.087 
  1-way ANOVA Age, PSD-95 KO Fag(2,14) = 9.267 pag = 0.003 
   P13-14 vs. P20-21  p = 0.010 
   P13-14 vs. P28-32  p = 0.001 
   P20-21 vs. P28-32  p = 0.523 
B GluN2A 2-way ANOVA Genotype Fgt(1,23) = 1.121 pgt = 0.301 
   Age Fag(2,23) = 0.550 pag = 0.585 
   Interaction Fgtxag(2,23) = 5.898 pgtxag = 0.009 
  1-way ANOVA Age, WT Fag(2,10) = 11.116 pag = 0.003 
   P13-14 vs. P20-21  p = 0.010 
   P13-14 vs. P28-32  p = 0.201 
   P20-21 vs. P28-32  p = 0.001 
  1-way ANOVA Age, PSD-95 KO Fag(2,13) = 1.612 pag = 0.237 
 GluN2B 2-way ANOVA Genotype Fgt(1,20) = 0.671 pgt = 0.422 
   Age Fag(2,20) = 0.222 pag = 0.803 
   Interaction Fgtxag(2,20) = 0.109 pgtxag = 0.897 
  1-way ANOVA Age, WT Fag(2,9) = 0.733 pag = 0.507 
  1-way ANOVA Age, PSD-95 KO Fag(2,11) = 0.008 pag = 0.993 
C GABAα1 2-way ANOVA Genotype Fgt(1,24) = 6.816 pgt = 0.015 
   Age Fag(2,24) = 0.444 pag = 0.646 
   Interaction Fgtxag(2,24) = 5.359 pgtxag = 0.012 
  1-way ANOVA Age, WT Fag(2,10) = 4.207 pag = 0.047 
   P13-14 vs. P20-21  p = 0.027 
   P13-14 vs. P28-32  p = 0.857 
   P20-21 vs. P28-32  p = 0.025 
  1-way ANOVA Age, PSD-95 KO Fag(2,10) = 2.204 pag = 0.147 
      
Figure 20: Synaptotagmin 1 uptake assay   
  Two-tailed, unpaired Student’s t-test   
   TCM vs. Control  p = 0.348 
   KCl vs. Control  p = 0.014 
   Sucrose vs. Control  p = 0.210 
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